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DEDICATION
This dissertation is dedicated to dogs, creatures whose presence on earth
immeasurably enriches the lives of their companion humans. It is dedicated to
them in the hope that its content will contribute a tiny bit to the maintenance of
their good health.
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ABSTRACT
This study of c anine hypoadrenocorticis m(canine Addison's disease ; adrena l
l
insu fficiency ) used severa ltechni ques to deter mine the incidence and p reva ence
of the disease and to identi fy factors associated with its occu rrence. These
techni ques were histo irca l; statist ca
i l, inc uding
l

meta a- na y
l sis and

ol gistic

regression ; and epide mio ol gic , inc uding
l
both case series and case contro ldata.
Data were gathered by : extract ng
i the detai sl of cases reported in the veterinary
ilterature , a rudi mentary meta -ana ysis
l
; using data ob tained by Ciba Ani ma lHea tlh
in the c inical
l
trial of the drug microcrysta lline deso xycorticosterone piva al te
(DOCP) ; using data obtained fro mthe Vete irnary Medica l Data Base (VMDB) ,
a data reposito ry of c inica
l
linfor mation fro mco lleges of vete irnary medicine in
the United States -aug mented by direct yl querying VMDBnon p
- articipant co lleges
of vete rina ry

medicine in the Un ted
i States and Canada ; su rveying by mai l

veterinarians enro lled in the Ciba Ani ma l Hea tlh c inica
l
l tria l of DOCP; and
su rveying by ma illO
, OO practicing s ma l lani ma lveterinarians se el cted rando mly
fro mthe ma iling ist
l of the A merican Veterinary Medica l Association.
The historical study focused on how hu mans first recogn ized the existence
of the adrena l g al nds , next unde rstood they were invo ved
l with disease in hu mans
and other ani ma sl , and then deve ol ped methods for identi fying and treating
hypoadrenocorticis m. The histo irca lstudy began with Ga en
l in the second centu y
r
A.D . , continued as hu man understanding expanded overthe centuries , ended with

vi

th econt empo ra ry und erstanding of hypoad renoco tricism , and p rovid ed a cont ext
in which th esp ecific r esults of th es tudy b ecam em eaningfu .l
In cid enc e es timat es for canin ead renal insu ffici ency w ere, d ep ending on th e
data s et us ed to obtain th e estimat e, 0. 1 3 /1 000 dogs y
/ r , 0. 34 /1 000 dogs y
/ r , and
0 .6 /1 0 00dogs y/ r. A point estimat ewas 0. 36 /1 000 dogs y
/ r. Preva lenc e esti mates
w ere 3 .2 /1 000 dogs , 1 .7 /1 0 00dogs , and 0. 6 /1 000 dogs. A point estimat ewas
1 .8 /1 000 dogs.
Estimat es

of th e av erag e ag e (yr) at diagnosis

fo r dogs

with

hypoad renocorticis mw ere 4. 3 , 4.9 , and 5. 4 , again d ep ending on th edata s et. A
point estimat ewas 4.9 . Th eag es of cas es and controls sugg est ed , bas ed on th e
computation of ag e-sp ecific odds ratios (OR) and ol gistic r eg ression , that ag ewas
associated with th e occu rrenc e of dis eas e and that th e p o
r bab ility of dis eas e
inc reas ed with ag e.
Fema ledogs w er e mo relikely to b ehypoadr enal than mal es , and n eut er ed
dogs of eith er s ex w ere mo re il kely than intact on es . Thes econc ul sions w erebas ed
on s ex-sp ecific incid enc e estimat es , s ex s- pecific OR, and logistic r egr ession. Th e
al tt er con firmed

that

s ex

was

a

significant

facto r associat ed

with

hypoadr enocorticis min dogs.
Br eed was , bas ed on b reed -s pe cific ORand logistic r egr ession , a significant
facto rin wh eth ero rnot a dog d ev elop ed ad renal insu ffici ency. Ai redal eT er ir ers ,
Bass et Hounds , Beard ed Colli es , G erman Sh eph erds , G erman Sho trhair ed
Point ers , Gr eat Dan es , Poodl es , Saint Bernards , Sp irng er Spa niels , and West
Vll

High and
l
Whit e T erriers w ere at inc reas ed ris k of dis ease. Boston T erriers ,
Box ers , Coc ker Spani els , Dalmatians ,

Lhasa Apsos , Pit Bu l l T erri ers ,

Pomera nians , Sh etland Sh eepdogs , Shih Tzus , and Yo rkshi reT erriers w ereat
dec reas ed risk. Th erewas l ess comp elling evid enc ethat Lab rado r Retri ev ers and
Mi xed b reed dogs w ereat d ec reas ed ris k.
Av erag ebody w eight (kg ) es timat es fo rhypoad renal dogs w ere 23. 4 , 24. 5 ,
and 19.7 , d ep ending on th edata s et. A point estimat ew as 22. 5. Thebody w eights
of cas es and cont o
r ls sugg est ed , based on ag e-sp eci fic O Rand logist ci reg ression ,
that body w eight was associated with diseas eand that th ep robabi il tyof dis eas e
inc reas ed with body w eight.
Hypoad rena l dogs w erecharact eriz ed by hyponatr emia , h yperkalemia , and
a d ec reas ed rat oi of s erumsodiumto potassiumconc ent ar tions. Point esti mat es fo r
s erumsodiu mconcent ar tion , s erumpotassiumconc entration , and s erumsodiu m
to potass ui m conc en tration ratio w ere 1 3 2. 1 meq/L, 6. 6 meq/L, and 21 . 1 ,
resp ectiv ely. Th erewas evid enc ethat h ypoad renal dogs w eres eldomno rmal fo r
all three diagnostic indicato sr.
Co mmon clinical findings among hypoad rena l dogs w ereano rexia , vo miting ,
d ep ression , w eakn ess , w eight loss , azote mia , and di arrh ea. Though p o
r bably
a ffect ed by

measu rement bias , the re was evid enc e that dogs with ad rena l

insu ffici ency w ere mo re lik ely than dogs from th e g en era l population to hav e
an emia , arthritis , c ruciat e ligament

ruptu re, diab et es

..
v m
.

mellitus , h epatitis ,

hypothyroidis m, ke ratocon unctivitis
j
s cca
i , megaesophagus , myasthenia gravis ,
nephritis , and thro mbocytopenia.
The

study

conc ul ded

that

epide mio ol gic

studies

of

canine

hypoadrenocorticis m may use the practi cing veterin arian s' diagnosis as a case
de finition rather

than

re qu ire

a

s trict

c ase

de fin tion
i

based

on

the

adrenocorticotropic hor mone sti mu ation
l
test. This wou dl produce al rger nu mbers
of cases , be ess
l co mp ex
l , more convenient , and el ss cost y.
l
Logistic regression of data fro mthe ma ilsu rvey of veterinarians e nro led
l in
the c ilnical tria lof DOC Pindicated that age , breed , sex , and body weight were
associated with canine hypoadrenocorticis m. The probabi ity
l of disease increased
with age and body weight , was g er ater in fema es
l than ma les , was greater in
neutered than intact dogs , and va ired with breed. There was mode l-dependent
evidence of higher order inte ractions , but the exact na ut re of these interactions
cou dl not be dete rmined. Models were prepa er d which cou dl predict the relative
probabi il ty of hypoadrenocorticis min different dogs. It was e mphas ized that these
mode sl undoubted yl ove rlooked other unknown variab es.
l
Data fro m the veterina y
r itera
l
ture , VMDB, c inica
l
l t ira l of DOC P, and
su rvey of veterin arians e nrol ed
l in the DOC Pc inica
l
l tria l were all usefu .l The
mai lsu rvey methodo ol gy was va uab
l el , and shou dl be a usefu ltoo lin veterinary
epide mio ogic
l
studies. The mai lsu rvey of randomly se ected
l
veterinarians was a
poor

method for studying an uncommon disease ; this de ficiency

overco me if ar
l ger sa mp es
l were obtain ed .
IX
.

might be

PREFACE
Th e Univ ersity of T enn ess ee (UT) awarded its first Ph D
. . d eg reein 1 886 in
th efield of G en era .l Th eaward of th ePh.D. in G en era lhar kens bac kto th eday
wh en on eindividua lcou dl legiti mat ely al y c ai
l mto at least a rudi ment ary grasp
of a ll hu man know ledg e. That grasp , a fter all, was th e who le pu rpos e of th e
d egr ee .
ThePh.D. in G en era l has sad yl disappeared in th e short 1 1 0 y ears sinc e
1 886. (For t imep erspectiv e, r ememb er that th er eis a lady a ilv ein Franc e--this is
writt en in mid -Feb ruary 1996--who could hav ea ttended the 1 886 graduation as a
s ma ll, but s ent ient , chi d.
l ) Th eG en era ld egr e s' disapp earanc e, and its gradua l
r ep ac
l ement by subs equ ent gen erations of ev er mor e sp eci alized d egr ees , is a
natura l, unavoidab le, and sa uta
l ry cons equ enc eof th e ogarith
l
mic growthof hu man
know ledg e in th e last c entu ry. No san e p erson today wou dl c ai
l m ev en th e
sha llow est , most t enuous grasp of al lhu man know led ge, and that is as it shou dl
b e. A sing le hu man brain can co mpr eh end only so much. But th e in evitab le
transition fro mG en era lto v ery , v ery s peci alized has co meat a pric e, in on es ens e
an unacc eptab yl high pric e.
It s eems that th ei mpossibility today of mast er ni g ev en a tiny part of hu man
know led gehas b eco mea conv eni ent excus efor avoiding th e effort entir ely . Whil e
mast ery is i mpossib le, and failur e to do so is not caus e for d espond ency or
opprobriu m,

making th e effo rt is n ev erth eless worthwhi le and

ess ent ai l to

mean ngfu
i
lscho arship.
l
Whil eth eorig nal
i goal of th ePh.D. d egr ee, i. e. , mast ery
X

of all human knowledge, may be unattainable, the goal's pursuit is not. Those who
do not pursue the goal, and particularly those who are contemptuous of its pursuit,
show disrespect for the very Ph.D. degree they have or covet.
With the foregoing in mind,

I feel very fortunate to be enrolled in the

Comparative and Experimental Medicine program, a program specifically defined
by its interdisciplinary character. Therefore, while I recognize that this thesis is
and should be principally about science, I hope that it is a bit more. I hope I have
not been guilty either of "scientific hubris"• or the "ignorant barbarism of
scientific progress. nb I have tried to conduct and report good science, but to do
so in an historical and interdisciplinary context. I hope that the thesis melds my
admittedly limited knowledge of clinical veterinary practice, endocrinology,
epidemiology, the philosophy of causality, the mail survey methodology of the
social sciences, and statistics. I hope it demonstrates an effort, however inevitably
unsuccessful, to achieve the original goal of the Ph.D. degree.

•william F. Buckley, Jr., "Firing Line," November 1 2, 1995 , WSJK
Television, Channel 2, Public Broadcasting System, Sneedville, Tennessee.
bWilliam Hamilton, "Morning Edition," June 9
FM, National Public Radio, Knoxville, Tennessee.
.
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, 1995 , WUOT Radio, 9 1 .9
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CHAPrERl

A BRIEF IDSTORY OF HYPOADRENOCORTICISM

Introduction
Hypoadrenocort ci sm
i has almost certa nly
i a fflicted humans and other an mals
i
s ni ce they first evolved , but the d sease
i
was not w el -defined
l
unt li about 15 0 years
ago , and the deta ls
i of ts
i phys ology
i
, d agnos
i
si , and therapy were not understood
or developed unt li the 2 0th centu ry. n
I fact , defin itive therapy was not ava lable
i
unt li the 1 950s .
The follow ni g si a br ef
i h story
i
through the early 195 0s of how understand ni g
o f the d sease
i
evolved over the decades. The h story
i
ends w th
i the early 195 0s
because , though knowledge about the adrenal glands has ce rta ni ly advanced
substant ally
i
s ni ce then , the advances can generally be character zed
i
as
refinements , such as improved synthet ci co rticostero ds
i and improved cl ni cal
i ca es
management , rather than altogether new advances. The art cles
i
rev ewed
i
and
c

ni cluded ni th si h sitory , though ve ry numerous and qu te
i comprehens ve
i , do not
�e one area ni wh ch
i substant al
i new contribut ons
i have , ni fact , been made
s ni ce the early 195 0s si understand ng
i the et ology
i
of hypoadrenocort ci sm.
i
tIs
141
i ple
i cause appears to be mmune
i
-med ated
i
des truct on
i of the adrenal co rtex ,
pr nc
and , s ni ce the field of m
i munology si so complex and has progressed so much
s nce
i the 195 0s , a d scuss
i
on
i of the h story
i
of progress ni m
i munology si well
beyond the sco pe of th si thes si . Thus ti has not been ni cluded.
1

p er tend to be e xhaust ve-i
.ie. , many , many a rt cles
i
a er not included -but the
i
lte ra ut re reviewed d oes paint a clear pictu er of the scienti fic p o
r g er ss which
er sulted in our knowledge of the disease today. This chapte r focuses on the
g ar dua l , stepwise unfolding of knowledge of hypoad er noco rticis m, and also , since
many otherdiseases we er b eing si milarly characte ir zed du ring this pe riod , it se rves
as a model fo rhow " mode m medicine" studied disease p o
r cesses in gene ral.
This chapte rd oes not focus on the disease in dogs since the following chapte r
is a histo ry of clinical cases in the dog fro m the first er ported cases in 1953
th rough 199 4. Neve trheless , dogs and oth eran ima sl are fre quen tly mentioned since
they we er used extensively as labo rato y
r an imals , and so me info rmation of inte er st
to p ar cticing vete irn arians is included if it is not b o
r ught ou tin the next chapte r.

Early Period
Galen , in about 177 A.D . , while describing the veins wh ci h enterthe caudal
vena cava , refe rred to "A twig fro mth si not inconside rable vein [p robably the le ft
ph er nic ] joins and connects with the spongy flesh lying the re . "106 The "spongy
flesh "is clearly the ad er nal gland. Bartolo meo Eustacchio desc irbed the ad er na l
glands in 1563 as "glandulae Ren bus
i
incu mbentes. "223 His work was

first

publ shed
i
in 17 1 4 by the Italian clin ci an
i Lanc si
i , who added h si own notes. 223
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Edward Tyson (165 0-17 08�, an Eng lish phys ci an
i , stated that " Glandulae Renales
1
n
i Emb ryos and Infants are greater , at least proport onably
i
, than in Adultis. "31
These "Glandulae Renales" were , of course , the adrenal glands , and ti si
ni terest ng
i to note that Tyson recogn zed
i the d ff
i erent proport oi ns of the adrenals
ni adults and ni fants -i.e. , he recogn zed
i that an ni fant was not s mply
i
a m ni ature
i
adult. 131 This could be viewed as an earl er
i , adm ttedly
i
very c rude , phys oi log ci
obse rvat on
i about the funct on
i of the adrenal glands. With regard to domest ci
an mals
i
, August Chauveau (1827 -1917 ) desc ribed "The Supra-renal Capsules" ni
deta l.i 21 Notably , Chauveau also used the word "adrenals" when refe rring to these
organs , and he recogn ized the d fiference between "the cortical and the medullary

substance."21 Two other early vete rinary anatomy books also descr bed
i
the gross
anatomy of the adrenal g ands
l
, both comment ni g on the ri ductless nature. 198.241 One
of these sources stated , ni teres tingly , but wrongly , that the adrenal glands are "sa di
to be replaced fi removed. "241

First Descriptions of Disease
Thomas Add son
i , M.D. (1793 -186 0 ) , an Eng lishman educated ni med ci ni e
ni Scotland at the UDivers ty
i of Ed nburgh
i
, was a d st
i ni gu shed
i
phys ci ai n of h si
tm
i e w th
i very eclect ci talents. He worked ni surgery , dermatology , to xicology ,

dJul an
i , not Gregor ai n , calendar.
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pathology , anatomy , and physiology. He wrote the first English language book on
the actions of poisons on the l v
i ing body in 1 829 , was first to use sta tic electrici ty
to treat convulsive disease in 1837 , and described ap pendicit si in 1 839. In 18 49
he described a pe rnicious anemia and a disease of the suprarenal capsules (adrenal
glands ) in a pa per to the South London Medical Socie ty. Addison felt that he had
indeed described the disease for the first ti me , although he did so humbly ,
recogni zing that he could be fa lling prey to the "bias and pre udice
j
inseparable
from the hope or vani tyof an original discove ry. "This "Addison's anemia "was
described as "a state of gene ral ane mia incident to adult males. ne,I
Six years later , in 1855 , Addison published a much more detailed account of
the disease which included deta led
i case repo rts , autopsy findings , and sketches of
patients and their organs. He described clinical hypoadrenocorticism (not the term
used then , of course ) with remarkable acumen , and (refreshingly ) the tone of his
writing put the disease in the context of a "philoso phic"view of medicine and the
pursuit of knowledge , not in a cold , steri el scientific context. Addison prefaced his
paper as fo llows :

�ough now recogn ized as more o ften a condition of females , Addison s'
obse rvat on
i that the disease occu rred more o ften in males may , specula tively , have
resulted from chance alone , fro mmales see king medical attent on
i more o ften , or
from occupat onal
i
exposure by males , especially since tuberculosis was , though
not recogni zed as such at the time , a p rincipal cause of the disease. Other
explanations , of course , are possi ble.
4

If Pathology be to disease what Physiology is to health, it appears reasonable
to conclude, that in any given structure or organ, the laws of the former will
be as fixed and significant as those of the latter; and that the peculiar
characters of any structure or organ may be as certainly recognized in the
phenomena of disease as in the phenomena of health. . . . it is as a first and
feeble step towards an inquiry into the functions and influence of these
organs [the adrenal glands]. . . that I now put forth the following pages. r,2
Addison described the condition with incredibly remarkable accuracy:
The leading and characteristic features of the morbid state to which I would
direct attention, are, anaemia, general languor and debility, remarkable
feebleness of the heart's action, irritability of the stomach, and a peculiar
change of colour in the skin, occurring in connexion with a diseased
condition of the "supra-renal capsules.". . . Notwithstanding these
unequivocal signs of feeble circulation, anaemia, and general prostration,
neither the most diligent inquiry, nor the most careful physical examination,
tends to throw the slightest gleam of light upon the precise nature of the
patient's malady: nor do we succeed in fixing upon any special lesion as the
cause of this gradual and extraordinary constitutional change. 2
Given some updating to a modem-day medical vocabulary, this could easily serve
as a contemporary clinical description of hypoadrenocorticism. Addison's careful
description of and observations on the 11 clinical cases reported in his article
clearly qualify as classics in medical history.
Forty-one years later, in 1896 , no lesser personage than William Osler added
his imprimatur to Addison's findings. He said, "Recent studies render it very
probable that the original view of Addison is correct--namely, that the symptoms
of the disease are caused by loss of function of the adrenals. "144 Osler discussed
six of his own cases of Addison's disease, and, importantly, put the disease in the

Whatever happened to prose like this in the scientific literature?
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context of other conditi ons , su ch as thyr oid mal fun cti ons , whi ch unders cored ''the
imp ortan ce of the du ctless glands. "144 Notably , three of Osler s' six pa tients had
tuber culosis , and five of the six died , but one was apparently cured by treatment
with p or cine suprarenal extra cts .144
During the same era , a veterina ry physi ol ogy text stated , "The Renal
Capsules [Bold in origina l] have been supp osed to be conne cted with the removal
of wo rn-out pigment fr om the b ody , but their fun ction is involved in myste ry. " 199
This p oints out a pr ominent hyp othesis of the time whi ch was that the adrenal
glands were inv olved in s ome s ort of det oxifi cati on . While m ore than a half 
cen tury would pass bef ore a clini cal case was rep orted in the dog ,68 th si text
re cognized that , "In d ogs and other animals , the effe ct of rem oving these glands
has been the produ cti on of pr of ound degeneration in the central ne rvous system ,
f ollow ed by death ."199

Adrenal Glands Recognized as Essential to Life and
Early Anatomic and Physiologic Studies
Th ough Addis on and Osler , as clini cians , felt that the adrena lglands were
essential to life , this had st ill n ot been ascertained with s cientifi c certitude .
Theref ore , resear chers studied whether or n ot these glands were essential , and , if
s o, why , for about a qua rter- centu ry , from r oughly 1 900 until 1 925. The sear ch
for definitive answers was made a pa rticularly difficult one because , in addition
6

to the crudity of physiologic and surgical studies of the day, the adrenal glands
were, of course, comprised of two parts, the cortex and the medulla, with,
unbeknownst to the researchers, completely different physiologic roles. Adding
further to the complexity were the facts that the cortex itself, again unbeknownst
to the researchers, had several different physiologically important products, and
that some species, due to the presence of accessory adrenal tissue located
elsewhere in the body, could occasionally survive bilateral adrenalectomy.
Many studies demonstrated during this first quarter of the twentieth century
that animals which were bilaterally adrenalectomized died. 39•102•132.156-ISS,210.213.214.243
One study, trying to experimentally mimic Addison's disease, showed that tying
the adrenal veins in cats eventually led to death, but death ensued more slowly
than in bilaterally adrenalectomized animals.72 One study demonstrated that
bilateral adrenalectomy in the goat was not necessarily fatal, 132 while another
indicated that in cats bilateral adrenalectomy "practically always" led to death.39
These survivals after bilateral adrenalectomy presumably resulted from the
presence of accessory adrenal tissue elsewhere in the body, or possibly from
incomplete surgical excision of the glands. One report documented the survival of
a bilaterally adrenalectomized cat because of the presence of accessory adrenal
tissue. 254 In any case, early in this period, the absolute biological requirement for
functioning adrenal glands was still in question. By about 1925 , however, the issue
was pretty well settled, and the conclusion was reached that adrenal glands were
indeed necessary to life.15•82•209•254
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Although it was clearly understood by the end of this quarter-century that the
adrenal glands were necessary to life, why they were necessary was not understood
at all. The hypotheses posited about why they were necessary included that they
were related to some vaguely defined "nervous influences" associated with the
glands,214 that the glands were essential to the detoxification of certain substances
i n the body,61•118.213.214,243 that they produced a substance necessary to life,214 that
they were involved in some essential way in muscle metabolism, 243 and that they
played an active role in antibody production.61 One quote from this period
illustrates just how wrong a statement of scientific certitude can be. It said that the
adrenals have two functions: " an antitoxic, protective function accomplished by the
internal secretion of cholesterol of cortical origin, and the other the tonic effect of
adrenalin of medullary origin. " 118 Regardless of this erroneous certainty, the lifemaintaining function of the adrenal glands was not defined during this period, and,
as illustrated in the preceding quotation, the epinephrin produced by the adrenal
medulla caused a good deal of confusion. 8
The physiologic role of the adrenal glands was extraordinarily bewildering
i n large part because of the adrenal medulla and its physiologically powerful
secretion epinephrin. Researchers, faced with this extremely powerful vasoactive

'Ironically, though the author of the quotation was quite wrong about the life
sustaining role of the adrenal glands, he was prescient in one sense-he did contend
that the adrenal cortex and the adrenal medulla had separate functions. In that
respect, he stumbled, perhaps accidentally, perhaps not, onto the truth.
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hormone, quite naturally looked for years and years to discover how epinephrin
from the adrenal glands was key to life. It was not, of course, so the research
community was led astray for a long time. Several papers were published which
indicated the (quite predictable and logical) focus on epinephrin.72,209.21 l.242
Eventually, researchers, still understanding of course the physiologic power of
epinephrin, recognized that adrenal medullary epinephrin was not the key to
survival. 103.212 One paper, after reviewing the assertions of others regarding the
role of epinephrin in carbohydrate metabolism, said with forthright lucidity:
Although not one of these statements is true, the theory has possessed a
charm from which many have not been able to free themselves, and it has
also been productive of work which has shown the matter in its proper light.
. . . The theory that epinephrin causes a production of sugar from fat,
decreases the power of the organism to oxidize glucose through inhibition of
pancreatic function, and stimulates the thyroid so that protein metabolism is
increased, is untenable in any of its particulars. h.103
Researchers eventually realized that the adrenal cortex, rather than the adrenal
medulla, was the part of the adrenal glands essential to life.i• 15•82.212.243.254

hAnother

example of the refreshing use of language in a scientific article.

i'fwo fascinating historic notes from this period follow. First, a purportedly
pathognomonic diagnostic test for hypoadrenocorticism was described in 1917
which involved tracing a geometric pattern on the abdomen of the patient with a
blunt object such as a fountain pen. If a pale white line appeared which became
more distinct over a period of about one minute, and then disappeared in one to
three minutes more, the patient was hypoadrenal. 191 Second, in 1 9 19 in the wake
of the influenza pandemic of 1918 , one paper claimed that dysfunctional adrenal
glands were involved in influenza and influenza! pneumonia, and that, in fact, the
severity of the influenza was proportional to the endocrine dysfunction .25

9

The Fundamentals: Adrenal Cortex,
Anterior Pituitary, and Hypothalamus
Having concluded that the adrenal cortices, not the adrenal medullae, were
necessary to sustain life, the research community next tried to determine
specifically how the adrenal cortices helped maintain life. An obvious possibility
was that some substance required for life was being secreted by the adrenal
cortices. Pursuing this hypothesis, a bevy of researchers extracted various fractions
from the adrenal glands, and used the extracts to attempt to maintain the lives of
bilaterally adrenalectomized animals.j,73.Z19 Extracts of tissues other than the
adrenal glands such as brain, testes, liver, spleen, and heart were used in attempts
to extend the lives of experimental animals with adrenal insufficiency, 1 6 as were
other physiologically active chemicals
ephedrine. 16

These

extracts

and

such as pituitrin,

chemicals

all

failed

to

ergotamine,
sustain life

and
in

adrenalectomized animals. One paper, intriguingly, reported that the survival time
of four bilaterally adrenalectomized female dogs was significantly extended
because they were in heat. 160 This "adrenocortical effect" of the estrogenic
hormones gave a hint,

apparently unrecognized at the time, of the often

jOne quotation from this period illustrates how very crude the surgical
techniques being used at that time were: "It is never permissible for an
experimenter with an inadequate [surgical] technique to assume that his operations
will be of a uniform degree of badness [Italics added] in a control set of animals
and in a set subjected to a certain procedure, the effect of which is to be tested,
so that this factor can be considered as eliminating itself. " 161
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overlapping physiologic effects of the steroid hormones. This result led these
researchers to use only male dogs in the study of adrenocortical extracts. Another
study confirmed that bitches in heat survived adrenalectomy longer than those not
in heat, but also showed that luteal extracts did not similarly extend life. This same
study demonstrated that in cats, but not in dogs, anterior pituitary extracts
extended life in adrenalectomized animals (presumably, based on present-day
knowledge, because of the presence of some accessory adrenocortical tissue), and
that, in rats, growth hormone from the anterior pituitary did not.2 1 6 This began to
show an acknowledgment of the interplay between the anterior pituitary and the
adrenal cortices.

Another study found that progesterone would

maintain

adrenalectomized ferrets in ''excellent health. " 62 This contradicted (unless one
posits a species difference) at least one other study which showed that progesterone
did not extend the life of adrenalectomized cats.216 The authors suggested that this
apparent discrepancy probably resulted from the use of different dosages of
progesterone.62 In any case, this clearly illustrated again that researchers were
gradually realizing the often overlapping physiologic effects of the steroid
hormones.
Having established that adrenocortical extracts of one sort or another would
sustain the life of adrenalectomized animals, the researchers naturally turned to the
next issue, which was

what specifically in the extracts sustained life. Several
11

papers discussed the isolation and efficacy of compounds isolated from
22
7
adrenocortical extracts or their synthetic analogs. 1 •196.20 .228 These extracts or
synthetics were then, of course, used to treat humans with adrenal insufficiency,
sometimes successfully and sometimes not,

and to maintain the life of

adrenalectomized experimental animals. 22•48•94•126•197•227•236
By 1 9 40 , as pointed out in a review article discussing the diagnosis and
treatment of adrenal insufficiency,

the

synthetic

crystalline corticosteroid

desoxycorticosterone acetate (DOCA) was the most sophisticated therapeutic agent
of the day. It was efficacious and available in large quantities at reasonable cost.224
The DOCA could be injected intramuscularly or implanted subcutaneously as
pellets. 7•230 Successful sublingual administration of DOCA dissolved in propylene
glycol and alcohol was also reported.'
Advances in knowledge in this area were fascinating. First, the determination
that the adrenal cortices were required for life; second, the determination that
extracts from the adrenal cortices and their synthetic analogs could sustain life in
adrenalectomized animals; third, the purification in crystalline form of components
of the extracts; and, last, the preparation of synthetic DOCA in large quantities at
reasonable cost. While use was made of both the purified adrenal extracts and
synthetic DOCA, as time went on more of the latter was used to treat human
Addison's disease.
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Despite

these

rapid

advances

in

understanding

and

treating

hypoadrenocorticism , therapeutic results were still not entirely satisfactory. Though
DOCA , often combined with the administration of sodium chloride to help
alleviate sodium loss ,t was reasonably effective therapy , there were continuing
problems related to an ill-defined failure in their "carbohydrate -regulating
capability , "226.235 and some required treatment with cortical extracts in addition to
DOCA. 172 Although unknown at the time , this resulted from the powerful
mineralocorticoid effect , but very weak glucocorticoid effect , of DOCA. (The
words " mineralocorticoid .. and glucocorticoid were not , of course , in use during
11

11

this period. ) Gradually , however , researchers began to realize that the adrenal
cortices produced two distinctly different types of corticosteroids , one with an
electrolyte -regulating function Oater to be known as mineralocorticoids ) , and a
second with a carbohydrate -regulating one Oater to be known as glucocorticoids ).
A study in 1940 showed that Addison's disease patients with low normal fasting
blood glucose values , an increased tolerance for hypoglycemia , and a low normal
basic metabolic rate were non-responsive to DOCA , but responsive to 17 -hydroxy 11 -dehydrocorticosterone and corticosterone.238 Another study demonstrated the
effects on carbohydrate metabolism in adrenalectomized dogs of crystalline 17 -

klJse of this exogenous sodium chloride sometimes led to hypertension , edema ,

and even heart failure. These problems were occasionally attributed to the
concomitant use of DOCA since the now well -known connection between
hypertension and high salt intake was not well understood at the time.247
13

hydroxy- 1 1-dehydrocorticosterone isolated from an adrenal cortical extract.96 These
studies presaged the distinction between mineralocorticoids and glucocorticoids.
By 1 946 it was reasonably clear that both glucocorticoid and mineralocorticoid
treatment (though, again, these words were still not in use) provided the best
therapy for Addison's disease. Specifically, one article stated,
In most patients [ 1 1-dehydrocorticosterone] therapy alone . . . failed to effect
a significant change in the clinical condition. When . . . [ 1 1 dehydrocorticosterone] was added to . . . desoxycorticosterone acetate . . . ,
a striking improvement over and above that observed
with
desoxycorticosterone acetate alone was observed. 57
By 1 949 the idea that treatment should consist of cortical extract for its
glucocorticoid effect and DOCA for its mineralocorticoid effect had found its way
into a medical textbook.206 Notably, this textbook also indicated the need for
sodium chloride therapy as well, and commented that 1 1-dehydrocorticosterone
(described as a " carbohydrate-active hormone") could also be used, but that there
was still no source of it for general clinical use. This textbook also recognized that
Addison's disease could sometimes be part of a multiglandular disease involving
the pituitary, thyroid, gonads, pancreas, thymus, and, perhaps, parathyroid. The
relationship between Addison's disease and other endocrinopathies had been

1Sodium chloride could be given in normal food, per os as a supplement,
intravenously, and even per rectum. One paper stated that "In a typical [Italics
added] case of Addison's disease, the symptoms of severe adrenal insufficiency
were relieved by treatment consisting of the administration of NaCl by mouth and
by rectum. 101
14

reported earlier. One report of a man with concomitant Addison's disease and
diabetes mellitus noted that these diseases had often been reported simultaneously
in the same patient.225
The present-day terms glucocorticoid and mineralocorticoid were in use by
1950. One review article of that year used both these terms, and also made several
other important points. 18 1 It said that,

although the exact active natural

adrenocorticoids had still not been defined chemically, their physiologic roles, such
as glucocorticoid and mineralocorticoid, had been. Further, the article said that,
though the exact roles of the zona glomerulosa, zona fasciculata, and zona
reticularis had not yet been defined, they might have distinctly different roles. This
paper also recognized the physiologic interplay between the anterior hypophysis
and the adrenal cortices. The idea that the adrenal cortices produced at least two
distinctly different kinds of hormones, glucocorticoids and mineralocorticoids, was
controversial.

Some

believed

that

only

one

corticosteroid,

17-

hydroxycorticosterone, was required. But a further study discussed the secretion
of a salt-retaining hormone by the adrenal cortex. 195
So, by the end of the 1940s, the idea was established that the adrenal cortices
regulated electrolyte, carbohydrate, protein, and fat metabolism . The recognition
by researchers and physicians of this functional duality was reflected in several
publications.66,23 1

,232 .234

One article even specifically identified the zona glomerulosa

of the adrenal cortex as the source of desoxycorticosteroids which regulated fluid
15

and electrolyte balance, and the zona fasciculata as the source of 1 1-oxy
corticosteroids which regulated gluconeogenesis. 66 Papers emphasized the
physiologic effects of the "carbohydrate-regulating" corticosteroids5•ss,229 and the
effects of "electrolyte-regulating" ones. 17•23•47•125•151.229.237 During the decade of the
1940s, some elucidation of the physiologic interplay between the anterior pituitary
and the adrenal cortices occurred.
Two papers in 1943 described the isolation of pure adrenocorticotropic
hormone (ACTH), one isolation from the anterior hypophyses of sheep,97 and
another from pigs. 182 The physiologic and therapeutic effects in humans of ACTH
included those on blood and blood constituents, 58•76 electrolytes,58 metabolism,58
androgens,58 and urine,58 as well as those on normal humans and those afflicted
with Addison's disease, Cushing's disease, and hypothyroidism.154 By the early
1950s, adrenal cortical insufficiency had been clearly classified into primary and
secondary disease. Thorn's article in 1951 reported, "Adrenal cortical insufficiency
may occur as a result of disease of the adrenal gland itself (primary) or as a
consequence of inadequate secretion of ACTH due to anterior pituitary or
hypothalamic

disease

(secondary). "233

Therefore,

by

the

early

1950s,

hypoadrenocorticism was understood as a disease related directly to the adrenal
cortices or indirectly to the anterior pituitary or hypothalamus. The control
mechanism for the adrenocorticoids was shown, however, to be more complicated
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than a simple feedback loop between the anterior hypophysis and the adrenal
cortices.
Steinbeck described three major mechanisms regulating ACTH and, hence,
adrenocorticoid

secretion.208

The

three

were

negative

feedback

from

adrenocorticoids, circadian rhythm, and stress; the latter two, significantly, were
mediated through the hypothalamus. The hypothalamus released corticotropin
releasing hormone which stimulated the anterior pituitary to release ACTH, the
ACTH stimulated the release of adrenocorticoids from the adrenal cortices, and
these adrenocorticoids then controlled further secretions by the hypothalamus and
the anterior pituitary. 150 This relationship between the central nervous system and
the adrenal cortices is one mechanism whereby altered emotional and psychologic
states are translated into altered physiologic function.223 Stresses such as pain,
trauma, and anxiety could lead to this stimulation of adrenocorticoid release by the
central nervous system. 37
The historical treatment of Addison's disease138 pointed out that cortisol had
been shown to be a major product of the adrenal cortex in man and dog, 139•140 that
aldosterone was a major salt-retaining hormone secreted by the adrenal cortex, 195
and that the adrenal gland produced androgenic substances.60 Consequently, "the
three major types of adrenal hormones produced were [by 1952] represented by
specific hormones: glucocorticoids-cortisol, mineralocorticoids-aldosterone, and
the androgens, androstenedione and dehydroepiandrosterone, which are converted
17

to testosterone to produce their androgenic effects. " 138 By the early 1950s, the
fundamental physiology and control of the adrenal cortices were understood. It
involved the secretion of glucocorticoids, mineralocorticoids, and androgens by the
adrenal cortices under the control of the anterior pituitary and the hypothalamus.
Interestingly, just as these fundamentals were first clearly understood, the
veterinary profession reported the first three clinical cases
hypoadrenocorticism. 68
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of canine

CHAPfER 2

REVIEW OF 244 CASES OF NATURALLY OCCURRING
CANINE HYPOADRENOCORTICISM REPORTED
BETWEEN 1953 AND 1994

Introduction
Hypoadrenocorticism

(Addison's

disease,

adrenal

insufficiency,

adrenocortical hypofunction) was first described in the dog in 1953 .68 It is thought
to be an uncommon disease. 41•43 Clinical signs of disease include vomiting,
anorexia, weakness, depression, weight loss, diarrhea, and dehydration. These
signs result from a deficiency of mineralocorticoids, glucocorticoids, or both.
Hypoadrenocorticism can be classified as primary or secondary. In primary
hypoadrenocorticism, the adrenal glands fail to produce enough glucocorticoids,
mineralocorticoids, or both. It may be caused by granulomatous diseases such as
histoplasmosis and blastomycosis, hemorrhagic infarctions, cancer metastases,
amyloidosis of the adrenals, intoxication, and treatment for hyperadrenocorticism
withtheadrenocorticolyticdrug2,4'-dichlorodiphenyldichloroethane(o,p'-DDD).41
Immune-mediated destruction of the adrenal glands occurs in human beings, and,
though it has not been definitively demonstrated, it may also occur in dogs. 41 The
cause of adrenal failure is usually not identified, so it is classified as idiopathic.41
In secondary hypoadrenocorticism, decreased secretion of adrenocorticotropic
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hormone (ACTH) by the pituitary or corticotropin releasing hormone by the
hypothalamus leads to decreased glucocorticoid production.4 1 It can be associated
with neoplasia, inflammation, and trauma.4 1
The diagnosis ofhypoadrenocorticism is based on histopathology,9•13.27•36•59•68•
83•92• 133• 134• 163•1 71 • 176• 184• 194,222.246

either high serum potassium concentration or low

serum sodium concentration or both
193'222 ,24•4 246

'

10,1 1 , 14,26,27,42,43,59,10,75,86,87,104,105,n9,134,135, 142,152,153,

and a low plasma cortisol response to ACTH stimulation. 12•20•28•42•45•46•

95,104·tos,t27,IS2,t5S,t7 1 • 1 83• 1 84,244.246

Definitive diagnosis· is demonstrated by a lack of

adequate plasma cortisol or aldosterone response to ACTH stimulation. 95•104•105
Treatment consists of administration of glucocorticoids and mineralocorticoids as
required to reestablish physiologic homeostasis.
This chapter reviews 244 naturally occurring (non-iatrogenic) cases of canine
hypoadrenocorticism reported in English language journals between 1953 and
1994.

Methods

Forty-six reports (Table 2. 1 ) in the English language of naturally occurring
canine hypoadrenocorticism were reviewed for ages, sexes, breeds, diagnostic
methods, serum potassium and sodium concentrations, and clinical findings. One
report was excluded from the review because the cases reported were biased by
selection of only hypercalcemic cases from a larger pool of cases. 147 Thirty-five
of 48 cases were excluded from another report because they were reportedly of
20

Table 2.1. Number of Cases Reported, Average Ages, Sexes, Breeds, Diagnostic Methods, and Mean Serum Sodium (Na +) and Polassium (K+) Concentrations of 244 Reported Cases of
Naturally Occurring Canine Hypoadrcnocorticiam
ACTH atim
ACTH stimulation test
EKG
electrocardiogram
F
female·inlact
FS
female-spayed
M = male-intact
=

=

=

=

Year
of
report

N

......

Author of report•

MC = male-castrated
Na + IK + "" diagnosis by serum sodium or polassium concentration,
or the ratio or sodium to polassium
NR
not reported
Path = gross and/or microscopic pathology
=

No. of
cases
reported

Average
ages
(yr)

Sexes (number)

Breeds (number)

Diagnostic methods (number)

NR (3)

Path (3)

Meao Na+

Meao K+

NR

NR

120

8.5

(meq/L)

(meq/L)

1953

Hadlow"

3

3 .2

FS(2),M(1)

1960

AMis'

2

4

F(l)

Welsh Corgi (1)

Eosinophilia(l);Na + IK + (1);
urinary steroids(l)

1960

Marshak et al.119

1

3.1

FS(2)

Cocker Spaniel (1); Mixed (1)

Path (2)

NR

NR

1961

Ditchlield et a1.34

1

4

FS(I)

German Shepherd (1)

Path (1)

NR

NR

1962

Howell et al.'1

1

6

M(1)

Cocker Spaniel (1)

Path (1)

NR

1965

Kelly91

1

6

F(l)

Boxer (1)

Path (1)

NR

NR

1

12

M(1)

Mixed {1)

Path(1)

NR

NR

1966

R.othenbacher et o.l.16'

1967

Siegel et al.'94

1

3

F(1)

Beagle (1)

Path(1)

NR

1968

Nimmons et al.141

1

3

M(l)

West Highland White Terrier(l)

Na+IK+(1); urinary chloride(1)

136

7.0

1968

Siegel'"

1

5 .5

M(1)

Mixed (1)

Na+IK+(1); path(1); urinary
ateroids (1)

NR

NR

1968

Theranm

1

2

M(l)

Saint Bernard (1)

EKG (1); NA+IK+ (1); path (1)

1970

Morales et al.1:u

2

2.5

F(1),FS(1)

German Shepherd (I); Gordon
Setter (1)

1971

Bonneau et al."

1

2

F(1)

1971

Mulnix134

8

4 .6

NR
NR

130.5

8.2

Path (2)

NR

NR

Poodle (1)

Na+IK+ (I)

126

7.2

F(2),FS(5),
MC(1)

Beagle {1); Irish Terrier (1);
Manchester Terrier (1); Mixed
(1); Springer S aniel (2); Poodle
(1); West High and White Terrier
(1)

EKG (3); Na+IK+ {8); path (3)

132.6

7.1

German Shepherd (1); Labrador
Retriever {1); Mixed (1); Poodle
(1); Saint Bernard (1)

EKG (2); hemogram (3);
Na+IK+ (S)

1 19 .3

6.7

139

8.0

1972

Keeton et al.''

5

3 .2

F(3),FS(1),M(1)

1972

de Lahunta11

1

3

F(l)

�

Mixed (1)

EKG (I); Na+IK+ (1); path (1)

Table 2.1 (continued)

Year

of
report

N
N

Author or report•

No. or
cases
reported

Average
ages
(yr)

Sexes (number)

Breeds (number)

Diagnostic: methods (number)

�

Mean Na+

Mean K +

(meq/L)

(meq/L)

130.5

7.1

NR

NR

NR

NR

1973

Fox et at."

2

4.3

FS(2)

Brittany (I); Dalmatian (I)

Eosino ilia (2); Na+IK+ (I);
path (1 ; urinary steroids (I)

1974

Sanger et at.'"

I

2.5

M(l)

German Shepherd (I)

Path (I)

1975

Musselman'�

I

3

F(l)

Mixed (I)

1975

O'Rourke10

2

4.5

FS(2)

Mixed(2)

Na+IK+ (2)

127

1.5

1976

Harlton10

1

4

M(l)

Poodle (1)

Na+IK+ (1)

1 14

6.0

1977

Feldman et al.''

II

4.3

F(3),FS(4),M(4)

133.1t

6.8t

19n

Feldman et al.02

I

4

FS(1)

1 19

8.6

1978

Bath et al.11

3

4.4

F(I),FS(2)

121.3

7.2

1978

Feldman et al.'"

8

4.1

F(1),FS(4),M(3)

NR

NR

1978

Reimers et at

..,,

2

8.5

F(1),FS(1)

1979

Atwell et al. 10

I

7

M(1)

Mixed (1)

1979

Crensbaw215

1

6

FS(I)

Mixed

1979

Hil11'

5

4.5

F(I),FS(3),M(1)

Kelpie (I); Mixed (3); Welsh
Corgi {I)

1980

DiBartola21

3

3.7

F(1),FS(1),M(I)

Mixed (I); Poodle (1);
Weimaraner (I)

1980

Murrell'"

I

s

F(l)

1980

Willard'"

1

6

FS(I)

3

6.7

1981

•

Rogers et ai.U'

FS(I),M(2)

EKG (I); urinary steroids (1);
water-loading test (I)

German Shepherd (I); Golden
Retriever (2); Great Dane (2);
Mixed (I); Poodle (3); Samoyed
(1); Schnauzer (1)

ACI'H stim (1 1)

Australian Terrier (I)

Na+IK+ (I); plasma ACI'H (1)

Mixed (2); Welsh Corgi (I)
German Shepherd (I); Golden
Retriever {1); Great Dane (1);
Irish Setter (I); Mixed (2);
Poodle (I); Samoyed (I)
Cockapoo (1); Poodle (I)

ACI'H stim (I); EKG (1);

�

H oglycemia (I); Na+IK+ (3);
pa (1); uremia (1)
ACI'H stim (8)

EKG (2); NA+IK+ (2)

120

8.8

132

9.3

1 33

7.4

121.6

7.4

EKG (3); ACI'H atim (1)

122

9.5

Mixed (1)

NA+IK+ (1)

124

6.4

Mixed (1)

ACTH atim (I); Na+/K+ (I)

126

5.0

1 44.7

4.6

(1)

Poodle (1); Pointer (I); Wheaten
Terrier (1)

EKG (1); eosinophilia (I);
hemogram (1); NA+IK+ (1);
uremia (I)
Na+IK+ (1); uremia (1)
Na+IK+

(S)

ACTH atim (3)

Table 2.1 (continued)
Year

or
report

N

IJ.J

Author or report•

No. of
cases
reported

Average
ages
(yr)

Sexes (number)

1982

Willard et a1.244

37

4.2

F(6),FS(l9),
M(7),MC(5)

1983

Schaer et at ..,

13

4.5

F(3),FS(3),M(7)

1984

Rakich ct at.1SJ

23

4.1

F(4),FS(12),
M(4), MC(3)

1985

Auge11

1

5

1985

Ruben et at.171

I

1986

Schaer et at.•M

1987

Breecb (number)

Diagnostic methods (number)

Mean Na+
(meq/L)

Mean K+
(meq/L)

129

7.4

140,4

6.2

NR (37)

ACI'H atim (16); Na+IK+ (17);
path (4)

Boston Terrier (I); Cocker
Spaniel (I); Dachshund (I);
Doberman Pinscher (3); German
Shorthaired Pointer (I); Irish
Setter (I); Mixed (I); Poodle (2);
Schnauzer (I); Whippet (I)

ACI'H slim (13)

Mixed (5); NR (18)

ACI'H stim (18); Na+IK+ (17)

131

7.0

M(l)

Poodle (I)

EKG (I); Na+IK+ (I)

1 16

8.4

0.2

F(l)

Lhasa Apao (1)

ACI'H atim (I); path (1)

NR

3

3 .9

FS(l),M(l),MC
(I)

Dachshund (I); Shar Pei (I);
Weimaraner (I)

NR

ACI'H slim (3); path (I)

1 14.5

6.6

Burrows"'

I

0.8

M(l)

Shar Pel (I)

ACI'H atim (1)

123

6.4

1989

Joaeph16

1

6

FS(l)

Collie (I)

Na+IK+ (I)

128

10.8

1991

Lynn et al.100*

21

4.1

F(l),FS(l l),
M(2) , MC(7)

Airedale Terrier (I); Cocker
Spaniel (1); Dalmatian (1);
German Shepherd (3); Golden
Retriever (I); Kuvaaz (I);
Labrador Retriever (3); Maltese
(1); Mixed (1); Poodle (3); Rat
Terrier (1); Rottweiler (2);
Scottish Terrier (I); Welsh Coral
(I)

ACI'H atim (21); Na+IK+ (21)

131.2

7.3

1992

Bartgea et al.12

1

5

FS(l )

Poodle (I)

ACI'H slim (I); eosinophilia (I)

ISO

4.8

•

Table 2.1 (continued)
Year

or
report

�

Author of report•

No. or
cases
reported

Average
ages
(yr)

60

4.6

Sexes (number)

1993

Lynn et al.10't

1993

Medinger et al .u

3

4

F(l ) , FS(2)

1994

Levy''

1

6

F(l)

•

F(3),FS(34),
M(S), MC(IS)

Mean Na+
(meqfL)

Mean K+
(meqfL)

ACTH slim (60); Na+IK+ (60);
plasma ACTH (14)

128.3

7.2

Chesapeake Bay Retriever (I);
Fox Terrier (1); Great Pyrenncs
(I)

ACTH stlm (3)

123.3

6.4

Poodle (1)

ACTH stim (I)

135

7.5

Breeds (number)

Diagnostic methods (number)

Alaskan Malamute (I); Basset
Hound (2); Brittany (I); Cairn
Terrier (I); Collie ( 1 );
Dachshund (2) ; Doberman
Pinscher (4); German Shepherd
(4); German Shorthaired Pointer
(3); Golden Retriever (1); Great
Pyrennea (I); Labrador Retriever
(9); Mastiff (1); Mixed (1 1);
Poodle (6); Pointer (I);
Portuguese Water Dog (2) ;
Rottweiler (3); Samoycd (I);
Welsh Colli (1); West Hi,hland
White Tomer (3); Yorkshtre
Terrier (1)

Table 2.1 (continued)
Year
or

report
Total

cases
reported

Average
ages
(yr)

244

4.3

No, oF

Author of report•

�

• Superscript indicates reference number.

Sexes (number)

Breeds (number)

Diagnostic methods (number)

F(41),FS(1 19),
M(S2),MC(32)

Airedale Terrier (1); Alaskan
Malamute (1); Australian Terrier
(1); Basset Hound (2); Beagle
(2); Boston Terrier (1); Boxer
(1); Brittany (2); Cairn Terrier
(1 ); Chesapeake Bay Retriever
(1); Coekapoo (1); Cocker
Spaniel (4); Collie (2);
Dachshund (4); Dalmatian (2);
Doberman Pinscher (7); Fox
Terrier (1); Oerman Shepherd
(13); Oerman Shorthaired Pointer
(4); Oolden Retriever (S); Oordon
Setter (1); Oreal Dane (3); Oreal
Pyrennes (2); Irish Setter (2);
Irish Terrier (I); Kelpie (I);
Kuvaaz (1); Lnbrador Retriever
(13); IJ!osa Apso (1); Maltese
(1); Manchester Temer (I);
Mastiff (I); Mixed (40); NR (58);
Pointer (2); Poodle (2S);
Portuguese Water Dog (2); Rat
Terrier (I); Rottweiler (S); Saint
Bernard (2); Somoyed (3);
Schnauzer (2); Scouish Terrier
(1}; Shar Pei (2); Springer
Spaniel (2); Weimaraner (2);
Welsh Colli (5); West Highland
White Temer (5); Wheaten
Terrier (I); Whippet (I);
Yorkshire Terrier (1)

ACTH slim (163); EKO (16);
eosinophilia (5); hemogram (4);
hypoglycemia (I); Na+IK+
(155); path (27); p lasma ACTH
(15); plasma c:ortJcoids (2);
uremia (3); urinary chloride (I);
urinary eteroids (5); water
loading test (1)

t Mean of 10 cases.
* Some breed information obtained by direct communication with the authors,
f Mean of 220 cases; normal sodium 136.0-150.0 meq/L;"1•41 normal potassium 3.5-S.O meq/L,••,.,

Mean Na+
(meq/L)

Mean K+
(meq/L)

129.4/

7.2/

iatrogenic origin, seven due to treatment with o,p' -DDD and 28 due to treatment
with glucocorticoids.183 Similarly, three iatrogenic cases were excluded from
another report.45 One report was excluded because the cases all came from the
same family of Standard Poodles. 192 Another was excluded because the endocrine
characteristics of the reported case were confounded with those of canine
distemper.24
Sex of the dog was classified as female, female-spayed, male, or male
castrated. If an individual dog was reported as being "male," it was considered to
be uncastrated. Similarly, "female" was considered to be unspayed. Two reports,
Willard et al. (1982) and Rakich et al. (1984), reported 37 and 23 dogs,
respectively, as all being either male or female. Since any group of 37 or 23
clinically ill dogs is likely to have at least a few castrated or spayed individuals,
it was assumed that these authors did not distinguish in their report between altered
and intact patients. Therefore, these studies were not included in calculations
regarding sex.
One report was not included in the clinical findings data since it reported no
clinical findings.46 Another report did not separate clinical findings between
naturally-occurring and iatrogenic cases, so the assumption was made that the
number of cases with a particular clinical finding was distributed proportionally
between naturally-occurring and iatrogenic cases.45
Since the reports generally did not distinguish among Toy, Miniature, and
Standard Poodles, all Poodles have been reported as one breed. Similarly, since
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the reports did not distinguish among Miniature, Standard, and Giant Schnauzers,
all Schnauzers have been reported as one breed. Clinical signs and response to
therapy were not included as methods of diagnosis because they were presumed
to always be consistent with the diagnosis.

Results, Discussion, and Conclusions
Cases
The year the report was published, author, number of cases reported, average
ages, sexes, breeds, diagnostic methods, mean serum sodium concentration, and
mean serum potassium concentrations are included in Table 2. 1 . Two hundred
forty-four cases from 46 reports were reviewed. Thirty-eight (82.6 %) of the 46
reports described five or fewer cases each, for a total of 63 (25. 8 %) of the 244
total cases. 9-14,20.26-28,36,42,43,59,68,10,75,83,86,87,92,95, 119, 127,133,135,136,142,153,155, 163,171,176,184,193, 194,
222.244

Eight of the reports accounted for the remaining 1 8 1

(74.2%)

cases. 45•46• 104• 105• 134• 152• 183•246 One hundred sixty-nine (69.3 %) cases were reported
after 1 980.

Ages
The average age was 4.3 yr for all dogs. The range of average ages for the
46 studies was 0.2 yr to 12.0 yr, with a mean of 4.3 yr. This suggested that canine
hypoadrenocorticism can occur in dogs of any age, with an average age between
4 and 5 yr.
27

Sexes
Sex was reported for 184 (75.4%) of the cases with 41 (22.3 %) male-intact,
24 (13 .0%) male-castrated, 3 1 (16. 8 %) female-intact, and 88 (47.8 %) female
spayed (Table 2.2) . However, without data about the sex distribution in the entire
dog population, the assertion that canine hypoadrenocorticism is typically a disease
of the female dog41 •43• 1 89 remains to be proved. One report, which did include
controls representing the entire dog population, concluded that females were more
likely to develop this disease. 148

Breeds
Breed was reported for 186 (76.2%) of the cases, and 50 breeds were
represented (Table 2.3). The most frequently reported purebreds (%) were Poodle
(13.4), German Shepherd (7.0), Labrador Retriever (7.0) , Doberman Pinscher
(3 .8), Golden Retriever (2.7), Rottweiler (2.7), Welsh Corgi (2.7) , and West
Highland White Terrier (2.7) . The breed data established that canine
hypoadrenocorticism can occur in many different breeds. As with sex, however,
without data about the proportion of each of these breeds in the entire dog
population, any conclusions about breed predispositions need to be proved.

28

Table 2.2. Sexes of 184 Reported Cases of Naturally Occurring Canine
Hypoadrenocorticism *

Sex

Number

Percent

Female-intact

31

16.8

Female-spayed

88

47. 8

1 19

64.7

Male-intact

41

22.3

Male-castrated

24

13.0

All males

65

35.3

184

100.0

All females

All dogs

*Two re�orts 152.246 were excluded because they apparently did not distinguish
neutered from intact dogs.
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Table 2.3. Breeds of 186 RepoiUd Cues of Naturally Occurring Canine Hypoadn:nocorticism•

Breed

Number

Pen:eot

Airedale Terrier

0.5

Alaskan Malamule

0.5

Australian Terrier

o.s

Basset Hound

2

Beagle

2

1.1
1.1

Boston Terrier

o.s

Boxer

o.s

Brittany

2

1.1

Cairn Terrier

0.5

Chesapeake Bay Retriever

o.s

Cockspoo

o.s

Cocker Spaniel

4

2.2

Collie

2

1.1

Dachshund

4

2.2

Dalmatian

2

1.1

Doberman Pinscher

7

3.8

0.5

Fox Terrier
German Shepherd

7.0

13

German Shorthaired Pointer

4

2.2

Golden Retriever

s

2.7

0.5

Gordon Scuer
Great Dane

3

1 .6

Great Pyrenncs

2

1.1

Irish Scaer

2

1.1

Irish Terrier

0.5

Kelpie

o.s

Kuvasz

0.5

Labrador Retriever

7.0

13

Lhasa Apso

0.5

Maltese

o.s

Manchester Terrier

0.5

Mastiff

o.s

Mixed

21.5

40

Poineer

2

1.1

Poodle

25

13.4

2

1.1

Portuguese Water Dog

0.5

Rat Terrier
Rottweiler

2.7

s
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Table

2.3 (continued)
Number

Percent

Saint Bernard

2

1 .1

Samoyed

3

1 .6

Schnauzer

2

1.1

Breed

Scottish Terrier

o.s

Shar Pei

2

1.1

Springer Spaniel

2

1.1

Weimaraner

2

1 .1

5

2.7

5

2.7

Welsh Corgi
West Highland While Terrier
Wheaten Terrier

o.s

Whippet

o.s

Yorkshire Terrier

0.5

•Breed was not reported for 58 of the 244 cases.
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Diagnostic Methods
Thirteen different diagnostic methods (in addition to clinical signs and
response to therapy) were used to diagnose canine hypoadrenocorticism (Table
2.4). The antemortem diagnostic acumen of veterinary practitioners who reported
their results to professional publications, as well as the availability and accessibility
of laboratory tests, has apparently improved with time. Diagnosis of the earliest
reported

cases

was

based

largely

on

necropsy

findings.

With

few

exceptions, 11•86• 1 52•246 all cases reported after 1980 were diagnosed using the ACTH
stimulation test, the definitive test. 95• 104• 105

Serum Sodium and Potassium Concentrations
The mean sodium concentration was 129.4 meq/L with range from 1 14.0150.0 meq/L, and the mean potassium concentration was 7.2 meq/L with range
from 4.6-10.8 meq/L. The mean sodium to potassium ratio (obtained by dividing
129.4 by 7.2) was 18.0, well below the published diagnostic criterion of 27.0 or
less suggested by two references,43•189 and also below the diagnostic criterion of
25.0 or less suggested by another.129 So sodium to potassium ratio seemed a
useful, though not definitive, diagnostic criterion. Other conditions such as
chylothorax245 and gastrointestinal disease29 can produce hyponatremia and
hyperkalemia.

32

Table 2.4. Methods Used to Diagnose 244 Reported Cases of Naturally Occurring
Canine Hypoadrenocorticism*

Method

Number

Percent

163

66.8

16

6.6

Eosinophilia

5

2.0

Hemogram

4

1 .6

Hypoglycemia

1

0.4

155

63.5

Path***

27

11.1

Plasma ACTH

15

6.1

Plasma corticoids

2

0.8

Uremia

3

1 .2

Urinary chloride

1

0.4

Urinary steroids

5

2.0

Water loading test

1

0.4

ACTH stimulation test
Electrocardiogram

Na+ IK.+ **

*Excluding "clinical signs" and "response to therapy. "
**Na + /K. +
Diagnosis by serum sodium or potassium concentration, or the
ratio of sodium to potassium.
=

***Path

=

Gross and/or microscopic pathology.
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Clinical Findings
Clinical findings frequently reported are tabulated in Table 2.5. The seven
most frequently reported (%) were anorexia (73.7), vomiting (64.0), depression
(61 .0) , weakness (54.2), weight loss (36.9), azotemia (25.8), and diarrhea (25.0).
Other less frequently observed clinical findings included changes in skin and hair,
microcardia, muscle atrophy, limb stiffness, panting, and hematuria. Table 2.5
should be useful to the veterinary clinician since it provides a picture of what
clinical findings to expect from a hypoadrenal dog.

Treatment
Treatment may be on an emergency basis to deal with a hypoadrenal crisis,
and maintenance to correct mineralocorticoid and glucocorticoid deficits on a long
term basis. The following is a composite treatment plan gleaned from the review
of the canine hypoadrenocorticism literature.
Emergency treatment must be tailored to each individually evaluated patient.
It generally consists of isotonic intravenous saline solution to correct hyponatremia,
hyperkalemia, and hypovolemia, and the immediate initiation of glucocorticoid and
mineralocorticoid therapy. 86 Intravenous sodium bicarbonate may be used to
correct metabolic acidosis and to lower serum potassium levels.28 A simple lead
II electrocardiogram can be used to monitor the patient's response to treatment for

hyperkalemia.28•86 As hyperkalemia is reduced, peaked T waves become less
34

Table 2.5. Clinical Findings for 236 Reported Cases of Naturally
Occurring Canine Hypoadrenocorticism*
Clinical fmding

Number

Percent

Anorexia

174

73 .7

Vomiting

151

64.0

Depression

144

6 1 .0

Weakness

128

54.2

Weight loss

87

36.9

Azotemia

61

25. 8

Diarrhea

59

25.0

Dehydration

51

21 .6

Polyuria or polydipsia

34

14.4

Shock or collapse

34

14.4

Bradycardia or arrhythmia

31

13. 1

Shaking or trembling

25

10.6

Ataxia or seizures

13

5.5

Gastroenteritis or abdominal pain

12

5.1

*Includes only 236 of 244 reported cases because one report46 of eight
cases did not report any clinical findings.

35

apparent, the amplitude of P and R waves will increase, the PR and QT intervals
will decrease, and bradycardia, if present, will subside.28 Intravenous 2.5 or 5.0%
dextrose solution can carefully be used in the hypoglycemic patient, recognizing
that the use of hypertonic solutions may cause or exacerbate dehydration. 86•95
Maintenance therapy requires that the glucocorticoid and mineralocorticoid
deficits be corrected. Mineralocorticoid activity may be obtained by administering
fludrocortisone acetate orally daily or microcrystalline desoxycorticosterone
pivalate (DOCP) intramuscularly about once a month. 28•95 The oral and parenteral
routes each have obvious advantages and disadvantages to the clinician and client.
Either drug may require additional glucocorticoid supplementation, such as
prednisone, though fludrocortisone acetate has greater glucocorticoid activity.95
Some dogs do not respond adequately to fludrocortisone acetate and should be
treated with DOCP, 95 which has near universal efficacy. 104•105 Maintenance therapy
should be tailored to the individual patient's response, both general health and
serum sodium and potassium concentrations, and to the convenience of the
clinician and client.
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CHAPfER 3

DESCRIPI10N OF CASES OF CANINE
HYPOADRENOCORTICISM ENROLLED IN THE
CLINICAL TRIAL OF MICROCRYSTALLINE
DESOXYCORTICOSTERONE PIVALATE

Introduction
This chapter has two purposes. First, it will review cases of canine
hypoadrenocorticism which were enrolled in a clinical trial of microcrystalline
desoxycorticosterone pivalate (DOCP), a mineralocorticoid drug used to treat the
disease. This review will provide descriptive data about ages at diagnosis, breeds,
sexes, body weights, serum sodium and potassium concentrations, and clinical
findings for the hypoadrenal dogs in the clinical trial. Second, this chapter will
compare two different case definitions, one which required a definitive
adrenocorticotropic honnone (ACTH) stimulation test to confirm the diagnosis of
hypoadrenocorticism, and a second unconfirmed diagnosis which required only that
the veterinarian diagnosed the disease regardless of the diagnostic method. This
chapter will examine the question whether for epidemiologic studies of canine
hypoadrenocorticism it was necessary to use the definitive, confirmed, ACTH
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stimulation testm as a case definition, or whether the less exacting, unconfirmed
case definition using only the veterinarian's judgment was satisfactory. If the
results were different or equivocal, depending on the definition, then clearly the
confirmed ACTH stimulation test definition must be used, despite its expense,
inconvenience, and fewer case numbers. If, on the other hand, the results were the
same, or nearly so, regardless of case definition, then the unconfirmed definition
using only the veterinarian's judgment could be used, thereby gaining in cost
effectiveness, convenience, and the number of cases available for study.

Methods
Data on 506 cases of naturally occurring canine hypoadrenocorticism were
compiled between April 18, 1989, and December 3 1 , 199 1 , in a clinical trial
conducted by Ciba Animal Health to test the efficacy of DOCP. Three hundred
ninety-four investigating veterinarians from 367 veterinary hospitals and clinics in
the United States and Canada participated in the clinical trial. Veterinarians were
enrolled if they requested DOCP to treat a patient from Ciba Animal Health, and
were willing to participate in the clinical trial. The veterinarian's diagnosis of
hypoadrenocorticism, regardless of the basis for the diagnosis, was satisfactory for
entry in the clinical trial. Most of the diagnoses were made using either the ACTH

mDemonstrating a lack of cortisol response to ACTH stimulation.
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stimulation test or diagnostic serum sodium and potassium concentrations. The
drug could not be obtained without enrollment in the clinical trial . Patient
information obtained during the trial included age at diagnosis, sex, breed,
diagnostic method, serum sodium and potassium concentrations, ACTH stimulation
test results, and clinical findings.
A subset of 262 (51 .7 %) of these 506 cases had confirmed diagnoses using
the ACTH stimulation test. These cases came from 239 investigating veterinarians
from 200 veterinary hospitals and clinics in 39 different states in the United States.
A subset of 244 (48.2%) of these 506 cases were unconfirmed by the ACTH
stimulation test, and the diagnosis was therefore based on the veterinarian's
judgment. These cases came from 203 investigating veterinarians from 198
veterinary hospitals and clinics in 42 different states in the United States and one
province of Canada. All the data came from the clinical records of practicing
veterinarians, and were therefore dependent on the accuracy of these records.
Since veterinarians often did not distinguish among different Poodle (Toy,
Miniature, or Standard) or Schnauzer (Miniature, Standard, or Giant) breeds,
Poodles and Schnauzers are each reported as one breed.
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Results
General
The following results (and the discussion that follows), except as noted, were
for the 262 cases which had confirmed diagnoses using the ACTH stimulation test.

Ages at Diagnosis
The average age at diagnosis (Figure 3 . 1)

was

4.9 yr (SD 3 .0) (SEM0 0.2)

(Range 0.3 - 13 .0) .

Breeds
The breeds of the 262 dogs (Table 3 . 1) demonstrated that canine
hypoadrenocorticism can occur in many breeds. The seven most frequently
represented breeds (%) were Mixed (12.2), Poodle (1 1 .8) , German Shepherd
(8.4), Labrador Retriever (8.0), West Highland White Terrier (6.5), Golden
Retriever (3.8), and Great Dane (3.8).

Sexes
The sexes ( % ) (Table 3 .2) of the 262 dogs were 1 6 (6. 1) female-intact, 1 62
(61 .8) female-spayed, 34 (13 .0) male-intact, and 50 (19. 1) male-castrated.
0Standard error of the mean (SEM) equals the standard deviation (SD) divided
by the square root of the sample size.
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Figure 3. 1 . Ages at Diagnosis of 232* Dogs with Canine Hypoadrenocorticism Enrolled in Clinical Trial

Table 3 . 1 . Breeds of 262 Dogs with Canine Hypoadrenocorticism Enrolled in Clinical Trial
by Breed Group

Breed

Number

Poodles (roy, Miniature, and Standard)
Schnauzers (Miniature, Standard, and Giant)

Percent

31
3

1 1. 8
1.1

2
3
2
1
1
9

0. 8
1.1
0.8
0.4
0.4
3 .4

21
10
6
8
5
1
1
1
1
1
1
1
57

8.0
3.8
2.3
3.1
1 .9
0.4
0.4
0.4
0.4
0.4
0.4
0.4
2 1 .8

8
4
6
1
1
1
1
22

3.1
1 .5
2.3
0.4
0.4
0.4
"0.4
8.4

2
3
1
1

0.8
1.1
0.4
0.4

Toy breeds
Chihuahua
Shih Tzu
Bichon Prise
Maltese
Pomeranian
All toy breeds
Sporting breeds
Labrador Retriever
Golden Retriever
Springer Spaniel
Cocker Spaniel
German Shorthaired Pointer
Chesapeake Bay Retriever
Irish Setter
English Setter
Nova Scotian Duck Tolling Retriever
Pointer
Portuguese Water Dog
Vizsla
All sporting breeds
Hound breeds
Dachshund
Beagle
Basset Hound
Afghan Hound
Norwegian Elkhound
Rhodesian Ridgeback
Saluki
All hound breeds
Non-sporting breeds
Chow Chow
Shar Pei
Keeshond
Lhasa Apso
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Table 3 . 1 (continued)
All non-sporting breeds

7

2.7

22
3
2
1
1
1
30

8.4
1.1
0.8
0.4
0.4
0.4
1 1 .5

10
7
6
4
3
4
2
36

3.8
2.7
2.3
1 .5
1.1
1 .5
0.8
13.7

17
4
2
1
1
1
1 .
27

6.5
1 .5
0.8
0.4
0.4
0.4
0.4
10.3

5
3
8

1 .9
1.1
3.1

32

12.2

262

100.0

Herding breeds
German Shepherd
Collie
Australian Shepherd
Welsh Corgi
Bouvier des Flanders
Old English Sheepdog
All herding breeds
Working breeds
Great Dane
Doberman Pinscher
Rottweiler
Siberian Husky
Alaskan Malamute
Akita
Saint Bernard
All working breeds
Terrier breeds
West Highland White Terrier
Airedale Terrier
Scottish Terrier
Bull Terrier
Fox Terrier
Pit Bull Terrier
Wheaten Terrier
All terrier breeds
Miscellaneous breeds
Bearded Collie
Border Collie
All miscellaneous breeds
Mixed
Total dogs

43

Table 3 .2 . Sexes of 262 Cases of Canine Hypoadrenocorticism Enrolled in Clinical Trial

Sex

Percent

Number

16

6. 1

Female-spayed

162

61 .8

All females

178

67.9

Male-intact

34

13.0

Male-castrated

50

19. 1

All males

84

32. 1

All dogs

262

100.0

Female-intact
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Body Weights

Body weights (Figure 3 .2) averaged 23.4 kg (SO 13.6) (SEM 0.8) (Range
2.7 -

72.7).

Serum Sodium and Potassium Concentrations

Two hundred forty-nine (95.0%) of the 262 cases had their serum sodium
and potassium concentrations determined. Table 3.3 presents these results with the
sodium to potassium ratio. The mean sodium concentration was 1 3 1 . 8 meq!L (SO
9.4) (SEM 0.6) (Range 104.0 - 174.0) (Normal 136.0 - 150.0'"•43}, the mean
potassium concentration was 6.8 meq/L (SD 1 .3) (SEM 0 . 1) (Range 3 .2 - 12.8)
(Normal 3.5 - 5.041•43}, and the mean sodium to potassium ratio was 20.2 (SO 4.8)
(SEM 0.3) (Range 10.5 - 38.8) (Normal ;;:: 27.041•43•1 89 or ;;:: 25.012�.

Clinical Findings

Clinical findings were tabulated for the 262 cases and are displayed in Table
3 .4. The seven most frequently reported, in order of decreasing frequency, were
vomiting (28.2%), anorexia (19.5 %), depression (18.3 %), weakness (14. 1 %),
weight loss (1 1 . 1 %), diarrhea (9.2%}, and bradycardia or arrhythmia (6.5 %).
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Figure 3.2. Body Weights of 262 Dogs with Canine Hypoadrenocorticism Enrolled in Clinical Trial
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Table 3.3. Serum Sodium and Potassium Concentrations and Sodium/Potassium Ratios for 249* Dogs with Canine Hypoadrenocorticism
Enrolled in Clinical Trial

Sodium
(meq/L)

Number

Number

Percent

Sodium
potassium ratio••

Number

Percent

> 1 00, � 1 10

6

2.4

> 3, �4

5

2.0

10. 1 - 1 5.0

21

8.4

> 1 10, � 120

18

7.2

> 4, �5

15

6.0

15. 1 - 20.0

123

49.4

> 1 20, � 130

79

3 1 .7

> 5, �6

47

1 8.9

20. 1 - 25.0

76

30.5

> 1 30, � 140

1 06

42.6

> 6, �7

85

34. 1

25. 1 - 30.0

15

6.0

> 1 40, � 1 50

36

1 4.5

> 7, � 8

56

22.5

30. 1 - 35.0

10

4.0

4

1 .6

> 8, �9

29

1 1 .6

35. 1 - 40.0

4

1 .6

> 9. � 10

11

4.4

1

0.4

< 150

�
-....)

Potassium
(meq/L)

Percent

I

Mean 1 3 1 .8
SD 9.4
SEM 0.6
Range 1 04.0 Normal 136.0
Number
Number
Number

174.0

1
1 50 .Q4 •43
below normal 1 7 1 (68.7%)
normal 74 (29.7%)
above normal 4 ( 1 .6%)

-

> 10

Mean 6.8
SD 1 .3
SEM 0. 1
Range 3.2 - 12.8
Normal 3 .5 - 5 .Q41•43
Number below normal 1
.4%)
Number normal 1 9 (7.6%
Number above normal 22

�

(92.0%)

Mean 20.2
SD 4.8
SEM 0.3
Range 1 0.5 - 38. 8
Normal � 27 .Q41•43•1 89 or � 25.0129
Number below normal 228
(91 .6%)***; 2 19 �8.0%)****
Number normal 2 1 ( .4%)***; 30
(12.0%)****

*Serum sodium and potassium concentrations were not reported for 13 of the 262 cases.
**Twenty-one (8.4%) of the sodium/potassium ratios exceeded 27 .0. A ratio below 27.0 is sometimes considered diagnostic of
canine hypoadrenocorttcism. 41•43•189 Twenty-nine (1 1 .6%) of the ratios exceeded 25.0, the diagnostic criterion suggested by a
commonly used reference. 129

***A sodium to potassium ratio � 27.0 was considered normal . 41•43•189
****A sodium to potassium ratio � 25.0 was considered normal .'29

Table 3 .4. Clinical Findings* for 262 Cases of Canine Hypoadrenocorticism
Enrolled in Clinical Trial

Clinical f"mding

Number

Percent

Vomiting

74

28.2

Anorexia

51

19.5

Depression

48

18.3

Weakness

37

14. 1

Weight loss

29

11.1

Diarrhea

24

9.2

Bradycardia or arrhythmia

17

6 .5

Shock or collapse

15

5.7

Shaking or trembling

11

4.2

Azotemia

10

3.8

Gastroenteritis or abdominal pain

10

3.8

Polyuria or polydipsia

9

3 .4

Dehydration

8

3.1

*Includes those clinical findings reported for five or more cases.
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Efficacy of Microcrystalline Desoxycorticosterone Pivalate

When simply asked whether or not DOCP was effective, veterinarians
responded yes for 260 (99.2 %) of the 262 cases.

Discussion
Ages at Diagnosis

The average age at diagnosis was 4.9 yr (SD 3 .0) (SEM 0.2) (Range 0.3 1 3.0) (Figure 3 . 1). These results suggested that the average age at diagnosis for
canine hypoadrenocorticism was about five years, but, notably, could vary from
very young to very old dogs. This was consistent with the estimate provided in a
well-known veterinary reference.43

Breeds

The seven most frequently reported breeds afflicted with canine
hypoadrenocorticism were, in order of frequency from most to least frequent:
Mixed, Poodle, German Shepherd, Labrador Retriever, West Highland White
Terrier, Golden Retriever, and Great Dane {Table 3. 1). These results demonstrated
that canine hypoadrenocorticism can occur in many different breeds. Without data
about breed distribution in the entire dog population, whether or not these breeds
are predisposed to adrenal insufficiency cannot be determined.
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Sexes

The sexes of dogs (percent) were female-intact (6. 1), female-spayed (61 . 8),
male-intact (13.0), and male-castrated (19. 1) (Table 3 .2). Thus females, both intact
and spayed, made up about 70% of the hypoadrenal patients. This was consistent
with two veterinary references which found that 70%43 and 76 %41 were female.
However, without data about sex distribution in the entire dog population, the
assertion that canine hypoadrenocorticism is typically a disease of the female
dog41•43 remains to be proved. One report, which did consider the sex distribution
in the entire dog pop:ulation, concluded that females were more likely to develop
this disease. 148 (This will be discussed at some length in succeeding chapters.)

Body Weights

Body weights averaged 23.4 kg (SD 13.6) (SEM 0.8) (Range 2.7 - 72.7) .
(Figure 3 .2). This established pretty convincingly that canine hypoadrenocorticism
occurs in all sizes of dogs , and confirmed the previously reported assertion that
the disease can affect dogs of any size.41•43

Serum Sodium and Potassium Concentrations

The sodium, potassium, and sodium to potassium ratio were, respectively,
13 1 .8 (SD 9.4) (SEM 0.6) (Range 104.0-174.0), 6.8 (SD 1 .3) (SEM 0 . 1) (Range
3 .2 - 12.8), and 20.2 (SD 4.8) (SEM 0.3) (Range 10.5 - 38.8) (Table 3 .3). The
normal values for sodium, potassium, and sodium to potassium ratio are,
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respectively, 136.0 - 150.0,4 1•43 3.5 - 5.0, 4 1•43 and � 27.0'41•43• 189 or � 25.0. 129 So,
the means of these diagnostic indicators were consistent with the hyponatremia and
hyperkalemia expected in the hypoadrenal patient.41•43•129 However, it is important
to note that 74 (29.7 %) of the patients had normal sodium concentrations, 19

(7. 6 %) had normal potassium concentrations, and 29 (1 1 . 6 %) (using diagnostic
criterion �25.0) or 21 (8 4%) (using diagnostic criterion � 27.0) had normal
.

sodium to potassium ratios. These results suggested that normal sodium and
potassium values in a clinical patient do not eliminate the possibility that the dog
suffers from an adrenal insufficiency. They also raised the interesting question as
to how many dogs had normal electrolyte values for all three diagnostic indicators-sodium concentration, potassium concentration, and sodium to potassium ratio.
The answer was 13 (5 .2%) of 249° were normal for all three diagnostic
indicators,P suggesting that a veterinarian pondering a list of differential diagnoses
can usually eliminate hypoadrenocorticism based on normal sodium and potassium
results. It is important to recognize that the truth of the converse is unknown based
on these data; i.e. , abnormal sodium and potassium results which are consistent
with hypoadrenocorticism do not necessarily make the diagnosis.

00f the 262 cases with valid ACTH stimulation test results, 249 also had
sodium and potassium concentrations determined; therefore, 1 3/249 = 0.052 =
5.2% is the meaningful datum.
PUsing either the > 25.0 or the �27.0 diagnostic criterion.
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Clinical Findings
The six most frequently reported clinical findings were vomiting, anorexia,
depression, weakness, weight loss, and diarrhea (Table 3 .4). Others included
bradycardia or arrhythmia, shock or collapse, shaking or trembling, azotemia,
gastroenteritis or abdominal pain, polyuria or polydipsia, and dehydration (Table

3 .4). This provided a reasonably comprehensive list of the clinical findings
associated with adrenal insufficiency in the dog when compared to other accounts
of the disease.44

Efficacy of Microcrystalline Desoxycorticosterone Pivalate
Since the veterinarians concluded that DOCP was effective in 99.2% of these
cases, it seemed clear that the drug was efficacious. This has been reported before,
but in much smaller groups of dogs . 104•105

Case Definition in Epidemiologic Studies of Canine Hypoadrenocorticism
To help answer the question if, for epidemiologic studies of canine
hypoadrenocorticism, it matters whether the ACTH stimulation test (confirmed
diagnosis) or the veterinarian's judgment (unconfirmed diagnosis) was used as a
case definition, a side-by-side comparison of ages at diagnosis, breeds, sexes, body
weights, serum sodium and potassium concentrations, and clinical findings is made
in Table 3 .5. An examination of Table 3 .5 revealed that the results were virtually
identical regardless of which definition was chosen. Age at diagnosis (yr) was 5 . 1
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Table 3.5. Comparison of Results Using Two Different Case Definitions for Cases of Canine Hypoadrenocorticism Enrolled in Clinical Trial
Result

Unconfinned diagnosis* (n=244)

Confinned diagnosis** (n=262)

Average age at
diagnosis (yr)

5. 1 *** (SO 2.9) (SEM 0.2) (Range 0.2 - 15.5)

4.9*** (SO 3.0) (SEM 0.2) {Range 0.3 - 13.0)

Seven most
frequently
reported breeds
(%)

Poodle (22.5)
Mixed (14.8)
Labrador Retriever (10.2)
Golden Retriever (6.6)
West Highland White Terrier (6. 1)
German Shepherd (4.5)
Springer Spaniel (4. 1)

Mixed ( 12.2)
Poodle (1 1 . 8)
German Shepherd (8.4)
Labrador Retriever (8.0)
West Highland White Terrier (6.5)
Golden Retriever (3.8)
Great Dane (3.8)

Sexes (%)

Female-intact (7. 8)
Female-spayed (67 .6)
All females (75.4)
Male-intact (8.6)
Male-castrated (16.0)
All males (24.6)

Female-intact (6. 1)
Female-spayed (6 1 . 8)
All females (67.9)
Male-intact (13.0)
Male-castrated (19. 1)
All males (32. 1)

Body weight
(kg)

2 1 .4 (SO 13.3) (SEM 0.9) (Range 2.7 - 75.0)

23.4 (SD 13.6) (SEM 0.8) (Range 2.7 - 72.7)

Serum
concentrations

Sodium (meq/L) 129.2 (SD 9.9) (SEM 0.7) (Range 104.0 - 1 59.0)
Potassium (meq/L) 7.0 (SD 1 .3) (SEM 0 . 1 ) (Range 4.0 - 1 1 .0)
Sodium/potassium ratio 1 9. 1 (SO 4.3) (SEM 0.3) (Range 1 1 .6 - 38.8)

1 3 1 . 8 (SO 9.4) (SEM 0.6) (Range 104.0 - 174.0)
6.8 (SD 1 .3) (SEM 0. 1) (Range 3.2 - 12.8)
20.2 (SO 4.8) (SEM 0.3) (Range 10.5 - 38.8)

Seven most
frequently
reported
chnical findings
(%)

Vomiting {32.0)
Weakness (24.2)
Anorexia (22.5)
Depression (1 8.9)
Diarrhea ( 12.3) .
Bradrcardia or arrhythmia (6.6)
Shakmg or trembling (6. 1)

Vomiting (28.2)
Anorexia (19.5)
Depression (1 8.3)
Weakness ( 14. 1)
Weight loss (1 1 . 1)
Diarrhea (9.2)
Bradycardia or arrhythmia (6.5)

Ul
Ul

****

*A case was defmed as a dog which the veterinarian, for whatever reason, said bad bypoadrenocorticism.
**A case was defmed as a dog which was diagnosed using the ACTH stimulation test.
*"'*Not significantly different at p=0.05.
*"'**Nonnal: sodium 136.0-150.0 meq/L;41•., potassium 3.5-5.0 meq/L;41•., sodium to potassium ratio :=:: 27.041•43•189 or

:=:

25.0.129

using the unconfirmed diagnosis, and 4.9 using the confirmed one; standard
deviations, standard errors of the mean, and ranges were almost indistinguishable.
Six of the seven most frequently afflicted breeds were the same. The sex
distributions were very similar, and the sexes ranked from most to least frequently
reported were identical for the unconfirmed and confirmed diagnosis: female
spayed, male-castrated, male-intact, and female-intact. Average body weight (kg)
differed by only two units, 23.4 using the confirmed diagnosis compared to 21 .4
using the unconfirmed one; again, the standard deviations, standard errors of the
mean, and ranges were virtually identical. Similarly, the results for serum sodium
and potassium concentrations were, for all intents and purposes, the same. As with
breeds, six of the seven most frequently reported clinical findings were the same,
and the percentages of each clinical finding were quite consistent between the two
definitions. Though the only way to definitively determine whether the
veterinarians' diagnoses were accurate would be to test each dog individually with
the ACTH stimulation test, these results suggested that, despite the probable
presence of an inconsequential number of misdiagnoses when a less rigorous case
definition is used, for epidemiologic studies of canine hypoadrenocorticism a
rigorous case definition may be unnecessary. A less rigorous case definition would
generally be more convenient and less costly. This recommendation cannot be
generalized to other diseases.
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Conclusions

The following conclusions were based on all the cases reported, both
confirmed and unconfirmed.
1 . Ages at Diagnosis. An estimated average age at diagnosis for hypoadrenal
dogs was 5 yr, but the disease can occur in dogs of any age.
2. Breeds. Poodle, Mixed, Labrador Retriever, German Shepherd, West
Highland White Terrier, and Golden Retriever breeds seemed to have a propensity
for developing hypoadrenocorticism. However, without data about the proportion
of each of these breeds in the entire dog population, any conclusions about breed
predispositions remain to be proved. (This issue will be explored in subsequent
chapters.)
3. Sexes. Females made up about 70% of hypoadrenal patients, and, of all
females, about 90 % of them were spayed. This was, again, consistent with the
estimates that 70 %43 or 76 % 41 of hypoadrenal patients are female, and with
assertions that canine hypoadrenocorticism is typically a disease of the female
dog. 4 1•43•93• 148 Again, however, without data about the sex distribution in the entire
dog population, these conclusions remain to be proved. (This issue will also be
addressed in subsequent chapters.)
4. Body Weights. An estimated average body weight for dogs with canine
hypoadrenocorticism was 23 kg, but the disease can occur in dogs of any size.
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5. Serum Sodium and Potassium Concentrations. Estimated average serum
sodium and potassium concentrations (meq/L) were 130 and 7, respectively. An
estimated average serum sodium to potassium ratio was 20. Nevertheless,
hypoadrenal patients had abnormally low, normal, and abnormally high values for
all three of these diagnostic indicators. Therefore, no single electrolyte indicator

should be used for diagnosis. However, only about 5 % of hypoadrenal patients
were normal for all three diagnostic criteria, so a dog normal for all three is
unlikely to be hypoadrenal. Conversely, sodium and potassium results consistent
with adrenal insufficiency do not necessarily make the diagnosis.
6. Clinical Findings. The most common clinical findings in hypoadrenal dogs
were vomiting, anorexia, weakness, depression, diarrhea, weight loss, shaking or
trembling, and bradycardia or arrhythmia.
7 .Efficacy of Microczystalline Desoxycorticosterone Pivalate. Based on
reports from veterinarians, DOCP was very effective in the treatment of canine
hypoadrenocorticism.
8. Case Definition in Epidemiologic Studies of Canine Hypoadrenocorticism.
Epidemiologic studies of canine hypoadrenocorticism may be conducted using the
case definition that, if the veterinarian says a dog has adrenal insufficiency, then
the diagnosis is made and the case definition satisfied. This will increase the
number of cases included in epidemiologic studies, and make them less
complicated, more convenient, and less costly.
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CHAPfER 4

THREE HUNDRED SEVENTY-SIX CASES DIAGNOSED
BY VETERINARY COLLEGES AND A REFERRAL INSTITUTION

Introduction

Colleges of veterinary medicine and other veterinary referral hospitals
typically maintain detailed case records. About two thirds of the colleges of
veterinary medicine in the United States and Canada contribute case data to the
Veterinary Medical Data Base (VMDB) at Purdue University, West Lafayette,
Indiana. The remaining third of the colleges and the referral hospitals maintain
their case data independently. These data are a rich source of information about
canine hypoadrenocorticism, and this source was used to estimate the incidence
and prevalence of canine hypoadrenocorticism; to describe the patients afflicted
with the disease as to ages at diagnosis, sexes, breeds, serum sodium and
potassium concentrations, and treatment; and to identify factors associated with the
disease.

Methods

The VMDB was queried for all the data on hypoadrenal dogs submitted by
participating universities during 1989, 1990, and 1991 . The data available included
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university, patient identification number, discharge date, length of hospitalization,
clinician, patient sex, species, breed � age, weight, diagnoses, and surgical
procedures. Since information not available from the VMDB was needed, a
collection form (Case Data Abstract Form, Appendix AI) was developed.
Additional data obtained using this form included adrenocorticotropic hormone
(ACTH) stimulation test results, serum sodium and potassium concentrations, other
diagnoses, and whether the dogs had been treated with fludrocortisone acetate or
microcrystalline desoxycorticosterone pivalate (DOCP). These forms were sent
with a cover letter explaining the purpose of the request to the 20 universities in
the United States and Canada known to have submitted cases of canine
hypoadrenocorticism to the VMDB in 1989, 1 990, or 1 991 .
Six universities and two veterinary referral hospitals which did not submit
data to the VMDB during the years of interest were also queried. A Population
Data Abstract Form (Appendix A2) and a modified Case Data Abstract Form
(Appendix A3) were developed to obtain the data. Data requested included number
of dogs seen during 1989, 1990, and 1991 by sex and breed if available, date of
diagnosis, age .at diagnosis, sex, breed, ACTH stimulation test results, other
diagnoses, and whether or not the dogs had been treated with fludrocortisone
acetate or DOCP. These forms were sent with a cover letter explaining the purpose
of the request.
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Only data from institutions responding with data forms were included in the
study. Non-responders were included for incidence and prevalence calculations if
they had contributed valid case and population data to the VMDB, but failed to
return data forms.
Confidence intervals for odds ratios (OR) were calculated using Cornfield's
approximation.49 If Cornfield confidence limits were inexact, exact confidence
limits were calculated. 128 Uncorrected chi-square statistics were reported.40 Fisher
exact probability calculations for the 2x2 contingency tables were calculated when
the expected value of a cell was less than five (Appendix B) . 162
The selected clinical findings were chosen either because of their anecdotal
association with canine hypoadrenocorticism (they seemed from clinical experience
to

be

associated

with

canine

hypoadrenocorticism),

or,

since

canine

hypoadrenocorticism may be an autoimmune disease,4 1 because of their putative
autoimmune etiology. They were selected to investigate whether or not they were
actually associated with hypoadrenocorticism in the dog. The list of selected
clinical findings requested was not exhaustive.
The VMDB coded ages into eight categories, zero through seven, rather than
the specific age of each patient. Each category represented an age range. The
midpoint of each range (yr) was used as the dog's age for this study. Table 4. 1
includes the VMDB age codes, age code ranges, and the midrange ages used for
this study.
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Table 4. 1 . Veterinary Medical Data Base (VMDB) Age Codes and Corresponding
Midrange Ages Used in Veterinary College and Referral Institution Study of
Canine Hypoadrenocorticism
VMDB age code

Age code range

Midrange age used in
study (yr)

0

0 - 2 wk

0.019

1

2 wk - 2 mo

0. 1 03

2

2 - 6 mo

0.333

3

6 - 12 mo

0.750

4

1 - 2 yr

1 .500

5

2 - 4 yr

3 .000

6

4 - 7 yr

5.500

7

7 - 10 yr

8 .500

8

10 - 15 yr

1 2.500

9

1 5 yr and older

1 5.000
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Although the VMDB data distinguished among Toy, Miniature, and Standard
Poodles, and among Miniature, Standard, and Giant Schnauzers, other data sets
reported in subsequent chapters did not. Dogs were, for example, frequently
reported as simply "Poodle" or "Schnauzer" without size specification. Therefore,
to maintain consistency among data sets, all Poodles in each data set have been
reported as one breed, and all Schnauzers have been reported as one breed.
The VMDB was queried a second time for the years 1989, 1990, and 1991
to gather data on seven diseases or other reasons for being taken to veterinary
referral hospitals in dogs both with and without hypoadrenocorticism (natural or
iatrogenic). These seven--cataracts, dental tartar, fleas, heartworm infection, mitral
insufficiency, rabies vaccination, and squamous cell carcinoma-were specifically
chosen because they were, in the judgment of several veterinarians, probably not
associated with hypoadrenocorticism. The data were collected as a check on
methodology, since, hypothetically, these seven reasons for presentation of dogs
should not have been related to hypoadrenocorticism.

Results
General

Unless noted otherwise, all results are for naturally occurring cases (as
opposed to iatrogenic).
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Institutional Participants

Nineteen of the 20 universities (Table 4.2) which submitted canine
hypoadrenocorticism case data to the VMDB for 1989, 1990, or 199 1 returned
Case Data Abstract Forms. All six universities (Table 4.2) which did not submit
data to the VMDB for 1989, 1990, or 1991 provided Case Data Abstract Forms,
and five provided Population Data Abstract Forms. The Angell Memorial Animal
Hospital provided Case Data Abstract Forms, but not a Population Data Abstract
Form. Therefore, all English-speaking colleges of veterinary medicine in the
United States and Canada, except one, which reported cases of canine
hypoadrenocorticism in 1989, 1990, or 199 1 , submitted data.

Cases

Three hundred seventy-six cases of canine hypoadrenocorticism were
reported (Table 4.2). Two hundred ninety-one (77.4%) were from universities
participating in the VMDB, and 85 (22.6%) were from non-participants. The total
number of canine patients seen at each institution during 1989, 1990, and 1991,
were available for 346 of the 376 cases. Three hundred forty-one of the cases were
naturally occurring hypoadrenocorticism. Thirty-five were iatrogenically produced
cases, virtually all of which were produced by treating hyperadrenocorticism
(Cushing's disease) with 2,4'-dichlorodiphenyldichloroethane (o,p·-DDD).
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Table 4.2. Universities and Veterinary Referral Hospitals in the United States and
Canada Responding with Canine Hypoadrenocorticism Case Data for 1989-1991
and Number of Cases Contributed*
Participants in the Veterinary Medical Data

Base

Auburn University
Colorado State University
Florida, University of
Georgia, University of
lllinois, University of
Iowa State University
Kansas State University
Michigan State University
Minnesota, University of
Missouri, University of
Ohio State University
Ontario Veterinary College
Pennsylvania, University of
Purdue UDiversity
Saskatchewan, University of
Tennessee, University of
Texas A&M University
Virginia Tech and University of Maryland
.
.
W.JSCODSJO,
• untve[SJty 0f

Subtotal

Non-narticipants in the Veterinary Medical
Data Base
Angell Memorial Animal Hospital
California, University of
Mississippi State University
North Carolina State University
Prince Edward Island, University of
Tufts University
Washington State University

Number: of cases
contntiuted
8
19
9
35
21
7
10
25
24
12
2
15
35
15
5
10
15
7
17
29 1

Number. of cases
contritiuted
16
23
4
23
2
14
3
85

Subtotal

376

Total

*Non-responders: Cornell University; Animal Medical Center, New York
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Incidence and Prevalence Estimates
Incidence and prevalence were estimated because measures of disease
frequency are fundamental to the study of any disease, and because Ciba Animal
Health requested the estimates in return for project support. Since incidence

can

only be determined prospectively, and since a prospective study of canine
hypoadrenocorticism would be too costly, incidence was estimated retrospectively.
Because the date of initial diagnosis could be easily retrieved from the VMDB, the
strategy was to estimate incidence and then estimate prevalence using the incidence
estimate and an estimate of average disease duration. Underlying the estimates is
the understanding that the focus is on the population of dogs seen by veterinarians,
not all dogs. The estimates are also based on the assumption that a dog with
hypoadrenocorticism will be presented to a veterinarian since it will not recover
spontaneously.
Incidence was estimated using the total number of dogs initially diagnosed
with hypoadrenocorticism during

1989, 1990, and 1 991 divided by the total

number of dogs seen by allthe institutions in

1989, 1990, and 199 1 . Institutions

which responded with case data, but not population data, were excluded. Cornell
University, which had 39 cases but did not respond with data forms, was included
in this computation because its number of cases and underlying population were
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reported to

VMDB. Since the VMDB does not distinguish between natural and

iatrogenic cases, the assumption was made that the 39 Cornell cases were divided
between natural and iatrogenic in the same proportions, 90.2% and 9 .8 % ,
respectively, as were the rest of the cases. This led to the computations below.
Incidence estimate (natural cases)

=

Number of cases diagnosed + Number of cases diagnosed
(all institutions except
(Cornell University)
Cornell University)
Total dogs seen in 1 989, 1990, 1991 (all institutions)
-

3 1 2 + (.902) (39)

=

207,388
=

1 .7 cases/1 ,000 dogs/3

0.001674

=

0. 1 674 %

yr

Adding iatrogenic cases yielded an incidence estimate (natural and iatrogenic cases)
of 1 .9 cases/1000 dogs/3

yr.

These incidence estimates were used with an estimate of average disease
duration of 4.9 yr (see Chapter 5 for computation of this estimate). Prevalence
estimates were computed using the following formula:
Prevalence

=

(Incidence) (Average disease duration)

This formula is well established in the epidemiologic literature as a method for
estimating the prevalence of diseases which have a low prevalence and a stable
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endemic rate of occurrence. 3•98• 120•123• 168.200.215.239 This led to the computation below.
Prevalence estimate (natural cases)

=

[Incidence estimate (natural cases)] [Average disease duration]
-

(1 .7 cases/1000 dogs/3 yr) (4.9

-

2.8 cases /1000 dogs

yr)

The prevalence estimate (natural and iatrogenic cases) was 3 . 1 cases/1000 dogs.
Sex-specific incidence estimates were calculated for naturally occurring cases.
These incidence estimates were (number of cases of the particular sex/1000 dogs
of that sex/3

yr) female-intact 1 .0, female-spayed 3 .0, all females 2. 1 , male-intact

0.7, male-castrated 1 .9, and all males 1 . 1 (Table 4.3) . The computation for
female-intact follows to illustrate the computation method.
Female-intact incidence estimate

=

Number of female-intact cases diagnosed
Total female-intact dogs seen in 1989, 1990, 1991 (all institutions)

43
43,249

=

0.000994

=

0.0994%

1 .0 case/1000 female-intact dogs/ 3
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yr

Table 4.3. Sex-Specific Incidence Estimates of Naturally Occurring Canine
Hypoadrenocorticism Seen in Veterinary Referral Hospitals in 1989-1991, United
States and Canada
Number
of cases

Sex-specific incidence
estimate*

Female-intact

43

1 .0

Female-spayed

159

30

202

2. 1

Male-intact

40

0.7

Male-castrated

55

1 .9

All males

95

1.1

Sex

All females

.

*Expressed as number of cases of the particular sex with hypoadrenocorticism/
1000 dogs of that sex/3 yr.
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Breed-specific incidence estimates were calculated for naturally occurring
cases reported by 19 institutions which participated in the VMDB. These incidence
estimates were calculated for the seven breeds most frequently affected with canine
hypoadrenocorticism (see Breeds section which follows). Incidence estimates were
(number of diseased dogs of the particular breed/1 000 dogs of that breed/3 yr), in
decreasing order, West Highland White Terrier 12.0, Great Dane 7.6, Poodle 4.9,
Rottweiler 2.2, Mixed 1 . 7, German Shepherd 1 .2, and Labrador Retriever 0.9; the
incidence estimate for all other breeds combined was 1 .4 (Table 4.4).

Ages at Diagnosis

Age at diagnosis (yr) was reported for 329 (96.5 %) of the 341 naturally
occurring cases. It averaged 5.4 (SD 3 .2) (SEMq 0.2) (Range 0. 1 - 15.0). Age is
stratified by sex in Table 4.5.
Age-specific OR were calculated for age at diagnosis (Table 4.6). These OR
are based on all the cases submitted to the VMDB, except those from Cornell
University, during 1989, 1990, and 1991 .

qStandard error of the mean (SEM) equals the standard deviation (SD) divided
by the square root of the sample size.
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Table 4.4. Breed-Specific Incidence Estimates of Naturally Occurring Canine
Hypoadrenocorticism Seen in Veterinary Referral Hospitals in 1989-1991, United
States and Canada

Breed

Number
of cases

Breed-specific
incidence estimate*

9

1 .2

10

7.6

9

German Shepherd
Great Dane
Labrador Retriever
Mixed

58

0.9
1 .7

Poodle

35

4.9

7

2.2

12

12.0

118

1 .4

Rottweiler
West Highland White Terrier
All other breeds

*Expressed as number of cases of a particular breed with hypoadrenocorticism/
1000 dogs of that breed/3 yr.

69

Table 4.5. Average Age at Diagnosis for 329 Naturally Occurring Cases of Canine
Hypoadrenocorticism Seen in Veterinary Referral Hospitals in 1989-1991 , United
States and Canada

Sexes of cases

Number of cases

Average age at diagnosis
(yr) (SD) (SEM) (Range)

Female-intact

46

3.9 (2.5) (0.4) (0. 1 - 10.2)

Female-spayed

176

5.9 (3.2) (0.2) (1 .3 - 15.0)

222

5 .4 (3 .2) (0.2) (0. 1 - 15.0)

Male-intact

40

5.2 (3.6) (0.6) (0. 8 - 15.0)

Male-castrated

62

5.3 (3. 1) (0.4) (0.7 - 12.5)

All males

102

5.2 (3.3) (0.3) (0. 7 - 15.0)

329

5.4 (3 .2) (0.2) (0. 1 - 15.0)

All females

All sexes*

*Includes five dogs of unknown sex.
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Table 4.6. Age-Specific Odds Ratios (OR) for Age at Diagnosis of Dogs with Naturally Occurring and Iatrogenic Hypoadrenocorticism Seen in Veterinary
Referral Hospitals in 1989-1991, United States and Canada
x2 statistic (p value)
Number of cases

Total number of dogs
n= l47,037

OR

95 % confidence
interval for OR49

Uncorrected40

0 < age < 1

ll

32,790

0. 12

0.06 - 0.22

68.45 ( < 0.000 1)

1 � age < 4

92

40,829

1 .01

0.78 - 1 .29

0.00 (0.9641)

4 � age < 7

101

27,688

1 .90

1 .49 - 2.42

29.84 ( < 0.0001)

7 � age < 10

73

23,238

1 .5 1

1 . 16 - 1.98

9.87 (0.00 17)

53

22,492

1 .06

0.78 - 1 .43

0. 1 5 (0.7002)

Age interval (yr)*

-...)

age

�

10

n=330

-

* The comparison group is all other dogs.

Sexes

Sex was reported for 329 (96.5 %) of the 341 naturally occurring cases. The
number (%) of each sex is reported in Table 4.7, and sex-specific OR in Table
4.8.

Breeds

Breed was reported for 333 (97.7 %) of the 341 naturally occurring cases
(Table 4.9). The seven most frequently reported breeds with number (%) were:
Mixed 68 (20.4); Poodle 46 (13 .8); Labrador Retriever 16 (4.8); Gennan
Shepherd 15 (4.5); Great Dane 12 (3.6); Rottweiler 12 (3.6); and West Highland
White Terrier 12 (3.6). Breed-specific OR were calculated for these seven breeds
(Table 4. 10).

Serum Sodium and Potassium Concentrations

Serum sodium and potassium concentrations were reported for 250 (75 . 1 %)
of the 341 naturally occurring cases (Figures 4. 1 and 4.2, respectively). The
sodium to potassium ratios are reported in Figure 4.3. One hundred forty (56.0%)
of the ratios were 25.0 or less, the diagnostic indicator suggested by one
reference, 129 and 151 (60.4 %) were 27.0 or less, the diagnostic indicator suggested
by two others. 43•1 89
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Table 4. 7. Sexes of 329 Naturally Occurring Cases of Canine
Hypoadrenocorticism Seen in Veterinary Referral Hospitals in 1989-199 1 , United
States and Canada
Number

Percent

Female-intact

46

14.0

Female-spayed

177

53. 8

223

67.8

Male-intact

43

13 . 1

Male-castrated

63

19. 1

All males

106

32.2

329

100.0

Sexes

All females

All sexes
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Table 4.8. Sex-Specific Odds Ratios (OR) for Dogs with Naturally Occurring Hypoadrenocorticism Seen in Veterinary Referral Hospitals in 1 989-199 1 ,
United States and Canada
X: statistic (p value)

Sex*

Number of cases
n=297

Total number
of dogs
n = 1 8S,026

OR

95 % confidence
interval for OR49

Uncorrected40

Female-intact

43

43,206

0.56

0.40 - 0.78

13.05 (0.0003)

Female-spayed

159

52,839

2.88

2.28 - 3.64

90.60 ( < 0.0001)

Female-spayed*"'

159

52,839

3.02

2 . 1 3 - 4.30

45.75 ( < 0.000 1)

Female (intact and spayed)

202

96,045

1 .97

1 . 53 - 2.53

30. 8 1 ( < 0.000 1)

40

60,484

0.32

0.23 - 0.45

49. 8 1 ( < 0.0001)

Male-castrated

ss

28,497

1 .25

0.92 - 1 .69

2.21 (0. 1 37 1 )

Male-castrated***

55

28,497

2.92

1 .9 1 - 4.47

29. 1 6 ( < 0.0001)

2 14

8 1 ,336

3.29

2.53 - 4.27

94.99 ( < 0.000 1)

-...) Male-intact

.a::.

Neutered (either sex)

* Except as noted, the comparison group is all other dogs.
*"' Female-spayed compared to female-intact.
"'"'* Male-castrated compared to male-intact.

Table 4.9. Breeds of 333 Naturally Occurring Cases of Canine Hypoadrenocorticism Seen
Referral Hospitals

in VeteriDary

in 1989-199 1, United States and Canada

Number

Percent

Afghan Hound

1

0.3

Airedale Terrier

3

0.9

Alaskan Malamute

1

0.3

Junerican Foxhound

1

0.3

Australian Heeler

1

0.3

Australian Shepherd

4

1.2

Australian Terrier

1

0.3

Basset Hound

9

2.7

Beagle

3

0.9

Bearded Collie

3

0.9

Bedlington Terrier

1

0.3

Bichon Frise

2

0.6

Border Collie

3

0.9

Boston Terrier

1

0.3

Bouvier des Flandres

1

0.3

Brittany

1

0.3

Bull Terrier

1

0.3

Cairn Terrier

3

0.9

Chesapeake Bay Retriever

2

0.6

Chihuahua

4

1 .2

Chow Chow

2

0.6

Cocker Spaniel

6

1.8

Collie

1

0.3

Dachshund

5

1.5

Dandie Dinmont Terrier

1

0.3

Doberman Pinscher

8

2.4

English Bulldog

1

0.3

English Setter

1

0.3

Fox Terrier

2

0.6

French Bulldog

1

0.3

15

45

German Shorthaired Pointer

2

0.6

Golden Retriever

8

2.4

Gordon Setter

1

0.3

Breed

German Shepherd
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Table

4.9 (continued)

Breed

Number

Percent

12

3.6

2

0.6

Greyhound

1

0.3

Irish Setter

1

0.3

Irish Wolfhound

1

0.3

Keeshond

1

0.3

Kuvasz

1

0.3

Labrador Retriever

16

4.8

Mixed

68

20.4

Newfoundland

2

0.6

Nova Scotian Duck Tolling Retriever

1

0.3

Pit Bull Terrier

4

1.2

Pointer

4

1.2

Pomeranian

1

0.3

Poodle

46

13.8

Rottweiler

12

3.6

Saint Bernard

2

0.6

Samoyed

4

1 .2

Schipperke

1

0.3

Schnauzer

7

2.1

Scottish Terrier

3

0.9

Shar Pei

2

0.6

Shetland Sheepdog

2

0.6

Shih Tzu

2

0.6

Siberian Husky

3

0.9

Silky Terrier

1

0.3

Springer Spaniel

9

2.7

Vizsla

2

0.6

Weimaraner

1

0.3

Welsh Corgi

2

0.6

Welsh Terrier

1

0.3

12

3.6

Wheaten Terrier

3

0.9

Whippet

2

0.6

Yorkshire Terrier

1

0.3

Great Dane
Great

Pyrennes

West Highland White Terrier
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Table 4. 10. Selected Breed-Specific Odds Ratios (OR) for Dogs with Naturally Occurring Hypoadrenocorticism Seen in Veterinary Referral Hospitals in
1 989-199 1 , United States and Canada

X: statistic (p
value}
Number of cases
n=258

Number of controls
n = 149,208

OR

95 % confidence
interval for OR49

Uncorrected40

Mixed

58

34,697

0.96

0.71 - 1 . 29

0.09 (0.7689)

Poodle

35

1,045

3. 17

2. 1 8 . 4.58

44.65 ( < 0.000 1)

Labrador Retriever

9

10,255

0.49

0.24 . 0.98

4.61 (0.03 17)

German Shepherd

9

7,229

0.71

0.34 . 1 .42

1 .03 (0.3 105)

Great Dane

10

1 ,309

4.56

2.28 . 8.83

26.48 ( < 0.0001)

Rottweiler

7

3, 154

1 . 29

0.56 . 2.8 3 •••

0.45 (0.5038)

12

986

7.33

3.90 . 1 3.46

6 1 . 83 ( < 0.000 1)

Breed•

.....:)
.....:)

West Highland White
Terrier

"' The comparison group is all other dogs.
*"'

Calculated only if an expected cell value is < S; the preferred p value for this OR.

••• Inaccurate; exact calculation of confidence interval beyond computing ability.

Fisher exact (2-tailed
p value) ...,..161

0,000 1

< 0.0001
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Figure 4. 1 . Serum Sodium Concentrations for 250 Naturally Occurring Cases of Canine Hypoadrenocorticism Seen
in Veterinary Referral Hospitals in 1989-199 1 , United States and Canada
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Figure 4.2. Serum Potassium Concentrations for 250 Naturally Occurring Cases of Canine Hypoadrenocorticism
Seen in Veterinary Referral Hospitals in 1 989-199 1 , United States and Canada

30 T-------�

25 -1·-----�

C/1
CIJ
C/1
ca
0

...

0

...

c
CIJ

20

15

�

CIJ
a.

10

00
0

5

0
10.1-15.0

1 5.1-20.0

20.1-25.0

25.1-30.0

30.1-35.0

35.1-40.0

40.1-45.0

45.1-50.0

Serum Sodium to Potassium Ratios
Mean 25.2 (SO 8.3) (SEM 0.5) (Range 1 1 .1 -46.6)
Normal >=27.o or >=25.0

Figure 4.3 . Serum Sodium to Potassium Ratios for 250 Naturally Occurring Cases of Canine Hypoadrenocorticism
Seen in Veterinary Referral Hospitals in 1989-1991 , United States and Canada

One hundred fifteen (46.0%) of the sodium results were normal. Eighty-four
(33. 6 %) of the potassium results were normal. Fifty-eight (23 .2%) were normal

for both sodium and potassium. Forty-four percent were normal using the
diagnostic criterion for disease of a sodium to potassium ratio of 25.0 or less, and
39.6 % were normal using the 27.0 or less criterion. No case was normal for

sodium, potassium, and sodium to potassium ratio (using either the 25.0 or the
27.0 criterion).

Occurrence of Selected Clinical Findings

The most frequently reported (%) of the selected clinical findings among the
341 naturally occurring cases were anemia (6.7), hypothyroidism (5.9),

thrombocytopenia (3 .5), and megaesophagus (2.9). A complete list of frequencies
is included as Table 4. 1 1 .

Treatment

Of the reports for the 341 naturally occurring cases, 312 indicated whether
or not fludrocortisone acetate was used to treat the disease, and 285 indicated
whether DOCP was used. Of those, 235 (75.3 %) and 36 (12.6%) used,
respectively, fludrocortisone acetate and DOCP (Table 4. 12).
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Table 4. 1 1 . Frequency of Occurrence of Selected Clinical Findings* for 341
Naturally Occurring Cases of Canine Hypoadrenocorticism Seen in Veterinary
Referral Hospitals in 1989-1991, United States and Canada
Number

Percent

Anemia

23

6.7

Arthritis

3

0.9

Cruciate ligament rupture

2

0.6

Diabetes mellitus

2

0.6

Hepatitis

4

1 .2

20

5.9

4

1 .2

10

2.9

Myasthenia gravis

4

1 .2

Nephritis

3

0.9

12

3 .5

Clinical f"mdiog

Hypothyroidism
Keratoconjunctivitis sicca
Megaesophagus

Thrombocytopenia

*Clinical findings were chosen either because of their anecdotal association with
canine hypoadrenocorticism, or their putative autoimmune etiology.
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Table 4. 12. Treatment of 341 Naturally Occurring Cases of Canine Hypoadrenocorticism Seen
in Veterinary Referral Hospitals in 1989-199 1 , United States and Canada

Total number
of dogs*

Number o f dogs
treated with drug

Percent

Desoxycorticosterone p ivalate

285

36

12.6

Fludrocortisone acetate

312

235

75.3

Treatment

*Indicates th e number o f dogs o f the 341 naturally occurring cases where reports indicated
whether or not the drug was used for treatment.
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Odds Ratios for Diseases (or Other Reasons for Presentation of Dogs to
Veterinary Referral Hospitals) Hypothetically Not Associated with
Hypoadrenocorticism

The OR for these diseases are included in Table 4. 1 3 . When case information
was requested the second time from the VMDB, information on 434 cases was
received. This number of cases differed from the 376 reported earlier for two
reasons. First, the VMDB is constantly being updated. Second, to be included in
the 376, a Case Data Abstract Form had to be provided by the institution. In
contrast, diseases or other reasons for presentation that were coincident with cases
of canine hypoadrenocorticism could be extracted directly from the VMDB.

Discussion

Institutional Participants

Virtually all the colleges of veterinary medicine in the United States and
Canada submitted data, and data were very complete. A weakness of the study was
that colleges of veterinary medicine are referral hospitals which do not represent
all

veterinary hospitals. A corollary was that colleges of veterinary medicine are

a particular kind of referral hospital which do not necessarily represent all
veterinary referral hospitals.
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Table 4. 13. Odds Ratios (OR) for Diseases or Other Reasons for Presentation to Veterinary Referral Hospitals for Dogs with Naturally Occurring or
Iatrogenic Hypoadrenocorticism in 1989-199 1 , United States and Canada
X: statistic (p
value)
Disease or reason
for presentation*

00
Vl

Number of cases

Number of controls

n=434

n= 189,909

OR

95% confidence
interval for OR49

Uncorrected40

Fisher exact (2-tailed
p value)**162

Cataracts

6

5,6 15

0.46

0. 19-1 .06*"'"'

3. 74 (0.0530)

Dental tartar

20

4,284

2.09

1.30-3.34

10.84 (0.0010)

Fleas

5

2,428

0.90

0.33-2.25*"'"'

0.05 (0.8148)

Heartworm infection

0

1,472

0.00

0.00-1.42"'"'"'

3.39 (0.0656)

0.0881

Mitral insufficiency

7

1,394

2.22

0.96-4. 83"'"'"'

4.58 (0.0324)

0.0435

Rabies vaccination

24

25,447

0.38

0.24-0.58

23. 14 ( < 0.0001)

Squamous cell carcinoma

0

653

0.00

0.00-3.21"'"'"'

1 .50 (0.221 1)

"'
••

The comparison group is all other dogs.
Calculated only if an expected cell value is < 5; the preferred p value for this OR.

"'"'"' Inaccurate; exact calculation of confidence interval beyond computing ability.

0.4 127

Cases

The large numbers of cases, 341 naturally occurring and 35 iatrogenically
produced, provided, at least for summary calculations for the entire population,
reasonable confidence in the results. This confidence diminished as the overall
population was subdivided by variables such as sex and breed.

Incidence and Prevalence Estimates

A discussion of the incidence and prevalence estimates must be prefaced with
an understanding of the method underlying their calculation. Most fundamental are
the definitions of incidence and prevalence. Incidence was defined as the number
of new cases diagnosed during this time period divided by the population at risk.
This

definition

1s

consistent

with

several

textbook

definitions

of

incidence. 50•123•188•190 The population at risk was defined as all dogs (individual
dogs, not dog visits) which were presented to veterinary referral hospitals during
these years for any reason. Since all dogs can develop hypoadrenocorticism, the
only dogs which should have been excluded from the population at risk were those
which already had the disease. But, since the disease is so uncommon, these cases
were ignored; i.e. , the denominator would not change substantially whether or not
they were included.
The incidence estimates of 1 . 7 cases/1000 dogs/3 yr (0.6 cases/1000 dogs/yr)
for naturally occurring disease provide useful information to veterinary
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practitioners who need to know roughly how many cases they might expect to see
in their practices. For example, if a practice sees 5,000 dogs a year, it would
expect to see (5000) (0.6)

=

3 dogs with hypoadrenocorticism. Chance will dictate

a good deal of variation among practices, but if the practice did not diagnose any
cases (or, conversely, diagnosed two dozen), the veterinarians in the practice might
want to reevaluate their approach to hypoadrenocorticism. Similarly, with the
prevalence estimates of 2.8 cases/1000 dogs for naturally occurring disease, the
veterinarians might look askance at their diagnostic acumen if they had 10,000
patient records and no cases of hypoadrenocorticism (or, conversely, 100 cases).
So, both the incidence and prevalence estimates should be useful to the
veterinarian. This logic must be cautiously considered since the data extant came
from veterinary referral hospitals and the interpretation has been extended to
private veterinary practitioners. Since veterinarians may be more likely to refer
cases of canine hypoadrenocorticism, this logic is more sound for veterinarians in
referral hospitals than for those in private practice.
The prevalence estimate for naturally occurring and iatrogenically produced
canine hypoadrenocorticism should be useful to producers of drugs used to treat
the disease. The prevalence estimate would help the producers plan for the
manufacture, marketing, and distribution of their drugs as illustrated below.
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Microcrystalline DOCP is used as a mineralocorticoid to treat hypoadrenal
dogs. The dosage of the drug used therapeutically varies among dogs, but averages
about 1 mg/4.5kg/25da. Using an estimate of the United States dog population of
52.5 million, 6 and an estimate of 22.4 kg for the average weight of a hypoadrenal
dog (see Chapter 3), the following computation is straightforward.

Potential amount of DOCP (mg)
which could be used in one
Dog population
(dogs)
yr in United States
=

dose (mg/kg/da)

1 mg/4.5 kg/25 da

•

365 da
= 52,500,000
yr
total dogs
•

365 da
yr

•

•

Prevalence (diseased dogs)
(dogs)
•

3. 1 diseased dogs
1000 dogs

•

•

Average weight (kg) •
diseased dog

22.4 kg
diseased dog

•

1 1,830,000 mg/yr

This computation assumes that DOCP is the only drug used to treat canine
hypoadrenocorticism, which it is not. The computation does, however, indicate the
potential market for the drug, and can be adapted to accommodate a market
penetration of whatever percent seems reasonable. For example, a 20 % market
penetration would require 20% of the above amount of DOCP per yr.
The sex-specific incidence estimates {Table 4.3) suggested that female dogs
are more likely to be hypoadrenal than males. This was indicated by the incidence
estimate of0.7 case/1000 female dogs/yr compared to 0.4 case/1000 male dogs/yr.
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The data also suggested the possibility that neutering either a female or a male
leads to an increased probability of disease. The incidence estimate for female
spayed was 1 .0 case/1000 female-spayed dogs/yr, three times the incidence
estimate for female-intact dogs, which was 0.3 case/1000 female-intact dogs/yr.
Similarly, the incidence estimate for male-castrated dogs was 0.6 case/1 000 male
castrated dogs/yr, compared to the incidence estimate for male-intact of 0.2
case/1000 male-intact dogs/yr. There may be variables such as age which mitigate
this seeming predilection of the neutered dog for hypoadrenocorticism. Increased
age (Table 4.6) and neutering (Table 4.8) led to a predilection for the disease. This
possibility will be explored by stratified data analysis in Chapter 5 .
The breed-specific incidence estimates (Table 4.4) suggested that Great Danes
(7.6 cases/1000 dogs/3 yr), Poodles (4.9 cases/1000 dogs/3 yr), and West
Highland White Terriers (12.0 cases/1000 dogs/3 yr) were at increased risk. Other
variables may account for this effect, but none is an obvious possibility.
Using 1989, 1990, and 1991 registration statistics for the American Kennel
Club,11.s.1 17 the same years included in this study, Great Danes comprised 0.7% of
total registrations, Poodles 5.9 % , and West Highland White Terriers 0.9 % . In this
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study (using Table 4.9 and calculating breed percentages of pure-bred dogs only,
i.e., excluding Mixed dogs), Great Danes comprised 4.5 % of total cases, Poodles
17.4 % , and West Highland White Terriers 4.5 % . These percentages were all
substantially higher than for the general population. Recognizing that American
Kennel Club registrations do not represent all pure-bred dogs, this was further
evidence that these breeds were more likely to be hypoadrenal.

r

Ages at Diagnosis

The average ages at diagnosis (Table 4.5) were unremarkable with the
possible exception of the difference between the average age for female-intact dogs
of 3 .9 yr compared to female-spayed dogs of 5.9 yr. Older dogs may be more
likely to be spayed than younger ones, but a similar disparity might be expected
between male-intact and male-castrated. But this difference did not exist between
the 5.2 yr and 5.3 yr ages of male-intact and male-castrated dogs, respectively.
Perhaps owners who eventually spay their females delay the procedure for some
reason, while owners who castrate their males are less likely to delay. (Data on
To ensure that the 1989, 1990, and 1991 American Kennel Club registrations
represented American Kennel Club registrations over a longer time period, and
that the percentages of these breeds in the general population were relatively stable
over time; percentages of total registrations for Great Danes, Poodles, and West
Highland White Terriers were calculated for the years 1981 through 1988. These
were: Great Danes 1 . 0 % , Poodles 7. 9 % , and West Highland White Terriers 0. 8 % .
These were all consistent with the percentages for 1989, 1990, and 199 1 , and
107fHPPOrted the conclusion that these breeds were more likely to be hypoadrenal.
r
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average age at the time of spaying or castrating, as well as proportion of males
and females neutered, would be useful in addressing this issue.) In any case, the
age disparity between female-intact and female-spayed was interesting, but
unexplained.
Regarding age-specific OR in Table 4.6, dogs in the 0-1 yr age range were
less likely to be diseased (OR

=

0. 12), though dogs as young as 0. 1 yr were

diagnosed. Dogs in the 1-4 yr age range had neither an increased nor decreased
probability of disease (OR

=

1 .01), but age beyond 4 yr seemed to predispose to

disease. Significant OR for the 4-7 yr and 7-10 yr age groups were 1 .90 and 1 .5 1 ,
respectively. Variables other than age were possibly involved, but an age effect
seemed clear. The age effect seemed to disappear in very elderly dogs--the OR for
the over 10 yr age group was not significant. Nevertheless, three 15 yr old dogs
were diagnosed as hypoadrenal. While recognizing the necessarily arbitrary
selection

of the age

categories

above,

the

probability

of onset

of

hypoadrenocorticism in dogs increased with age, significantly between 4 and 10
yr.

Sexes

Females (intact and spayed) made up 5 1 .9 % of dogs in the 1989, 1990, and
1991 VMDB data base; males (intact and castrated) made up the remaining 48. 1 % .
Among the hypoadrenal dogs, 67.8 % were females (intact and spayed) and 32.2%
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were males (intact and castrated) (Table 4. 7). The predisposition of females to the
disease has been reported previously.41 •43•93• 148• 1 89 This study confirmed this effect
by the sex-specific incidence of hypoadrenocorticism among females (intact and
spayed) of 2. 1 cases/1000 female dogs/3 yr compared to 1 . 1 cases/1000 dogs/3 yr
for males (intact and castrated) (Table 4.3).
Since female-spayed comprised 53 . 8 % (Table 4.7) of all the hypoadrenal
patients in this study, it seemed that female-spayeds were at increased risk of
having adrenal insufficiency. This could have resulted from an overrepresentation
of female-spayeds in the overall population. However, the overall population of
dogs reported to the VMDB in 1989, 1990, and 199 1 included only 27.7% female
spayed dogs. Though other variables may be at work, it seemed likely that the
large percentage of female-spayeds in the diseased population resulted from a real
predisposition of female-spayeds to the disease. This was consistent with the
discussion above of sex-specific incidence estimates.
Interestingly, female-intact dogs comprised 14.0 % of the hypoadrenal
patients, and 24.3 % of the general VMDB population . This suggested that an
unspayed female may be less likely to be hypoadrenal. This was consistent with
the sex-specific incidence estimates. It was inconsistent, however, with one report
that female-intacts had a higher risk than female-spayeds . 148
Male-castrates were 15. 1 % of the overall population, but were 19. 1 % of the
diseased group. This suggested that being neutered might increase the likelihood
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of disease. This was consistent with the sex-specific incidence estimates since
male-castrates had a substantially higher incidence of disease than male-intact
dogs. However, the overall incidence estimate for male-castrates (Table 4.3) was
exactly the same as the incidence estimate for all dogs of all sexes of 1 .9
cases/1000 dogs (all sexes)/3 yr.
The results for male-intact dogs were striking. They comprised 33.0% of the
general VMDB population, but only 13 . 1 % of the diseased population. This
suggested that male-intact dogs were less likely to be hypoadrenal than castrated
ones, and this was supported by the sex-specific incidence estimate of 0.7
case/1 000 male-intact dogs/3 yr compared to the incidence estimate for all dogs
of all sexes of 1 .9 cases/1000 dogs (all sexes)/3 yr.
The sex-specific OR reported in Table 4.8 reinforced these conclusions.
Females (intact and spayed) were more likely to be diseased than males (intact and
castrated). Female-spayeds were more likely to be hypoadrenal compared to all
other dogs and female-intact dogs. Male-castrates were (OR 1 .25 compared to all
other dogs, and OR 2.92 compared to male-intact dogs) more likely to be
diseased.s Female-intact dogs (OR 0.56) and male-intact dogs (OR 0.32) were less
likely to be affected.

1All the OR reported here were highly significant (p < 0.001) except the OR

1 .25 (p

=

0. 15) for male-castrates compared to all other dogs.
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Since female-spayed and male-castrated dogs seem predisposed to
hypoadrenocorticism, a neutering effect may be at work. This was reinforced by
the OR of 3 .29 (p < 0.0001) for neutered animals of either sex compared to intact
animals of either sex (Table 4.8). This may have been affected to some extent by
the age effects discussed above.

Breeds

Sixty-nine breeds were reported among the 333 naturally occurring cases
which reported breed (Table 4.9). This established that hypoadrenocorticism can
occur in many breeds.
The OR for the seven most frequently reported breeds (Table 4. 1 0) indicated
.

a predisposition for hypoadrenocorticism among the following breeds: Poodle (OR
3 . 17, p < 0.0001); Great Dane (OR 4.56, p

=

0.0001); and West Highland

White Terrier (OR 7.33, p < 0.0001). Another paper reported breed predilections
in the Standard Poodle, Great Dane, and West Highland White Terrier. 148 The OR
for the Labrador Retriever was 0.49 (p < 0.05), indicating that Labrador
Retrievers were less likely to be diseased. Possible familial predispositions for
hypoadrenocorticism have been reported in this breed.69
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Serum Sodium and Potassium Concentrations

Of the 250 naturally occurring cases for which serum sodium and potassium
concentrations were available, 1 15 (46.0%) had normal sodium concentrations, 84
(33 . 6 %) had normal potassium concentrations, and 58 (23.2%) had both normal
sodium and potassium concentrations. These results differed from others which
showed that only 18.7% and 4.4% of hypoadrenal dogs had normal serum sodium
and potassium concentrations, respectively. 148 Forty-four percent had normal
sodium to potassium ratios using the 25.0 or less diagnostic criterion, 129 and 39.6 %
had normal ratios using the 27.0 or less criterion.43•189 The remarkable result was
that no one case of the 250 was normal for all three diagnostic criteria--sodium
concentration, potassium concentration, and sodium to potassium ratio (regardless
of whether the less than 25.0 or the less than 27.0 criterion was used). This
suggested that a dog diagnosed with hypoadrenocorticism will usually have an
electrolyte abnormality. This could mean that most veterinarians are already not
diagnosing hypoadrenocorticism in dogs normal by all three criteria. If they are
not, it means they should seldom go to the time, trouble, and expense of the
ACTH stimulation test.

Occurrence of Selected Clinical Findings

The frequency (%) of occurrence of anemia (6.7), hypothyroidism (5.9),
thrombocytopenia (3.5), and megaesophagus (2.9) suggested that these conditions
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were associated with canine hypoadrenocorticism (Table 4. 1 1). However, since
this study contained no data about the frequency of these clinical findings in the
entire study population, these results must be viewed as anecdotal.

Treatment

Fludrocortisone acetate and DOCP were used in 75.3 % and 12.6% of the
patients, respectively. The more common use of fludrocortisone acetate may result
from its advantages: oral administration, glucocorticoid and mineralocorticoid
activity,69 and its easy availability since it is currently approved by the United
States Food and Drug Administration (FDA). It has some disadvantages as well:
cost in large dogs, difficulty of use in animals resistant to taking oral medication,
large doses sometimes required,69 occurrence of significant polyuria and polydipsia
in some patients, 69 and the failure of some dogs to respond to it. 69 Microcrystalline
DOCP has the advantages of nearly universally favorable response in dogs, and
its use obviates the need for daily administration since it is given by intramuscular
injection about every 25 da. Its disadvantages are: the need to visit the veterinarian
for an injection every 3 to 4 wk; it often requires supplemental administration of
glucocorticoids;69 and it is more difficult to obtain since it is not approved by the
FDA. Though both drugs will have therapeutic niches, the test of which drug is
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preferred by owners and veterinarians will have to wait until both drugs are readily
available to the veterinary practitioner.

Odds Ratios for Diseases (or Other Reasons for Presentation of Dogs to
Veterinary Referral Hospitals) Hypothetically Not Associated with
Hypoadrenocorticism

Data on seven diseases not believed to be associated with canine
hypoadrenocorticism were obtained from the VMDB as a methodology check. Of
the seven items included in Table 4. 13, four-cataracts, fleas, heartworm infection,
and

squamous

cell

carcinoma--were

not

statistically

related

to

hypoadrenocorticism. This was expected since these diseases were intuitively not
related to hypoadrenocorticism.
Two of the items--dental tartar and rabies vaccination--were positively and
negatively associated, respectively, with hypoadrenocorticism. These results were
unexplained, but dental tartar and hypoadrenocorticism may have been associated
because each was associated with older age. Conversely, younger dogs may have
had a lesser tendency to be hypoadrenal and a greater tendency to be vaccinated
for rabies; therefore, adrenal insufficiency and rabies vaccination were negatively
associated.
The results for mitral insufficiency were equivocal in that the Cornfield's
approximate 95 % confidence interval included one, but the 2-tailed Fisher exact
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p value was 0.0435. Since the Cornfield's approximation could be considered
inaccurate in this case, and an exact computation of the confidence interval was
beyond the computer's capability, the 2-tailed Fisher exact p value should be
considered definitive, thus leading to the conclusion that mitral insufficiency and
hypoadrenocorticism were positively associated. If so, they may have been
associated through age, as may be the case with hypoadrenocorticism and dental
tartar.

Conclusions

1.

Incidence and Prevalence Estimates. The incidence (0.6 case/1000

dogs/yr for naturally occurring, and 0.6 case/1000 dogs/yr for naturally occurring
and iatrogenic) and prevalence (2.8 cases/1000 dogs for naturally occurring and
3 .2 cases/1000 dogs for naturally occurring and iatrogenic) estimates from this
study

can

serve

as

baselines

for

the

expected

caseload

of canine

hypoadrenocorticism for referral hospitals. They could be used by pharmaceutical
companies for marketing decisions.
2.

Sex-Specific Incidence Estimates and Sex Predispositions. Sex-specific

incidence estimates suggested that female dogs were more likely than males to
develop hypoadrenocorticism. Further, the data suggested that neutering either
females or males increased the incidence of disease. This effect may have been
exacerbated by other variables, possibly age.
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The overrepresentation of females, particularly female-spayeds, in the
diseased population compared to the entire VMDB population suggested that
females, especially those spayed, were at increased risk for hypoadrenocorticism.
It also appeared that intact animals of either sex were less likely to develop disease

than their neutered counterparts. These conclusions were supported by both sex
specific OR and incidence rates.
3.

Breed-Specific Incidence Estimates and Breed Predispositions. Breed

specific incidence estimates suggested that Great Danes, Poodles, and West
Highland

White

Terriers

hypoadrenocorticism.

Other

were

at

variables

increased
may

be

risk
involved.

of

developing

These

breed

predispositions were supported by a pronounced overrepresentation of these
breeds in the study population of diseased dogs compared to American Kennel
Club breed registrations for the same years. Labrador Retrievers were less likely
to have the disease.

4.

Age-Specific Odds Ratios. Age-specific OR indicated that increasing age

was associated with an increased risk of developing disease. This effect was
particularly profound between the ages of 4 and 10 yr.
5.

Serum

Sodium

and Potassium

Concentrations.

No dog with

hypoadrenocorticism was normal for serum concentrations of sodium and
potassium and the sodium to potassium ratio. This suggested that dogs with this
disease seldom are normal for all three diagnostic criteria. As a practical matter,
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this means that veterinarians considering hypoadrenocorticism in a canine patient
can usually remove hypoadrenocorticism from the list of differential diagnoses if
all three diagnostic tests are within normal limits.

6.

Associated Conditions. Anemia, hypothyroidism, thrombocytopenia, and

megaesophagus were positively associated with canine hypoadrenocorticism. This
conclusion was based on anecdotal data, and must be viewed skeptically. These
associations warrant further investigation.

7.

Treatment. Fludrocortisone acetate was much more frequently used than

DOCP to treat hypoadrenocorticism. This probably resulted from several factors,
but the principal reason was probably that fludrocortisone acetate was more easily
available to veterinarians.
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CHAPfER 5

CASE CONTROL STUDY USING PATIENTS OF
VETERINARIANS ENROLLED IN THE CLINICAL TRIAL OF
MICROCRYSTALLINE DESOXYCORTICOSTERONE PIVALATE

Introduction

To this point the study has focused almost exclusively on cases of
hypoadrenocorticism: cases from the literature (Chapter 2), cases enrolled in the
clinical trial of microcrystalline desoxycorticosterone pivalate (DOCP) (Chapter
3), and cases from veterinary referral hospitals (Chapter 4). The cases have, with
a few exceptions for data gathered from veterinary referral hospitals, been without
controls. This limits the utility of any result. For example, if a certain percent of
cases are Poodles, and the percent seems to be inordinately high, does this
represent a breed predisposition for hypoadrenocorticism or not? Therefore,
controls needed to be obtained with cases as described in this chapter.

Methods

The veterinarians enrolled in the Ciba Animal Health clinical trial of DOCP
provided an ideal source of controls to compare with the hypoadrenal dogs.
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Detailed information was already known about the veterinarians and their patients,
and the veterinarians were accustomed to providing data. Therefore, a case control
study was designed using these veterinarians as respondents. The cases were the
dogs enrolled in the clinical trial. The two controls for each case were the next
dog in the veterinarian's patient record file which was owned by a different client,
and the fifth dog owned by a different client after the first control dog (see
Appendices A6 and A7). Whether the control dogs were sick or well wa8 not
considered.
A questionnaire (Appendices A4 and A5) with instructions (Appendices A6
and A7) was designed and used to query veterinarians enrolled in the clinical trial.
Veterinary hospitals known by Ciba Animal Health personnel to be referral
hospitals were not queried. The method of Dillman,35 slightly abbreviated, was
used for the mail survey. This involved mailing the questionnaire with instructions
and cover letter to 571 veterinarians who had diagnosed 767 cases of canine
hypoadrenocorticism. A follow-up reminder letter was sent to all the veterinarians
approximately 1 wk after the initial mailing, and subsequent mailings with
additional questionnaires and cover letters were made to those not known to have
responded approximately 4 and 7 wk after the initial mailing.
The questionnaire requested the number of dogs (not dog visits) seen in the
veterinary practice in 1 993, and the age, breed, sex, body weight, and other
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diseases diagnosed for cases and controls selected randomly from the hospital's
patient files. These data were used to calculate odds ratios (OR).
Confidence

intetvals

for

OR

were

calculated

using

Cornfield's

approximation.49 If Cornfield confidence limits were inexact, exact confidence
limits were calculated. 128 Uncorrected chi-square statistics were reported.40 Fisher
exact probability calculations for the 2x2 contingency tables were calculated when
the expected value of a cell was less than five. 162 Appendix B contains further
details regarding these calculations. Body weights for cases and controls were
compared using a technique for comparing means of unequal variances. 130
Logistic regression was done using JMp® statistical software. 177 Breeds were
specifically included in the logistic regression if they met two sequential criteria.
First, if the breed was represented in the study by either five cases or five
controls, an OR was calculated for the breed. Second, if the 95 % confidence
interval for the breed's OR did not include one, the breed was included in the
logistic regression. If the breed had neither five cases nor five controls in the
study, or if the 95 % confidence interval for its OR did include one, then it was
categorized as "Other11 in the logistic regression. Sexes were categorized as
female-intact, female-spayed, male-intact, and male-castrated. The units were yr
for age and kg for body weight.
Logistic regression models were developed generally using the method
advocated by Hosmer and Lemeshow. 80 This method calls for variable selection
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first by a univariate analysis of each variable; second, by the selection from the
univariate analysis of variables to be included in a multivariate analysis; third, by
a verification of the importance of each variable included in the multivariate
model; and, last, by consideration of whether or not to include variable interaction
terms in the model. This was done with the following admonition about the
pwpose of logistic regression:
Before beginning a study of logistic regression it is important to understand
that the goal of an analysis using this method is the same as that of any
model-building technique used in statistics: To find the best fitting and most
parsimonious, yet biologically reasonable model to describe the relationship
between an outcome (dependent or response variable) and a set of
independent (predictor or explanatory) variables. 78
Dogs were frequently reported as simply "Poodle" or 11 Schnauzer'' without
size specification. Therefore, all Poodles (Standard, Miniature, and Toy) have
been reported as one breed, and all Schnauzers (Giant, Standard, and Toy) have,
similarly, been reported as one breed.
The selected clinical findings were chosen for inclusion in the questionnaire
either because of their anecdotal association with canine hypoadrenocorticism, or
their putative autoimmune etiology. The list of selected clinical findings is not
exhaustive.
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Results
Questionnaire Responses and Description of Veterinary Clinics

Five hundred nineteen (90.9 %) of the 571 veterinarians from 494 separate
veterinary clinics in the United States returned questionnaires on 720 cases and
1 , 192 controls. One case was not included in the computations in this chapter

(except for Figure 5. 1) because the computations were completed before the
response was received. The first response was received 7 da after the first mailing,
and the last response was received 240 da after. Figure 5. 1 graphs number of
responses received vs. time after initial mailing.
Four hundred fifty-nine veterinarians reported a total of 1 ,208 full-time
veterinarians in the 459 clinics for an average of 2. 6 per clinic (SD 1 . 7) (SEM'
0 . 1) (Range 1 .0 - 13 .0). Figure 5.2 plots the number of full-time veterinarians in

the clinics vs. the percent of clinics employing that number of veterinarians.
Four hundred two of the veterinary clinics reported the number of dogs
diagnosed with canine hypoadrenocorticism in 1993 and the estimated number of
active dog patientsu seen in the practice in 1993. The estimated number of dogs
diagnosed for 1993 was 495.5 by the 402 veterinary clinics for a mean of 1 .23

'Standard error of the mean (SEM) equals the standard deviation (SD)
divided by the square root of the sample size.
uAn active dog patient was a dog seen in the practice in 1993 . Dogs were
counted only once, even if several visits to the hospital were made in 1993 .
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Clinical Trial

dogs newly diagnosed per clinic (SD 1 .9) (SEM 0. 1) (Range 0.0 - 21 .0) . These
402 clinics estimated that they saw 1 ,472,081 active dog patients during 1993.
Four hundred one clinics reported the number of dogs diagnosed in 1993 and the
number of full-time veterinarians employed in these clinics. The average annual
number of dogs diagnosed per full-time veterinarian was 0.53 (SD 0.92) (SEM
0.05) (Range 0.00 - 10.50). Four hundred six clinics reported the number of active
dog patients seen in the practice in 1993 and the number of full-time veterinarians
employed in these clinics. The average annual number of active dog patients seen
per full-time veterinarian was 1504.7v (SD 929.5) (SEM 46. 1) (Range 86.0 7000.0).

Incidence and Prevalence Estimates

Incidence was estimated at 0.34 case/1000 dogs/yr by dividing 495.5
estimated cases in 1 993 by 1 ,472,08 1 estimated dogs seen in practices in 1993.
This incidence estimate led to a prevalence estimate of 1 . 7 cases/1 000 dogs by
multiplying the incidence estimate by the average disease duration estimate of 4.9
yr (see Ages below). 3.98. t20.123 .t68.200.21S,239
Prevalence

=

(Incidence) (Average disease duration)

vnis was similar to the estimate of 1 ,600 dogs seen per veterinarian per yr
obtained on July 29, 1996 from personal communication with Dr. J. Karl Wise,
Center for Information Management, American Veterinary Medical Association.
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Ages

The ages reported in this survey were current age or age at death or age
when lost to follow-up, depending on which age applied to the particular patient.
This was a different definition of age from the ages at diagnosis reported in
Chapter 4, and was used so that the ages of cases and controls could be compared.
There were 666 (92.6 %) of the 719 hypoadrenal cases which reported age.
The mean age was 8 .7 yr (SD 3.2) (SEM 0. 1) (Range 1 .0 - 18.0). These ages are
displayed in Figure 5.3. Of these 666 cases, 405 (60.8 %) were alive, 23 1 (34.7 %)
were dead, 20 (3 .0%) were lost to follow-up, and 10 (1 .5 %) were of unknown
status. The average current age was 8 . 1 yr (SD 3 .0) (SEM 0. 1) (Range 1 .5 - 1 8.0)
compared to average age at death of 9.8 yr (SD 3 .4) (SEM 0.2) (Range 1 .0 17.2) , and average age when lost to follow-up of 8.6 yr (SD 3 . 1) (SEM 0.7)
(Range 4.0 - 13 .0). These data were combined and displayed in Figure 5.3.
Age was reported for 1 , 163 (97.6 %) of the 1 , 192 controls. The mean age
was 6.2 yr (SD 4. 1) (SEM 0. 1) (Range 0. 1 - 19.0) as displayed in Figure 5.4. Of
these 1 , 163 controls, 954 (82.0%) were alive, 44 (3 . 8 %) were dead, 98 (8.4%)
were lost to follow-up, and 67 (5. 8 %) were of unknown status. The average age
of the live dogs was 6 . 1 yr (SD 3 .9) (SEM 0. 1) (Range 0. 1 - 19.0) . The average
age at death of the dead dogs was 10.2 yr (SD 5.2) (SEM 0.8) (Range 0.3 - 17.0) .
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The average age of the dogs lost to follow-up was 5.7 yr (SD 4.3) (SEM 0.4)
(Range 0.2 - 16.0).
Age-specific OR and relevant statistics are presented in Table 5 . 1 .
Average disease duration was estimated as 4.9 yr by subtracting the estimated
average age at diagnosis (4.9 yr) from the average age at death (9. 8 yr). Average
age at death was likely influenced by euthanasia of dogs whose owners chose not
to treat their dog. This average age at diagnosis was estimated with a weighted
average of 4.3 yr for 244 1iterature review cases (Chapter 2), 4.9 yr for 232 cases
enrolled in the clinical trial of DOCP (Chapter 3), and 5.4 yr for 329 cases from
veterinary referral hospitals (Chapter 4).

Sexes

Sex was reported for 7 1 1 (98.9%) of the 719 cases and 1 , 152 (96.6%) of the
1 , 192 controls (Table 5.2). Sex-specific OR are presented in Table 5.3. Age
stratified sex-specific OR were calculated for the age intervals (yr) 0 < age < 5,
5 ::; age < 10, and age � 10 (Tables 5.4 - 5.6).
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Table S. l . Age*-Specific Odds Ratios (OR) for Dogs with Hypoadrenocorticism from 1994 Survey in the United States of Veterinarians Enrolled
in Clinical Trial
x.2 statistic (p value)

-

IJ,)

Age interval (yr)**

Number of cases
n=666

Number of controls
n = 1 , 163

OR

95% confidence
interval for OR'"

Uncorrected40

0 < age < 1

0

52

0.00

0.00 - 0. 12***

30.65 ( < 0.0001)

1 � age < 2

3

89

0.05

0.01 - 0. 17***

45.98 ( < 0.0001)

2 � age < 3

6

129

0.07

0.03 - 0. 16***

64.34 ( < 0.0001)

3 � age < 4

21

1 19

0.29

0.17 - 0.47

30.02 ( < 0.0001)

4 � age < S

51

108

0.81

0.56 - 1 . 16

1 .42 (0.2342)

5 � age < 6

52

92

0.99

0.68 - 1 .42

0.01 (0.9374)

6 � age < 7

54

88

1.08

0.75 - 1 .56

0. 17 (0.677 1)

7 � age < 8

75

78

1 .77

1 .25 - 2.49

1 1 .46 (0.0007)

8 � age < 9

74

69

1 .98

1.39 - 2.83

15.16 (0.0001)

9 � age < 10

70

77

1 .66

1.16 - 2.36

8.67 (0.0032)

10 � age < 1 1

69

68

1.86

1.29 - 2.68

12.45 (0.0004)

1 1 � age < 12

46

41

2.03

1.29 - 3.20

10.69 (0.001 1)

1 2 � age < 13

56

49

2.09

1 .38 - 3. 16

13.77 (0.0002)

13 � age < 14

40

41

1 .75

1 .09 - 2.80

6. 16 (0.0131)

1 4 � age < 15

28

30

1 .66

0.95 - 2.88

3.64 (0.0564)

age � IS

21

33

1.11

0.62 - 2.01

0. 15 (0.7012)

* Current age o r age at death or age when lost to follow-up.
** The comparison group is all other dogs.
*** Exact confidence limits. lltl

Table 5.2. Sexes of71 1 Cases of Canine Hypoadrenocorticism and 1 , 152 Controls
from 1 994 Survey in the United States of Veterinarians Enrolled in Clinical Trial
Controls

Cases
Sexes

Number

Percent

Number

Percent

Female-intact

37

5.2

157

13.6

Female-spayed

454

63.9

474

41 . 1

491

69. 1

63 1

54.8

73

10.3

272

23 .6

Male-castrated

147

20.7

249

21.6

All males

220

30.9

521

45.2

711

100.0

1 , 152

100.0

All females

Male-intact

All sexes
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Table 5.3. Sex-Specific Odds Ratios (OR) for Dogs with Hypoadrenocorticism from 1994 Survey in the United States of Veterinarians Enrolled
in Clinical Trial
X: statistic (p value)
Number of cases
n=7 1 1

Number of controls
n = 1 , 152

OR

95 % confidence
interval for OR49

Uncorrected40

Female-intact

37

157

0.35

0.24 - 0.51

33.45 ( < 0.0001)

Female-spayed

454

474

2.52

2.07 - 3.08

90.68 ( < 0.000 1 )

Female-spayed**

454

474

4.06

2.74 - 6.06

57.88 ( < 0.0001)

Female (intact and spayed)

491

63 1

1 .84

1 .51 - 2.25

37. 18 ( < 0.0001)

Male-intact

73

272

0.37

0.28 - 0.49

51 .10 ( < 0.0001)

Male-castrated

147

249

0.95

0.75 - 1 .20

0.22 (0.6410)

Male-castrated*"'*

147

249

2.20

1.56 - 3. 10

22.50 ( < 0.0001)

Neutered (either sex)

601

723

3.24

2.54 - 4. 13

101 .00 ( < 0.0001)

Sex*

......
......

U'l

"' Except as noted, the comparison group is all other dogs.
"' "' Female-spayed compared to female-intact.
"' *"' Male-castrated compared to male-intact.

Table 5.4. Sex-Specific Odds Ratios (OR) for Dogs (0 yr < Age < 5 yr) with Hypoadrenocorticism from 1994 Survey in the United States of
Veterinarians Enrolled in Clinical Trial
X: statistic {p value)
Number of cases
n=81

Number of controls
n = 478

OR

95% confidence
interval for OR49

Uncorrected40

Female-intact

6

108

0.26

0.09 - 0.65••

9.84 (0.0017)

Female-spayed

38

134

2.27

1 .37 - 3.77

1 1 .59 (0.0007)

Female-spayed•••

38

134

5. 10

2.03 - 15.26*"'

14.92 (0.0001)

Female (intact and spayed)

44

242

1 . 16

0.70 - 1 .91

0.38 (0.5386)

Male-intact

11

141

0.38

0. 18 - 0.76

8.86 (0.0029)

Male-castrated

26

95

1.91

1 . 10 - 3 .29

6.10 (0.0 135)

Male-castrated••••

26

95

3.51

1.57 - 7.97

1 1.68 (0.0006)

Neutered (either sex)

64

229

4.09

2.26 - 7.50

26.87 ( < 0.0001)

Sex•

-

0\

• Except as noted, the comparison group is all other dogs.
,..,.. Exact confidence limits. •28
••• Female-spayed compared to female-intact.
"' *** Male-castrated compared to male-intact.

Table 5.5. Sex-Specific Odds Ratios (OR) for Dogs (5 yr � Age < 10 yr) with Hypoadrenocorticism from 1994 Survey in the United States
of Veterinarians Enrolled in Clinical Trial
x? statistic (p value)

Number of cases
n=323

Number of controls
n=393

OR

95 % confidence
interval for OR4�

Uncorrected•

Female-intact

15

32

o.ss

0.28 - 1.07

3.54 (0.0600)

Female-spayed

202

190

1 .78

1.31 - 2.44

14.41 (0.0001)

Female-spayed"'"'

202

190

2.27

1 . 14 - 4.55

6.46 (0.01 10)

Female (intact and spayed)

217

222

1 .58

1 . 15 - 2. 17

8.55 (0.0035)

Male-intact

36

73

0.55

0.35 - 0.86

7.58 (0.0059)

Male-castrated

70

98

0.83

0.58 - 1 .20

1 .05 (0.3050)

Male-castrated"'"'"'

70

98

1.45

0.85 - 2.47

2.09 (0. 1484)

272

288

1.94

1 .32 - 2.87

12.42 (0.0004)

Sex"'

.....
.....

.....,J

Neutered (either sex)

"' Except as noted, the comparison group is all other dogs.
"'"' Female-spayed compared to female-intact.
"'"'"' Male-castrated compared to male-intact.

Table 5.6. Sex·Specific Odds Ratios (OR) for Dogs (Age
Enrolled in Clinical Trial

&;:::

10 yr) with Hypoadrenocorticism from 1994 Survey in the United States of Veterinarians
X: statistic (p value)

Number of cases
n=259

Number of controls
n=255

OR

95% confidence
interval for OR49

Uncorrected40

Female·intact

11

15

0.7 1

0.30 - 1 .68

0.72 (0.3976)

Female·spayed

1 83

140

1 .98

1 .35 - 2.89

13.66 (0.0002)

Female·spayed**

183

140

1.78

0.74 - 4.30

2.01 (0. 1566)

Female (intact and spayed)

194

ISS

1.93

1 .30 - 2.86

1 1.75 (0.0006)

Male·intact

21

48

0.38

0.21 - 0.68

12.69 (0.0004)

Male�astrated

44

52

0.80

0.50 . 1 .28

0.98 (0.3222)

Male-castrated•••

44

52

1 .93

0.96 . 3.91

3.99 (0.0459)

227

192

2.33

1.42 . 3.81

13.01 (0.0003)

Sex•

-

00

Neutered (either sex)

• Except as noted, the comparison group is all other dogs.
•• Female-spayed compared to femal�intact.
••• Male�trated compared to male·intact.

Breeds

Breeds were reported for 714 (99.3 %) of the 719 cases (Table 5.7). The
seven most frequently reported case breeds with number (%) were: Poodle 122
(17. 1); Mixed 72 (10. 1); Labrador Retriever 7 1 (9.9); German Shepherd 40 (5.6);
Golden Retriever 32 (4.5); West Highland White Terrier 3 1 (4.3); and Rottweiler
24 (3.4).
Breeds were reported for 1 , 1 84 (99.3 %) of the 1 , 192 controls (Table 5.7).
The seven most frequently reported control breeds with number (%) were: Mixed
152 (12. 8); Labrador Retriever 1 18 (10.0); German Shepherd 86 (7. 3); Golden
Retriever 68 (5.7); Cocker Spaniel 67 (5.7); Poodle 65 (5.5); and Shetland
Sheepdog 33 (2. 8). The number (%) of the seven most frequently reported case
breeds among controls was (in the same order as listed above for cases): Poodle
65 (5.5); Mixed 152 (12. 8); Labrador Retriever 1 1 8 (10.0); German Shepherd 86
(7.3); Golden Retriever 68 (5.7); West Highland White Terrier 9 (0. 8); and
Rottweiler 32 (2. 7).
Breed-specific OR were calculated for all breeds for which there were at least
five cases or five controls of ihe breed reported in the survey (Table 5 . 8).
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Table 5.7. Breeds of 7 14 Cases of Hypoadrenocorticism and 1.184 Controls from 1994 Survey in the
United States of Veterinarians Enrolled in Clinical Trial*
Cases
Breed

Nwnber

Controls

Percent

Nwnber

Percent

Airedale Terrier

14

2.0

9

0.8

Akita

5

0.7

4

0.3

Alaskan Malamute

7

1.0

6

o.s

Australian Shepherd

7

1.0

20

1.7

Basset Hound

20

2.8

10

0.8

Beagle

11

1.5

30

2.5

Bearded Collie

10

1.4

4

0.3

Bichon Frise

3

0.4

9

0.8

Border Collie

7

1.0

6

o.s

Boston Terrier

0

0.0

7

0.6

Boxer

1

0. 1

14

1 .2

Brittany

4

0.6

7

0.6

Chihuahua

5

0.7

10

0.8

Chow Chow

7

1.0

22

1.9

Cocker Spaniel

21

2.9

67

5.7

Collie

10

1.4

19

1.6

Dachshund

11

1.5

23

1.9

Dalmatian

0

0.0

14

1 .2

Doberman Pinscher

8

1.1

25

2. 1

English Bulldog

0

0.0

6

0.5

German Shepherd

40

5.6

86

7.3

German Shorthaired Pointer

15

2. 1

10

0.8

Golden Retriever

32

4.5

68

5.1

Great Dane

18

2.5

4

0.3

Irish Setter

4

0.6

7

0.6

Jack Russell Terrier

0

0.0

5

0.4

Labrador Retriever

71

9.9

1 18

10.0

3

0.4

22

1.9

Lhasa Apso

120

Table 5. 7 (continued)
Controls

Cases

Breed
Malte$e

Nmnber

Percent

Nmnber

Percent

5

0.7

19

1 .6

72

10. 1

152

12.8

Pekingese

3

0.4

7

0.6

Pit Bull Terrier

0

0.0

9

0.8

Pomeranian

1

0. 1

14

1 .2

1 22

17. 1

65

5.5

0

0.0

6

0.5

24

3.4

32

2.7

Saint Bernard

5

0.7

0

0.0

Schnauzer

11

1 .5

2S

2. 1

Scottish Terrier

8

1.1

6

0.5

Shar Pei

2

0.3

8

0.7

Shetland Sheepdog

3

0.4

33

2.8

Shih Tzu

3

0.4

20

1 .7

Siberian Husky

6

0.8

10

0.8

Spitz (American Eskimo)

1

0. 1

11

0.9

Springer Spaniel

24

3.4

16

1 .4

West Highland

31

4.3

9

0.8

2

0.3

23

1.9

Mixed

Poodle
Pug
Rottweiler

White Terrier

Yorkshire Terrier

* Breeds are included only if there were at least five cases or five controls of the breed reported in the
survey.
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Table 5.8. Breed-Specific Odds Ratios (OR) for Dogs with Hypoadrenocorticism from 1994 Survey in the United States of Veterinarians Enrolled
in Clinical Trial*

X: statistic (p value)
Number of cases
n=714

Number of controls
n= l . l 84

OR

95 % confidence
interval for OR49

Uncorrected40

14

9

2.61

1 .06 - 6.56

5.36 (0.0206)

Akita

5

4

2.08

0.45 - 10.52**"'"'

1 .24 (0.2655)

0.3098

Alaskan Malamute

7

6

1.94

0. 56 - 7.03**"'"'

1 .47 (0.2255)

0.2567

Australian Shepherd

7

20

0.58

0.20 - 1 .43*"'"'"'

1 .60 (0.2065)

Basset Hound

20

10

3.38

1 .50 - 7.79

1 0.96 (0.0009)

Beagle

11

30

0.60

0.28 - 1 .26

2.08 (0. 1494)

Bearded Collie

10

4

4.19

1 .20 - 1 8.36**"'"'

6.87 (0.0088)

Bichon Prise

3

9

0.55

0. 1 0 - 2.22****

0.82 (0.3654)

0.5520

Border Collie

7

6

1 .94

0.56 - 7.03****

1 .47 (0.2255)

0.2567

Boston Terrier

0

7

0.00

0.00 - 1 . 15****

4.24 (0.0396)

0.0498

Boxer

1

14

0. 12

0.00 - 0.77****

6.17 (0.0130)

Brittany

4

7

0.95

0.20 - 3. 74**""1'

0.01 (0.93 13)

Chihuahua

5

10

0.83

0.22 - 2.67••••

0. 1 2 (0.7309)

Chow Chow

7

22

0.52

0. 19 - 1 .28****

2.28 (0. 1 310)

Cocker Spaniel

21

67

0.51

0.30 - 0.85

7.44 (0.0064)

Collie

10

19

0.87

0.38 - 1 .98

0. 12 (0.7254)

Dachshund

11

23

0.79

0.36 - 1 .7 1

0.41 (0.5225)

Dalmatian

0

14

0.00

o.oo - o.5o••••

8.51 (0.0035)

Breed**
Airedale Terrier

-

[:j

Fisher exact
(2-tailed p
value)***102

1 .0000

Table 5.8 (continued)
X: statistic (p value)
Number of cases

Number of controls

n=714

n= 1 , 184

OR

95 % confidence
interval for OR49

Uncorrected40

Doberman Pinscher

8

25

0.53

0.22 - 1 .23

2.56 (0. 1096)

English Bulldog

0

6

0.00

0.00 - 1.4 1 "'"'"'"'

3.63 (0.0568)

German Shepherd

40

86

0.76

0.50 - 1 . 13

1 .98 (0. 1590)

German Shorthaired
Pointer

15

10

2.52

1 .06 - 6.06

5.41 (0.0200)

Golden Retriever

32

68

0.77

0.49 - 1.21

1 .42 (0.2334)

Great Dane

18

4

7.63

2.50 - 3 1.09"'"'"'"'

1 8.53 ( < 0.0001 )

Irish Setter

4

7

0.95

0.20 - 3.74"'"'"'"'

0.01 (0.93 13)

1.0000

Jack Russell Terrier

0

5

0.00

0.00 - 1.81"'"'"'"'

3.02 (0.0821)

0. 1639

Labrador Retriever

71

1 18

1 .00

0.72 - 1.38

0.00 (0.9875)

Lhasa Apso

3

22

0.22

0.04 - 0.75"'"'"'"'

7.09 (0.0078)

Maltese

5

19

0.43

0. 1 3 - 1 .20"'"'"'"'

2.92 (0.0876)

72

152

0.76

0.56 - 1 .04

3.24 (0.07 16)

Pekingese

3

7

0.71

0.12 - 3. 12"'"'"'"'

0.25 (0.6180)

0.75 15

Pit Bull Terrier

0

9

0.00

0.00 - 0.84*"'"'"'

5.45 (0.0195)

0.0165

Pomeranian

1

14

0. 12

0.00 - 0.77"'"'"'"'

6. 17 (0.0 130)

122

65

3.55

2.55 - 4.93

67.44 ( < 0.0001 )

0

6

0.00

0.00 - 1.4 1"'"'"'"'

3.63 (0.0568)

24

32

1 .25

0.71 - 2.21

0.67 (0.41 14)

Breed''""

-

�

Mixed

Poodle
Pug

Rottweiler

Fisher exact
(2-tailed p
value)**"'162

0.0895

0.0895

Table 5.8 (continued)
,(- statistic (p value)
Number of cases
n=714

Number of controls
n= 1 , 1 84

OR

95% confidence
interval for OR49

Uncom:cted40

Fisher exact
(2-tailed p
value)"'"'*161

Saint Bernard

5

0

... ... ....
. ....

...... ...... ...

8.3 1 (0.0039)

0.0075

Schnauzer

11

2S

0.73

Scottish Terrier

8

6

2.22

0.67 . 7.81••••

2.29 (0. 1301)

Sbar Pei

2

8

0.41

0.04 . 2.08••••

1 .33 (0.2488)

Shetland Sheepdog

3

33

0.15

0.03 . 0.47""""' "'

13.41 (0.0003)

Shih Tzu

3

20

0.25

0.05 . 0.83••••

5.99 (0.0144)

Siberian Husky

6

10

0.99

0.30 . 3.04••••

0.00 (0.9922)

Spitz (American Eskimo)

I

11

0.15

0.00 . 1 .03••••

4.4 1 (0.0357)

Springer Spaniel

24

16

2.54

1 .29 . 5.04

8.72 (0.003 1)

West Highland White
Terrier

31

9

5.93

2.69 . 13.46

27.69 ( < 0.000 1)

2

23

0. 14

o.o2 - o.58••••

9.47 (0.0021)

Breed••

-

�

Yorkshire Terrier

0.33

•

1 .55

0.78 (0.377 1)

• Breeds are included only if there were at )east five cases or five controls of the breed reported in the survey.
•• The comparison group is all other dogs.
••• Calculated only if an expected cell value is < 5; the preferred p value for this OR.
•••• Exact confidence limits. 128
••••• Undefmed.

0.3367

0.0377

Body Weights

Body weights were reported for 657 (91 .4%) of the 719 cases (Figure 5.5).w
The average body weight (kg) for cases was 24.5 (SD 14.5) (SEM 0.6) (Range 2.3
- 8 1 .8). Body weights were reported for 1 , 1 1 1 (93.2%) of the 1 , 192 controls

(Figure 5.6). The average body weight (kg) for controls was 19.7 (SD 12.7) (SEM
0.4) (Range 1 .4 - 68.2). Body weight-specific OR were calculated for 5 kg body

weight increments (Table 5.9).

Selected Clinical Findings Hypothetically Associated with Canine
Hypoadrenocorticism

Odds ratios were calculated for clinical findings which were either
anecdotally linked to hypoadrenocorticism or had a putative autoimmune etiology.
Table 5 . 10 tabulates these results and relevant statistics. Since aging may affect the
occurrence of many of these clinical findings, OR for clinical findings were
calculated after stratifying the ages into five-year intervals (Tables 5 . 1 1-5. 13).

"The questionnaire simply asked the veterinarian to report "body weight, " so
the weight reported was, presumably, the most recently recorded body weight in
the patient's medical record.
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Figure 5.5. Body Weights of 657 Dogs with Hypoadrenocorticism from 1994 Survey in the United States of
Veterinarians Enrolled in Clinical Trial
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Figure 5.6. Body Weights of 1 , 1 1 1 Control Dogs from 1 994 Survey in the United States of Veterinarians Enrolled
in Clinical Trial

Table 5.9. Body Weight-Specific Odds Ratios (OR) for Dogs with Hypoadrenocorticism from 1994 Survey in the United States of Veterinarians
Enrolled in Clinical Trial
'Jf statistic (p value)
Body weight
interval (kg)*

......

N

00

0 < weight

:S:

S

S < weight

:S:

10

Number of cases
n=657

Number of controls
n= l , 1 1 1

OR

95% confidence
interval for OR49

Uncorrected40

29

122

0.37

0.24 - 0.58

22.79 (< 0.0001)

1 19

224

0.88

0.68 - 1 . 13

1 . 1 1 (0.2923)

10 < weight

:s:

IS

56

ISS

O.S7

0.4 1 - 0.80

1 1 .57 (0.0007)

IS < weight

:S:

20

53

125

0.69

0.49 - 0.98

4.62 (0.0315)

20 < weight

:S:

25

107

1 14

1 .70

1 .27 - 2.28

1 3.70 (0.0002)

2S < weight

:S:

30

75

1 16

1.11

0.80 - 1 . 52

0.41 (O.S236)

30 < weight

:S:

35

74

109

1 . 17

0.84 - 1.61

0.94 (0.3327)

35 < weight

:S:

40

62

66

1 .6S

1 . 13 - 2.40

7.51 (0.006 1)

40 < weight

:s:

45

31

41

1 .29

0.78 - 2. 1 3

1 . 12 (0.2906)

45 < weight

:S:

SO

17

26

1.1 1

0.57 - 2. 14

0. 1 1 (0.7443)

SO < weight

:S:

55

11

6

3. 14

1 .06 - 10.37**

5.58 (0.0182)

23

7

5.72

2.36 - 15.86"'"'

20.40 ( < 0.0001)

weight > SS

"' The comparison group is all other dogs.
*"' Exact confidence limits.128

Table 5. 10. Odds Ratios (OR) for Clinical Findings Associated with Hypoadrenocorticism in Dogs from 1994 Survey in the United States of Veterinarians
Enrolled in Clinical Trial
X: statistic (p
value)
Clinical finding"'

OR

95 % confidence
interval for OR49

Uncorrected40

Fisher exact
(2-tailed p value)"'"'162

68

7

1 8.52

8.43 - 48.03"'"'"'

97.92 ( < 0.0001)

Arthritis

lOS

80

2.50

1 . 8 1 - 3.44

35.54 ( < 0.0001)

17

13

2.28

1.05 - 5.02

5.21 (0.0224)

s

4

2. 16

0.46 - 10.93**"'

1 .38 (0.2403)

Hepatitis

29

7

7.41

3 . 15 - 20. 14

30.35 ( < 0.0001)

Hypothyroidism

85

35

4.65

3.04 - 7. 12

64.29 ( < 0.0001)

Keratoconjunctivitis sicca

18

9

3.51

1 .49 - 8.49

10.57 (0.0012)

Megaesophagus

3

1

5.19

0.41 - 272.46•••

2.53 (0. 1 120)

0. 1434

Myasthenia gravis

3

0

... . ... ...

... ... ... ...

5. 1 8 (0.0229)

0.0494

41

11

6.77

3.33 - 14.08

40.85 ( < 0.0001)

9

3

5.22

1 .30 - 30.07"'"'"'

7.61 (0.0058)

Diabetes mellitus

�

Number of controls
n= 1 , 147

Anemia

Cruciate ligament rupture

-

Number of cases
n=666

Nephritis
Thrombocytopenia

0.3023

0.01 19

"' Clinical findings either anecdotally linked to hypoadrenocorticism or with a putative autoimmune etiology; comparison group is all other dogs.

•• Calculated only if an expected cell value is < S; the preferred p value for this OR.
"'"'"' Exact confidence limits. Ill!
"'"'"'"' Undefined.

Table 5. 1 1 . Odds Ratios (OR) for Clinical Findings Associated with Hypoadrenocorticism in Dogs (0 yr < Age < 5 yr) from 1994 Survey in the
United States of Veterinarians Enrolled in Clinical Trial
r statistic (p
value)
Number of cases
n =79

Number of controls
n=477

OR

95 % confidence
interval for OR49

Uncorrected40

Fisher exact
(2-tailed p
value)**162

Anemia

6

2

19.52

3.38 - 199.41 "'"'"'

24.61 ( < 0.0001)

0.0002

Arthritis

5

8

3.96

0.99 - 14. 12"'"'"'

6.42 (0.01 13)

0.0260

Cruciate ligament rupture

0

1

0.00

0.00 - 235.48"'"'"'

0. 17 (0.6838)

1 . 0000

Hepatitis

0

1

0.00

0.00 - 235.48•••

0. 17 (0.6838)

1 .0000

Hypothyroidism

6

6

6.45

1 .67 - 24.7 1 •••

12.89 (0.0003)

0.003 1

Keratoconjunctivitis sicca

1

0

••••

••••

6.05 (0.0139)

0. 142 1

Megaesophagus

1

1

6. 10

0.08 - 479.99•••

2. 1 1 (0. 1464)

0.2642

Myasthenia gravis

1

0

••••

••••

6.05 (0.0139)

0. 1421

Nephritis

2

1

12.36

0.63 - 730. 86•••

6.81 (0.009 1)

0.0544

Thrombocytopenia

0

1

0.00

0.00 - 235.48"'"'"'

0. 17 (0.6838)

1 .0000

Clinical fmding*

-

w
0

"' Clinical findings either anecdotally linked to hypoadrenocorticism or with a putative autoimmune etiology; comparison group is all other dogs; there
were no cases or controls for diabetes mellitus.
•• Calculated only if an expected cell value is < 5; the preferred p value for this OR.
"'"'"' Exact confidence limits.128
•••• Undefined.

Table 5. 12. Odds Ratios (OR) for Clinical Findings Associated with Hypoadrenocorticism in Dogs (5 yr
United States of Veterinarians Enrolled in Clinical Trial

:s;

Age < 10 yr) from 1994 Survey in the

i' statistic (p
value)
Number of cases
n= 307

Number of controls
n=389

OR

95 % confidence
interval for OR49

Uncorrected40

Anemia

29

2

20. 19

5.02 - 175.44***

32. 17 (< 0.0001)

Arthritis

27

15

2.40

1.20 - 4.84

7.38 (0.0066}

Crociate ligament rupture

5

5

1 .27

0.29 - 5.58***

0. 14 (0.7055)

0.7561

Diabetes mellitus

1

2

0.63

0.01 - 12.21**"'

0.14 (0.7064)

1 .0000

Hepatitis

16

1

21 .33

3.27 - 896.86***

17.68 ( < 0.0001)

Hypothyroidism

43

14

4.36

2.26 - 8.55

24.72 ( < 0.0001)

Keratoconjunctivitis sicca

7

I

9.05

1 . 15 - 409.05*"'"'

6.18 (0.0129)

Megaesophagus

2

0

...... ....
. .

...... ....
. .

2.54 (0. 1 109)

0. 1942

Myasthenia gravis

2

0

...... ... ...

... ... ......

2.54 (0. 1 109}

0. 1942

17

2

1 1 .34

2.65 - 101.72*"'*

16.31 (0.0001}

5

1

6.42

0.71 - 304.60**"'

3.78 (0.0520)

Clinical finding"'

w
-

Nephritis
Thrombocytopenia

Fisher exact
(2-tailed p value}**162

0.0925

* Clinical findings either anecdotally linked to bypoadrenocorticism or with a putative autoimmune etiology; comparison group is all other dogs.
** Calculated only if an expected cell value is < 5; the preferred p value for this OR.
*** Exact confidence limits.1211
**"'* Undefined.

Table 5.13. Odds Ratios (OR) for Clinical Findings Associated with Hypoadrenocorticism in Dogs (Age :::: 10 yr) from 1994 SuiVey in the
United States of Veterinarians Enrolled in Clinical Trial
x? statistic (p

value)

Number of
cases
n = 249

Number of
controls
n=2S4

OR

95 % confidence
interval for OR411

Uncorrected40

Anemia

30

3

1 1 .46

3.48 - 59.27***

24.22 ( < 0.0001)

Arthritis

67

53

1.40

0.9 1 - 2. 15

2.53 (0. 1 120)

Cruciate ligament rupture

12

6

2.09

0.7 1 - 6.90***

2.20 (0. 1380)

Diabetes mellitus

4

2

2.06

0.29 - 22.90***

0.72 (0.3976)

Hepatitis

12

4

3 . 16

0.94 - 13.62***

4.30 (0.0382)

Hypothyroidism

33

IS

2.43

1 .24 - 4.84

7.86 (0,0050)

Keratoconjunctivitis sicca

9

8

1 . 15

0.40 - 3.34

0.08 (0.7730)

Nephritis

19

6

3.41

1 .28 - 10.61•••

7.39 (0.0066)

4

1

4.13

0.40 - 204.21"'**

1 .88 (0. 1704)

Clinical finding*

-

w
N

Thrombocytopenia

Fisher exact
(2-tailed p value)""'ot6l

0.4462

0.2123

* Clinical findings either anecdotally linked to hypoadrenocorticism or with a putative autoimmune etiology; comparison group is all other dogs; there
were no cases or controls for megaesophagus and myasthenia gravis.
•• Calculated only if an expected cell value is < S; the preferred p value for this OR.
••• Exact confidence limits. 128

Logistic Regression

General
There were two objectives for the logistic regression: evaluating the
relationship of age, breed, sex, and body weight with the occurrence of
hypoadrenocorticism in the dog, and developing models which would predict the
relative probability of hypoadrenocorticism in dogs. The response variable was
dichotomous: the dog either had hypoadrenocorticism or did not. Next, unless
otherwise noted, the word "significant" means that the factor, interaction, test, or
model being evaluated had a p value less than 0.05. Finally,

R2

is 11the proportion

of the total uncertainty that is attributed to the model fit. " 178 More specifically, it
is the negative loglikelihood of the model divided by the negative loglikelihood of
a model in which no effects were specified. 178

Factor Evaluation
Single factor models. A model was fit for each of the individual independent
variables-age, breed, sex, and body weight-and the response variable. In each of
these models, the factor and the model itself (the words " factor" and "independent
variable" are used interchangeably) were significant. The R2 values were very low,
ranging from 0.02 to 0. 10.
The models for age and body weight each had significant lack of fit.
Therefore, the following higher order models were fit: case
133

=

age age*age, case

=

age age*age age�ge*age, case

=

body weight body weight*body weight, and

case = body weight body weight*body weight body weight*body weight*body
weight. The model case = age age*age still had a lack of fit problem, although
only a borderline one (p =0.0423). The lack of fit problem disappeared in the case
=

age age*age age*age*age model (p=O. l 605). (However, for the sake of

parsimony, the cubic term involving age was not used in model development.) The
lack of fit problem continued for both the higher order models using body weight
as the independent variable. Detailed results are included in Appendix C l .
Two factor models with no interactions. A model was fit for each pair of the
individual independent variables and the response variable. In each model, both
factors considered singly and the model were significant. The R2 values ranged
from 0. 07 to 0. 17. Detailed results are included in Appendix C2.
Two factor models with interactions. A model was fit for each pair of the
individual independent variables, plus the interaction involving those variables, and
the response variable. In these models, the factors considered singly may or may
not have been significant, but in no case was the interaction significant. The
models were all significant. The R2 values ranged from 0.07 to 0. 1 8 . Detailed
results are included in Appendix C3.
Three factor models with no interactions. A model was fit for each
combination of three of the independent variables and the response variable. In
each of these models, all three factors considered singly and the model itself were
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significant. The R2 values ranged from 0.12 to 0. 19. Detailed results are included
in Appendix C4.
Three factor models with two-way interactions. A model was fit for each
combination of three of the independent variables, plus all two-way interactions
involving those variables, and the response variable. In these models, the factors
considered singly may or may not have been significant, but no two-way
interactions except two were significant. The exceptions were the age*sex
interaction (p=0.0470) in the model case = age breed sex age*breed age*sex
breed*sex, and the sex*body weight interaction (p=0.0327) in the model case =
age sex body weight age*sex age*body weight . sex*body weight. The age*sex
interaction in the first model disappeared if dogs 1 .5 yr old and younger were
removed from the data set. It also disappeared if sex was categorized as just
female and male, rather than female-intact, female-spayed, male-intact, and male
castrated. The models were all significant. The R2 values ranged from 0.13 to
0.23 . Detailed results are included in Appendix C5.
Three factor models with two- and three-way interactions. A model was fit
for each combination of three of the independent variables, plus all two-way
interactions and the one three-way interaction involving those variables, and the
response variable. In these models, the factors considered singly were, with two
exceptions, not significant. The two-way interactions were, with three exceptions,
similarly not significant. Two of the four three-way interactions were significant;

135

two were not. The models were all significant. The R2 values ranged from 0. 13
to 0.24. Detailed results are included in Appendix C6.
Model fitting. The results from more than 100 models were evaluated in
choosing the two models which are presented below. The final models were
x

chosen to meet four criteria: the model itself had to be significant, each term in
the model had to be significant, the model lack of fit had to be insignificant, and
the model had to be reasonably parsimonious.
The factor evaluation described above provided a starting point for designing
the two recommended models. First, the single factor models and the two factor
models (with and without interactions) established that all factors were related to
the response variable. Adding the quadratic term for age improved the model's fit,
and, though the cubic term improved the fit more, the cubic term was not included
because of respect for parsimony. Therefore, the following basic model was
evaluated: case

=

age age*age breed sex body weight. This model met all the

selection criteria listed above. The model was significant (p < 0.0001). Each term
in the model was significant (each at p < 0.0001). The model lack of fit was not
significant (p

=

0.2692) . And, excepting the quadratic term for age, the model

was as parsimonious as a model could be and still include all four factors. The R2

XJ:t should be noted here that four factor-age, breed, sex, and body weight
models with all two- and three-way interactions included were beyond the
computer's capability. Thus, they were not considered.
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value for this model was 0.2418; but large R2 values are rare in categorical
models. 179 Appendix C7 includes more details about this model.
This model was then evaluated after the addition, one at a time, of all the
two-way interactions: age*breed, age*Sex, age*body weight, breed*Sex,
breed*body weight, and sex*body weight. Four of these six interactions were not
significant, but two of them were: age*body weight (p
weight (p

=

=

0.0003) and sex-.body

0.0368). Based on these results, both of these interactions were added

to the model above to yield a second useful model: case

=

age age*age breed sex

body weight age*body weight sex*body weight. This model also met all the
selection criteria. The model was significant (p < 0.0001). Each term in the
model was significant (each at p < 0.000 1 , except sex at p
weight at p

=

0.0003 , and sex*body weight at p

fit was not significant (p

=

=

=

0.0046, age*body

0.0370). The model lack of

0.3833). The R2 value for this model was 0.2516.

Appendix C7 includes more details about this model.

Discussion
Questionnaire Responses and Description of Veterinary Clinics
This was a large case control study involving questionnaires returned from
519 veterinarians, 494 separate veterinary clinics, 720 cases, and 1 , 192 controls.
The response rate was 90.9 % . The cases sampled probably do not represent the
average veterinarian in clinical practice, nor veterinarians from veterinary referral
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hospitals (Chapter 4). They probably represent veterinarians who are more diligent
than the randomly selected veterinarians surveyed (Chapter 6) since they were
submitted by private practitioners who went to the trouble of seeking DOCP and
doing the administrative work associated with enrolling in the clinical trial.
Figure 5 . 1 reveals that 9 1 . 8 % of the responses received were received within
60 da of the initial mailing. This is useful for planning similar future studies. A
cutoff of responses at 60 da would seem reasonable.
The average veterinary clinic had 2.60 full-time veterinarians (Figure 5.2),
and reported an average estimated number of dogs first diagnosed in 1993 of 1 .23.
If 2.60 full-time veterinarians see 1 .23 newly diagnosed hypoadrenal dogs per yr,
this suggested that the average small animal practitioner might see one-half case
per yr. This probably underestimated the number of cases since one individual in
each clinic :filled out the questionnaire. This veterinarian, being asked for summary
data about the entire practice, may not have been aware of all cases seen in the
practice. Nevertheless, this one-half case per yr per veterinarian probably can
serve as a useful benchmark. The average number of dogs seen per veterinarian
per yr (individual dogs, not dog visits) of 1 ,504.7 could serve as a similar
benchmark.
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Incidence and Prevalence Estimates
The incidence estimate of0.34 case/1000 dogs/yr and the prevalence estimate
of 1 . 7 cases/1 000 dogs suggested an approximate rate at which new cases may be
acquired, and a rough indicator of how many cases a veterinarian might expect to
be treating at any one time among all the dogs seen in the practice.

Ages
The mean age for hypoadrenal dogs was higher (8.7 yr) than the mean for
control dogs (6.2 yr). Similarly, the average age for live hypoadrenal dogs (8. 1
yr) exceeded that for live control dogs (6. 1 yr).
Table 5 . 1 shows the ages of hypoadrenal patients which might be expected
among a veterinarian's patient files. Compared to controls, dogs up to
approximately 4 yr were less likely to have adrenal insufficiency than other dogs,
those approximately 4 to 7 yr were about equally likely to be hypoadrenal, and
those approximately 7 to 14 yr were more likely to have adrenal insufficiency.
Dogs older than approximately 14 yr were about equally likely to be hypoadrenal
compared to controls. This might be explained by the earlier death of hypoadrenal
dogs when compared to controls.
The estimated average disease duration of 4.9 yr, coupled with the average
age at death of 9.8 yr, suggested that hypoadrenal dogs can live long lives.
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Sexes
The assertion that canine hypoadrenocorticism is more frequent in female
dogs4 1•43•93•148• 1 89 was confirmed. Females comprised 54.8 % of controls, but 69. 1 %
of cases (Table 5.2). The OR for female dogs compared to males was 1 .84 with
a 95 % confidence interval of 1 .5 1 to 2.25 (Table 5.3).
These data suggested that neutered animals were much more likely to be
hypoadrenal. The OR for female-spayed dogs compared to female-intact dogs was
4.06 (95 % confidence interval 2.74 - 6.06), and the OR for male-castrated dogs
compared to male-intact dogs was 2.20 (95 % confidence interval 1 .56 - 3. 10)
(Table 5.3). The OR for female-intact dogs compared to all other dogs was 0.35
(95 % confidence interval 0.24 - 0.51). These results suggested that female-intact
dogs were less likely to have adrenal insufficiency than other dogs, and,
specifically, female-spayed dogs. This contradicted another study. 148 The OR for
female-spayed compared to all other dogs was 2.53 (95 % confidence interval 2.07
- 3.08), and the OR for male-castrated dogs compared to other dogs was 0.95
(95 % confidence interval 0.75 - 1 .20). The OR for neutered dogs of either sex
compared to intact dogs of either sex was 3 .24 (95 % confidence interval 2.54 4. 13) (Table 5 .3). Except for the comparison of male-castrated dogs with all other
dogs, and this was mitigated by the comparison of male-castrated dogs with male
intact dogs, the comparisons above led to the conclusion that neutered dogs were
at greater risk of disease. The possibility existed that other variables, such as age,
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may have perturbed these data and reduced (or enhanced) the predispositions of
females and neutered dogs for the disease. To explore the possibility that age was
affecting these associations, age-stratified analyses were conducted. The results
generally confirmed the above conclusions.
That canine hypoadrenocorticism was more frequent in female dogs was
supported by the data for female dogs 5 yr and older (Tables 5.5-5 .6), but not for
females less than 5 yr (Table 5.4). Age-stratified data suggested that neutered dogs
of either sex were more likely than intact dogs to have adrenal insufficiency
(Tables 5.4-5.6).
Overall, there was little evidence from age stratification that age perturbed
the conclusions about the associations between sex and hypoadrenocorticism in the
dog. Female or neutered dogs were more likely to be hypoadrenal than their male
or intact kin.

Breeds
Tables 5.7 and 5.8 provide references for veterinarians and dog owners
interested in whether or not a particular breed was represented among the cases
or controls or both. Information about less common breeds has until now been
difficult to come by. Table 5. 8 indicated that, using an OR greater than one and
a 95 % confidence interval which did not include one as criteria, the following
breeds were predisposed to hypoadrenocorticism: Airedale Terrier, Basset Hound,
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Bearded Collie, German Shorthaired Pointer, Great Dane, Poodle, Springer
Spaniel, and West Highland White Terrier. It indicated that, using the criteria of
an OR less than one and a confidence interval which did not include one, the
following breeds were less likely to be hypoadrenal than other breeds: Boxer,
Cocker Spaniel, Dalmatian, Lhasa Apso, Pit Bull Terrier, Pomeranian, Shetland
Sheepdog, Shih Tzu, and Yorkshire Terrier. Another study, using the statistical
criterion of significance at the 0.05 level, found that Great Danes, Standard
Poodles,

and

West

Highland

White

Terriers

were

predisposed

to

hypoadrenocorticism, while Lhasa Apsos and Yorkshire Terriers were less likely
to be hypoadrenal. 148 Using the more exacting significance level of less than 0.01
(p value of uncorrected chi-square statistic), the Basset Hound, Bearded Collie,
Great Dane, Poodle, Springer Spaniel, and West Highland White Terrier were
predisposed to the disease, while the Cocker Spaniel, Dalmatian, Lhasa Apso,
Shetland Sheepdog, and Yorkshire Terrier were less likely to be afflicted. Table
5. 7 suggested that, since there were five Saint Bernards in 714 cases and none in
1 , 1 84 controls, Saint Bernards were predisposed to the disease. Though the OR
for Saint Bernards was undefined, the uncorrected chi-square statistic was
significant at p < 0.01 (Table 5.8).
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Body Weights

The evaluation of body weights must be done with the understanding that
reported body weights were likely an admixture of exact body weights determined
by weighing the dogs, and less exact body weights estimated by veterinarians and
their personnel. The latter should, nevertheless, be reasonably accurate. The
statistical comparison of average body weight of cases (24.5 kg) with that of
controls (19.7 kg) showed a difference (p < 0.0005) between these weights.
The body weight-specific OR (Table 5 .9)

suggested that

canine

hypoadrenocorticism was more likely in larger dogs. They suggested that small
dogs (lighter than about 20 kg) were less likely to be hypoadrenal, that middle
sized dogs (from about 20 kg to about 50 kg) were neither more nor less likely to
be hypoadrenal, and that large dogs (heavier than about 50 kg) were more likely
to be hypoadrenal. The conclusions about small dogs and large dogs were
supported by the data, while the conclusion about middle-sized dogs was not as
compelling. Recognizing that this body weight effect might be confounded with
other variables such as breed, body weight-specific OR were calculated in 10 kg
increments for Mixed dogs. These OR did not demonstrate a body weight effect
suggesting that body weight may be confounded with breed. Regarding one
·

specific breed, though the Poodle was clearly predisposed to hypoadrenocorticism,
it was the large Standard Poodle in which the predisposition has previously been
reported.11•44•192
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Though not specifically related to canine hypoadrenocorticism, Figure 5.6
provided a profile of the body weights of dogs seen in clinical veterinary practice.
About one dog in five (20.2%) weighed between 5 and 10 kg, and almost half
(45.2%) weighed 15 kg or less. Only 1 . 1 % were heavier than 50 kg.

Selected Clinical Findings Associated with Canine Hypoadrenocorticism
Before age stratification and based on OR and their 95 % confidence intervals
(fable 5 . 10), all the clinical findings except diabetes mellitus and megaesophagus
were associated with hypoadrenocorticism; i.e. , the OR were greater than one, and
the 95 % confidence interval did not include one. Y After age (yr) stratification, the
results were for the most part either confirmed or became equivocal, in most of
the latter cases because the sample sizes dropped to a point that made
demonstrating statistically significant associations difficult or impossible.
Anemia was associated with hypoadrenocorticism after age stratification: 0

< age < 5, OR 19.52, Table 5 . 1 1 ; 5 � age < 10, OR 20. 19, Table 5. 12); and
age

2:

10, OR 1 1 .46, Table 5 . 13 . The uncorrected chi-square statistics were

significant at less than 0.0001 for all these OR.

YThe OR for myasthenia gravis was undefined, but its uncorrected chi-square
statistic and its two-tailed Fisher exact computation were each significant at p <
0.05.
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Arthritis was associated with hypoadrenocorticism before age stratification.
Its OR was 2.50, significant at less than 0.0001 (Table 5 . 10) (here, and
subsequently in this section, the significance levels will, unless otherwise stated,
be for the uncorrected chi-square statistics). After age stratification, the association
between hypoadrenocorticism and arthritis became equivocal. The OR were all
greater than one, but for the age group 0 < age < 5, the 95 % confidence interval
for the OR of 3 .96 included one even though the ·uncorrected chi-square statistic
was significant at less than 0.05 (Table 5. 1 1) (this resulted here, and in a few
other places later in this section, from different statistical techniques used to
calculate the 95 % confidence interval and the uncorrected chi-square statistic). For
the age group 5

<

age < 10, the OR was 2.40, the 95 % confidence interval did

not include one, and the OR was significant at less than 0.01 (Table 5 . 12). For the
age group age � 10, the OR was 1 .40, the 95 % confidence interval did include
one, and the significance level was greater than 0.05 (Table 5. 13). Therefore, the
arthritis results suggested an association between hypoadrenocorticism and
arthritis, but the association may or may not be perturbed by age.
Cruciate ligament rupture was not associated with hypoadrenocorticism after
age stratification (Tables 5. 1 1-5.13). Therefore, it was impossible to say whether
or not the association between hypoadrenocorticism and cruciate ligament rupture
was affected by age.
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Although the OR before age stratification for diabetes mellitus was 2. 16, its
95 % confidence interval included one, and its significance level was greater than
0.05 (Table 5 . 1 0). Thus, there was no evidence that diabetes mellitus and canine
hypoadrenocorticism were associated.
Hepatitis was associated with hypoadrenocorticism before age stratification.
Its OR was 7.4 1 , significant at less than 0.0001 (Table 5 . 10). For the age group
0 < age < 5, the OR was 0.00 (Table 5 . 1 1). For the age group 5

<

age < 10,

the OR was 21 .33, the 95 % confidence interval did not include one, and the OR
was significant at less than 0.0001 (Table 5. 12). For the age group age

�

10, the

OR was 3. 16, the 95 % confidence interval did include one, but the significance
level was less than 0.05 (Table 5. 13). These results suggested an association
between hepatitis and hypoadrenocorticism, but whether or not the association was
affected by age remained unknown.
Hypothyroidism was associated with hypoadrenocorticism before age
stratification (Table 5. 10). For the age group 0 < age < 5, the OR was 6.45, the
95 % confidence interval did not include one, and the 2-tailed Fisher exact p value
was 0.003 1 (Table 5. 1 1). For the age group 5

<

age < 10, the OR was 4.36, the

95 % confidence interval did not include one, and the OR was significant at less
than 0.0001 (Table 5. 12). For the age group age > 10, the OR was 2.43, the
95 % confidence interval did not include one, and the significance level of the OR
was less than 0.05 (Table 5. 13). Thus, there was evidence of an association
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between hypothyroidism and hypoadrenocorticism after age stratification.
However, hypothyroidism is not unique to hypoadrenocorticism.
Keratoconjunctivitis sicca was associated with hypoadrenocorticism before
age stratification (Table 5.10). For the age group 0 < age < 5, the OR was
undefined because there were no control dogs with keratoconjunctivitis sicca, but
the p value for the uncorrected chi-square statistic was less than 0.05 (Table 5. 1 1).
For the age group 5

:::;;

age < 10, the OR was 9.05, the 95 % confidence interval

did not include one, and the OR was significant at less than 0.05 (Table 5 . 12). For
the age group age

�

10, the OR was 1 . 15, the 95 % confidence interval did

include one, and the p value for the uncorrected chi-square statistic exceeded 0.05
(Table 5. 13) . These results suggested that keratoconjunctivitis sicca and
hypoadrenocorticism were associated; the association was affected by age, and the
effect disappeared as the dogs aged.
The OR before age stratification for megaesophagus was 5. 19, its 95 %
confidence interval included one, and its significance level was greater than 0.05
(Table 5 . 10). Age stratification yielded no additional useful results (Tables 5. 1 15 .13).
Although the OR for myasthenia gravis was undefined, its two-tailed Fisher
exact p value was less than 0.05 (Table 5. 10). This suggested an association
between myasthenia gravis and hypoadrenocorticism. Age stratification yielded no
useful results because of small sample sizes.
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Nephritis was associated with hypoadrenocorticism before and after age
stratification (Tables 5 . 10-5 . 1 3).
Thrombocytopenia was associated with adrenal insufficiency before age
stratification (Table 5 . 10). For the age group 0

<

age

<

5, the OR was 0.00

because there were no cases with thrombocytopenia (Table 5 . 1 1). For the age
group 5

s;

age

<

10, the OR was 6.42, its 95 % confidence interval included one,

and its significance level was greater than 0.05 (Table 5. 12). For the age group
age

;;:::

10, the OR was 4. 13, the 95 % confidence interval included one, and the

p value for the uncorrected chi-square statistic was greater than 0.05 (Table 5. 13).
Therefore, thrombocytopenia was associated with hypoadrenocorticism, but
whether or not age or other variables were involved was unclear.

Logistic Regression
Several things must be understood before discussion of the logistic regression
begins. The most important understanding is that the specific results in Appendices
C 1 -C8 should be examined by the reader. While the discussion below attempts to
describe and summarize, based on the logistic distribution, the effects of age,
breed,

sex,

and

body

weight

on

the probability

of occurrence

of

hypoadrenocorticism in dogs, the reader must understand that these relationships
do not lend themselves to simple characterizations. So, while easy clear
relationships can be sought, they are seldom found with this kind of data. Results
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are always model-dependent. Conclusions should always be viewed skeptically,
and a look at the specific results in the appendices is usually appropriate.
The R1 values in this study were low, never getting above about 0.25. While
this is expected since categorical models seldom yield high R1 values, 179 it leaves
many of the factors associated with canine hypoadrenocorticism completely
undiscovered.
Next, the logistic regression model, like other models, is imperfect. While
it is useful in describing biologic systems, and, while a better categorical model
will seldom provide a better fit, 8 1 it is an imperfect description of how the world
works. The reader should keep this in mind.
The reader should also be aware that the probabilities predicted from the
models outlined in Appendix C7 are relative, not absolute. Probabilities calculated
from the use of the estimated coefficients represent probabilities based on the data
set extant. This data set is, of necessity, not a random one in terms of the number
of cases vs. the number of controls. At a prevalence rate of 1 . 7 cases/1 000 dogs,
a data set large enough to include 30 hypoadrenal dogs would have to contain
about 1 8,000 randomly selected dogs. This is impractical. Nevertheless, the
probabilities are still useful. They can be used to compare relative probabilities.
For example, the estimated probability of hypoadrenocorticism for a 4 yr old,
female-spayed, 1 1 kg West Highland White Terrier is, using the case

=

age

age*age breed sex body weight model, 0.74061 . The probability for a 1 yr old,
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male-intact, 30 kg Boxer is, using the same model, 0.0000 1 . While these
probabilities mean nothing in the absolute sense, they say that the West Highland
White Terrier is relatively much more likely to be diseased than the Boxer.
And, finally, the reader should remember that not all breeds were included
in the logistic regression. The data set included 75 breeds, and the use of that
many breeds in a categorical variable was impractical because of computational
difficulties.
Given the above, interpretation of the results was straightforward. The factors
age, breed, sex, and body weight were each associated with hypoadrenocorticism. z
The single factor models (Appendix C l), the two factor models with no
interactions (Appendix C2), and the three factor models with no interactions
(Appendix C4) were evidence of this. The evidence for whether or not two-way
interactions existed was muddier.
The two factor models with interactions (Appendix C3) suggested no
significant two-way interactions. However, when a third factor was added, a
significant age*sex interaction appeared in one model, and a significant sex-.body
weight interaction in another (Appendix C5). The three factor models with two
and three-way interactions included significant age*sex, breed-.body weight, and
sex*body weight interactions, again depending on the model specified. There were

D.

zwhether or not this association constituted causation is discussed in Appendix
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significant

model-dependent

age*breed*sex

and

breed*sex*body

weight

interactions. Among the dozens of other models considered, there were also many
which included significant two- and three-way interactions. So were there
significant two- and three-way interactions? This question was not definitively
answered. However, the second model selected included age*body weight and
sex*body·weight interactions because they provided the best fit based on the model
selection criteria.

Conclusions
1.

Questionnaire Responses and Description of Veterinary Clinics. The

size (720 cases and 1 , 192 controls) of this study suggested that its results should
be viewed as reasonably reliable. Over 90 % of the questionnaire responses
received were received within 60 da, indicating that a 60 da cutoff of responses
would be reasonable for similar studies. In 1993, the veterinary clinics had an
average 2.60 full-time veterinarians, and initially diagnosed 1 .23 dogs with
hypoadrenocorticism. A veterinarian in predominantly small animal practice might
expect to initially diagnose about one-half case of canine hypoadrenocorticism per
yr. The full-time small animal practitioners in this study saw about 1 ,500 dogs
(individual dogs, not dog visits) per yr in 1993.
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2.

dogs/yr)

Incidence and Prevalence Estimates. The incidence (0.34 case/1000
and

prevalence

(1 .7

cases/1000

dogs)

estimates

for

canine

hypoadrenocorticism were lower than for veterinary referral hospitals (Chapter 4).
3.

Ages. On average, hypoadrenal dogs were older than control dogs, but

the age at death was similar. This suggested that with proper medical management,
hypoadrenal dogs may live a normal life span. The estimated average disease
duration was 4.9 yr. Age-specific OR suggested that the risk of adrenal
insufficiency increased with age.
4.

Sexes. Females, as previously reported, 41•43•93•148•189 were more likely to

be hypoadrenal. Female-spayed dogs were more likely to be hypoadrenal than their
intact counterparts, and male-castrated dogs were more likely to be hypoadrenal
than intact ones. Thus, neutered dogs of either sex were more likely to have
adrenal insufficiency than intact dogs. Other variables such as age may have
perturbed these results. However, results after stratification by age generally
supported the above conclusions.
5.

Breeds . Using a n OR of greater than one and the absence of one i n the

95 % confidence interval as criteria, these breeds were predisposed to adrenal
insufficiency: Airedale Terrier, Basset Hound, Bearded Collie, German
Shorthaired Pointer, Great Dane, Poodle, Springer Spaniel, and West Highland
White Terrier. Using the same criteria, except an OR less than one, these breeds
were less likely to be hypoadrenal: Boxer, Cocker Spaniel, Dalmatian, Lhasa
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Apso, Pit Bull Terrier, Pomeranian, Shetland Sheepdog, Shih Tzu, and Yorkshire
Terrier. Using the more exacting criterion of a significance level of less than 0.01
(p value of uncorrected chi-square statistic), the Basset Hound, Bearded Collie,
Great Dane, Poodle, Springer Spaniel, and West Highland White Terrier were
more likely to have disease, while the Cocker Spaniel, Dalmatian, Lhasa Apso,
Shetland Sheepdog, and Yorkshire Terrier were less likely. The results suggested
that Saint Bernards were predisposed to the disease, and that Boston Terriers were
less likely to be affected.
6.

Body Weights. Small dogs were less likely to be hypoadrenal. Middle

sized dogs were neither more nor less likely to have adrenal insufficiency. Large
dogs were more likely to be hypoadrenal.
7.

Selected

Cli nical

Findings

A s s ociated

with

C anine

Hypoadrenocorticism. Anemia, hypothyroidism, and nephritis were associated with
hypoadrenocorticism, and the association remained after age stratification.
Arthritis, cruciate ligament rupture, hepatitis, keratoconjunctivitis sicca,
myasthenia

gravis,

and

thrombocytopenia

were

all

associated

with

hypoadrenocorticism, but the associations became equivocal after age stratification.
8.

Logistic Regression. Age, breed, sex, and body weight were

significantly associated with hypoadrenocorticism in the dog. The probability of
occurrence of canine hypoadrenocorticism increased with age and body weight,
was greater in females than males, was greater in neutered than intact dogs, and
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varied with breed. There was model-dependent evidence of higher order
interactions; the exact nature of these interactions could not be determined. Models
were selected which could predict the relative probability of this disease in
different dogs.
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CHAPfER 6

CASE CONTROL STUDY USING PATIENTS OF
RANDOMLY SELECTED VETERINARIANS FROM THE
AMERICAN VETERINARY MEDICAL ASSOCIATION'S
LIST OF SMALL ANIMAL PRACTITIONERS

Introduction
While the case control study using the patients of veterinarians enrolled in
the clinical trial (Chapter 5) introduced randomly selected control animals to the
overall study, this group of veterinarians and their patients might be a biased
sample. Veterinarians enrolled in the clinical trial had to enroll the dog with its
attendant signatures, paperwork, restrictions on use of the drug, and other
inconveniences. Consequently, a case control study of randomly selected
veterinarians was developed.

Methods
The American Veterinary Medical Association (AVMA) maintains a list of
veterinarians in the United States which includes AVMA members and
nonmembers. Veterinarians on the list self-classify themselves as to principal
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occupation within the profession such as small animal practitioners, large animal
practitioners,

practitioners

in

mixed practice,

academics,

and

military

veterinarians. From the AVMA list, 1 ,000 veterinarians were randomly selected
who had classified themselves as either exclusively small animal practitioners or
as practitioners in mixed practice whose patients were predominantly small
animals.
A questionnaire with instructions (Appendices A8 and A9) was designed to
query these veterinarians about cases of hypoadrenocorticism and controls. The
cases were hypoadrenal dogs diagnosed by the veterinarians. The control was the
next dog in the veterinarian's patient record file owned by a different client.
Whether the control dogs were sick or well was not considered . The method of
Dillman,35 slightly abbreviated, was used to distribute the questionnaires. A
reminder letter was sent to the veterinarians approximately one week after the first
mailing, and another mailing with two more questionnaires and a cover letter was
made to those not known to have responded approximately four weeks after the
first mailing.
The questionnaire requested the number of dogs (not dog visits) seen in the
veterinary practice in 1993, and the age, breed, sex, body weight, and selected
clinical findings for cases and controls. These data were used to calculate odds
ratios (OR).
Confidence

intervals

for

OR

were

calculated

using

Cornfield's

approximation.49 If Cornfield confidence limits were inexact, exact confidence
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limits were calculated. 128 Uncorrected chi-square statistics were reported.40 Fisher
exact probability calculations for 2x2 contingency tables were calculated when the
expected value of a cell was less than five. 162 Appendix B contains further details
regarding these calculations. Body weights for cases and controls were compared
using a technique for comparing means of unequal variances. 130
Dogs were frequently reported as simply "Poodle" or "Schnauzer" without
size specification. Therefore, all Poodles have been combined as one breed, and

all Schnauzers have been combined as one breed.
The selected clinical findings were chosen because of their anecdotal
association with canine hypoadrenocorticism, or their putative autoimmune
etiology. The list of selected clinical findings is not exhaustive.

Results
Questionnaire Responses and Description of Veterinary Clinics
Five hundred fifty-five (55.5 %) of the 1 ,000 veterinarians returned
questionnaires which included a total of 151 cases and 141 controls. The first
response was received 3 da after the first mailing, and the last response was
received 1 16 da after. Figure 6.1 graphs the number of responses received vs.
time after the initial mailing. Forty-eight (8.6%) of the responses were excluded
because no useful data were received, usually because the veterinarian sa� no dogs
during 1993 . The reasons for excluding responses are catalogued in Table 6 . 1 .
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Figure 6. 1 . Time Questionnaires Received After First Mailing from 1994 Survey of Randomly Selected
Veterinarians in the United States

Table 6. 1 . Reasons for Excluding 48 Questionnaires from 1 994 Survey of
Randomly Selected Veterinarians in the United States

Reason

Number

Percent

1 994 graduate

3

6.3

Cats-only practice

6

12.5

Consultant

3

6.3

Miscellaneous

6

12.5

No access to records

7

14.6

17

35.4

Referral practice

2

4.2

Retired

1

2. 1

University employee

3

6.3

48

100.2

Not in practice

Total

159

Four hundred ninety-five veterinarians reported 1 ,050 full-time veterinarians
in 495 clinics for an average number of full-time veterinarians per clinic of 2. 1
(SD 1 .3) (SEMaa 0. 1) (Range 1 .0 - 9.0). Figure 6.2 plots the number of full-time
veterinarians in the clinics vs. the percent of individual clinics employing that
number of full-time veterinarians.
Four hundred fifty-six of the veterinarians reported the number of dogs
diagnosed in 1993 and the estimated number of active dog patientsbb seen. The
estimate of hypoadrenal dogs diagnosed for 1993 was 159 divided by the 456
veterinary clinics for a mean of 0.35 dogs diagnosed per clinic (SD 0.8) (SEM

0.04) (Range 0.0 - 10.0). These 456 clinics estimated 1 ,246,229 active dog
patients during 1993. Four hundred ninety-one veterinarians reported the number
of dogs diagnosed in 1993 and the number of full-time veterinarians employed in
their practices. The average number of dogs diagnosed per full-time veterinarian
was 0. 17 (SD 0.41) (SEM 0.02) (Range 0.00 - 3 .33). Four hundred fifty-one
veterinarians reported the number of active dog patients in 1993 and the number
of full-time veterinarians employed. The average number of active dog patients
seen per full-time veterinarian was 1455.6ce (SD 1 , 156.3) (SEM 54.4) (Range

25.0 - 1 1 ,000.0).

aastandard error of the mean (SEM) equals the standard deviation (SD) divided
by the square root of the sample size.
bb

An active dog patient was a dog seen in the practice in 1993 . Dogs were
counted only once, even if several visits to the hospital were made in 1993.
CC'fhis was similar to the estimate of 1 ,600 dogs seen per veterinarian per yr
obtained on July 29, 1996 from personal communication with Dr. J. Karl Wise,
Center for Information Management, American Veterinary Medical Association.
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Incidence and Prevalence Estimates
Incidence was estimated at 0. 13 case/1000 dogs/yr by dividing the estimate
of 159 cases in 1993 by the estimate of the total number of active dog patients of
1 ,246,229.
A prevalence estimate of 0.6 case/1000 dogs was obtained by multiplying
0. 13 case/1000 dogs/yr times the average disease duration estimate of 4.9 yr (see
Chapter 5) using the formula: 3,9&,t20,t23,t68.200.2 1S.239
Prevalence

=

(Incidence) (Average disease duration)

Ages
Ages at diagnosis were reported for 149 (98.7%) of the 151 cases. These
ages are, notably, differently defined from the current age or age at death or age
when lost to follow-up used in Chapter 5. The mean age was 6.7 yr (SD 3 .7)
(SEM 0.3) (Range 0.5 - 16.0). These ages are displayed in Figure 6.3. Of these
149 cases, 1 14 (76.5 %) were alive, 27 (1 8 . 1 %) were dead, 6 (4.0%) were lost to
follow-up, and 2 ( 1 .3 %) were of unknown status. The average age at diagnosis of
the live dogs was 6.5 yr (SD 3 . 8) (SEM 0.4) (Range 0.5 - 16.0). The average age
at diagnosis of the dead dogs was 7.9 yr (SD 3.2) (SEM 0.6) (Range 0.5 - 14.0).
The average age at diagnosis of the dogs lost to follow-up was 4.3 yr (SD 2.4)
(SEM 1 .0) (Range 2.0 - 8 .0).
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the United States

Age was reported for 138 (97.9 %) of the 141 controls. The mean age was

5.6 yr (SD 3 . 6) (SEM 0.3) (Range 0.2 - 16.0). These ages are displayed in Figure
6.4. Of these 138 controls, 130 (94.2%) were alive, 2 (1 .4%) were dead, 4
(2.9%) were lost to follow-up, and 2 (1 .4%) were of unknown status. The average
age of live dogs was 5.5 yr (SD 3.6) (SEM 0.3) (Range 0.2 - 15.0). The sample
sizes for dead dogs (two) and dogs lost to follow-up (four) were so small that
averages for these groups were not meaningful.
Age-specific OR with relevant statistics are presented in Table 6.2.

Sexes
Sex was reported for 147 (97.4%) of the 151 cases, and 139 (98.6%) of the

141 controls (fable 6.3). Sex-specific OR were calculated with 95 % confidence
intervals, chi-square statistics, and significance levels (p values) for the chi-square
statistics (fable 6.4).

Breeds
Breeds were reported for 149 (98.7%) of the 151 cases (Table 6.5). The
seven most frequently reported case breeds with number (%) were: Poodle 22

(14.8); Mixed 15 (10. 1); German Shepherd 1 1 (7 .4); Labrador Retriever 8 (5.4);
Cocker Spaniel 6 (4.0); Rottweiler 6 (4.0); and Schnauzer 6 (4.0).
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Table 6.2. Age*-Specific Odds Ratios (OR) for Dogs with Hypoadrenocorticism from 1994 Survey of Randomly Selected Veterinarians in the United States
X: statistic (p value)
Age interval (yr)**

Number of cases
n = 149

Number of controls
n= l38

OR

95 % confidence
interval for OR49

Uncorrected40

0 < age < S

49

61

0.62

0.37 - 1 .03

3.88 (0.0488)

S � age < 10

65

51

1 . 10

0.67 - 1.81

0. 16 (0.6912)

35

20

1 .8 1

0.95 - 3.48

3 .74 (0.0530)

age

�

10

• Age at diagnosis.
•• The comparison group is all other dogs.
-

01
01

Table 6.3. Sexes of 147 Cases of Canine Hypoadrenocorticism and 139 Controls
from 1994 Survey of Randomly Selected Veterinarians in the United States
Cases
Sexes

Number

Controls

Percent

Number

Percent

Female-intact

4

2.7

17

12.2

Female-spayed

78

53. 1

68

48.9

82

55.8

85

6 1 .2

Male-intact

22

15.0

21

15. 1

Male-castrated

43

29.3

33

23 .7

All males

65

44.2

54

38.8

147

100.0

139

100.0

All females

All sexes

167

Table 6.4. Sex-Specific Odds Ratios (OR) for Dogs with Hypoadrenocorticism from 1994 Survey of Randomly Selected Veterinarians in the United States
x? statistic (p value)
Sex•

-

01

00

Number of cases
n= 1 47

Number of controls
n= 139

OR

95 % confidence
interval for OR49

Uncorrected40

Female-intact

4

17

0.20

0.05 - 0.64••••

9.50 (0.0021)

Female-spayed

78

68

1.18

0.72 - 1 .93

0.49 (0.4839)

Female-spayed**

78

68

4.88

1 .48 - 20.70"'"'"'"'

8.68 (0.0032)

Female (intact and spayed)

82

85

0.80

0.49 - 1 .32

0.85 (0.3572)

Male-intact

22

21

0.99

0.49 - 1 .99

0.00 (0.9732)

Male-castrated

43

33

1 .33

0.76 - 2.33

1 . 1 1 (0.29 17)

Male-castrated***

43

33

1 .24

0.55 - 2.82

0.33 (0.5686)

121

101

1 .75

0.96 - 3.20

3.83 (0.0503)

Neutered (either sex)

"' Except as noted, the comparison group is all other dogs.
•• Female-spayed compared to female-intact.
••• Male-castrated compared to male-intact.
*"'** Exact confidence limits. 128

Table 6.5. Breeds of 149 Cases ofHypoadrenocorticism and 140 Controls from 1 994 Survey of Randomly
Selected Veterinarians in the United States*
Controls

Cases
Breed
Akita

Australian Shepherd
Basset Hound
Beagle
Bearded Collie
Boston Terrier
Brittany
Cairn Terrier

Chihuahua
Chow Chow
Cocker Spaniel
Dachshund
Doberman Pinscher
German Shepherd
Golden Retriever
Great Dane
Great Pyrennes
Labrador Retriever
Lhasa Apso

Nmnber

3
2
5
3
2
3
2
2
1
3
6
3
3
11
4
3
2
8

Mixed

1
15

Pomeranian

2

Poodle
Rottweiler

22

Percent

Nmnber

Percent

2.0
1 .3
3.4
2.0
1.3
2.0
1.3
1.3
0.7
2.0
4.0

0
5
0
2
0
2
1
0

0.0
3.6
0.0
1 .4
0.0
1.4
0.7
0.0

3
2
9

2. 1
1.4
6.4

2.0

0

0.0

2.0
7.4
2.7
2.0
1.3

3

2. 1
9.3
5.7
0.0
0.0
10.7

13
8
0
0
15
3

5.4
0.7
10. 1

28

1.3
14.8
4.0
4.0
2.0

2
13
4
2
0

1.4
9.3
2.9
1.4

2. 1
20.0

Schnauzer

6
6

Scottish Terrier

3

Shetland Sheepdog

1
2

0.7

2

1.4

1.3

2

West Highland White Terrier

3

3.4
1.3
2.0

2

Welsh Corgi

5
2

1.4
1.4
0.0

Shih Tzu
Springer Spaniel

0
0

0.0

0.0

* Breeds are included only if there were at least two cases or two controls of the breed reported in the
survey.
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Breeds were reported for 140 (99.3 %) of the 141 controls (Table 6.5). The
seven most frequently reported control breeds with number (%) were: Mixed 28

(20.0); Labrador Retriever 15 (10.7); German Shepherd 13 (9.3); Poodle 13 (9.3);
Cocker Spaniel 9 (6.4); Golden Retriever 8 (5.7); and Australian Shepherd 5 (3 .6).
The number (%) of each of the most frequently reported case breeds among
controls was (in the same order as listed above for cases) Poodle 13 (9 .3); Mixed

28 (20.0); German Shepherd 13 (9.3); Labrador Retriever 15 (10.7); Cocker
Spaniel 9 (6.4); Rottweiler 4 (2.9); and Schnauzer 2 ( 1 .4) .
Breed-specific OR were calculated for all breeds for which there were at least
five cases or five controls. These OR are reported in Table 6.6.

Body Weights
Body weights were reported for 149 (98.7 %) of the 151 cases (Figure 6.5).
The average body weight (kg) for cases was 20.2 (SD 14. 1) (SEM 1 .2) (Range 1 . 1

- 63 .6) . Body weights were reported for 140 (99.3 %) of the 141 controls (Figure
6.6). The average body weight (kg) for controls was 19.8 (SD 13.5) (SEM 1 . 1)
(Range 1 .4 - 74. 1). Body weight-specific OR were calculated for 5 kg body weight
increments (Table 6.7).
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Table 6.6. Breed-Specific Odds Ratios (OR) for Dogs with Hypoadrenocorticism from 1994 SuJVey of Randomly Selected Veterinarians
in the United States*
X: statistic {p value)
Number of
cases
n= 149

Number of
controls
n= 140

OR

95 % confidence
inteJVal for OR49

Uncorrected40

Fisher exact
(2-tailed p value)***16l

Australian Shepherd

2

5

0.37

0.03 - 2.30****

1 .52 (0.2180)

0.2698

Basset Hound

s

0

*****

**"'**

4.78 (0.0288)

0.0609

Cocker Spaniel

6

9

0.61

0. 17 - 1 .98"'"'*"'

0.85 (0.3577)

Gennan Shepherd

11

13

0.78

0.3 1 - 1.93

0.34 (0.5579)

Golden Retriever

4

8

0.46

0. 10 - 1 .75****

1.66 (0. 1970)

Labrador Retriever

8

IS

0.47

0. 1 8 - 1 .24

2. 82 (0.0934)

Mixed

15

28

0.45

0.22 - 0.92

5.62 (0.0177)

Poodle

22

13

1 .69

0.77 - 3.73

2.04 (0.1536)

Rottweiler

6

4

1 .43

0.33 - 7.02***"'

0.30 (0.5866)

0.7508

Schnauzer

6

2

2.90

0.5 1 - 29.71***"'

1.81 (0. 1785)

0.2841

Springer Spaniel

5

2

2.40

0.38 - 25.48*"'**

1 . 13 (0.2869)

0.4490

Breed**

-

�

* Breeds are included only if there were at least five cases or five controls of the breed reported in the survey.
** The comparison group is all other dogs.
*** Calculated only if an expected cell value is < 5; the preferred p value for this OR.
**** Exact confidence limits. 128
**"'** Undefined.
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Figure 6.5. Body Weights of 149 Dogs with Hypoadrenocorticism from 1994 Survey of Randomly Selected
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Table 6. 7. Body Weight-Specific Odds Ratios (OR) for Dogs with Hypoadrenocorticism from 1994 Survey of Randomly Selected Veterinarians in the United
States•

r statistic (p value)
Number of
cases
n= 149

Number of
controls
n= 140

OR

95 % confidence
interval for OR49

Uncorrected40

0 < weight � 5

13

18

0.65

0.29 - 1 .46

1 .29 (0.2566)

5 < weight � 10

3S

25

1 .41

0.77 - 2.61

1 .39 (0.2380)

10 < weight � IS

24

23

0.98

o.so - 1 .91

0.01 (0.941 1)

15 < weight � 20

10

14

0.65

0.26 - 1 .62

1.03 (0.3 1 13)

20 < weight � 25

22

10

2.25

0.97 - 5.33

4.26 (0.0390)

25 < weight � 30

10

19

0.46

0. 19 - 1 .09

3. 76 (0.0524)

30 < weight � 35

10

10

0.94

0.35 - 2.52

0.02 (0.8852)

35 < weight � 40

12

12

0.93

0.38 - 2.32

0.03 (0.8734)

40 < weight � 45

4

s

0.74

0. 14 - 3.54•••

0. 19 (0.6645)

weight > 4S

9

4

2. 19

0.59 - 9.92•••

1 .70 (0. 1920)

Body weight
interval (kg)"'

_

-l
..J::o.

• The comparison group is all other dogs.
** Calculated only if an expected cell value is < S; the preferred p value for this OR.
••• Exact confidence limits.128

Fisher exact
(2-tailed p value)"'*16l

0.7435

Selected Clinical Findings Associated with Canine Hypoadrenocorticism
Odds ratios were calculated for the selected clinical findings, including 95 %
confidence intervals and uncorrected chi-square statistics with significance levels
(p values) (Table 6.8) .

Discussion
Questionnaire Responses and Description of Veterinary Clinics
A review of these results must recognize the limitations of sending a
questionnaire to veterinarians randomly selected from the AVMA's mailing list.
These include: the list must be accurate; and certain veterinarians, such as 1994
graduates and those with cats-only practice, did not see any patients in 1993.
This case control study was large, particularly for an uncommon disease,
since it obtained 555 responses. The response rate of 55.5 % of those initially sent
questionnaires was satisfactory, though less than ideal. Figure 6. 1 revealed that
95.9 % of the responses were received within 60 da. This suggested that a cutoff
of responses after 60 da would be reasonable in similar studies.
The average veterinary clinic had 2. 10 full-time veterinarians (Figure 6.2),
and reported an average estimated number of dogs first diagnosed in 1993 of 0.35
dogs. If 2. 10 full-time veterinarians see 0.35 newly diagnosed hypoadrenal dogs
per yr, this suggested an average small animal practitioner might expect to see 0.2
case per yr. This probably understated the number of cases since one veterinarian
filled out the questionnaire for the entire practice. This veterinarian, being asked
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Table 6.8. Odds Ratios (OR) for Clinical Findings Associated with Hypoadrenocorticism in Dogs from 1994 Survey of Randomly Selected Veterinarians
in the United States
x2 statistic (p value)

Number of
cases
n = l 43

Number of
controls
n= 140

OR

95 % confidence
interval for OR49

Uncorrected40

Anemia

22

1

25.27

3.94 - 1050.33*"'"'

20.39 ( < 0.0001)

Arthritis

19

11

1.80

0.77 - 4.22

2.20 (0. 1380)

Cruciate ligament rupture

3

3

0.98

0. 13 - 7.43*"'"'

0.00 (0.9791)

Diabetes mellitus

8

0

............

*"'"'"'

8.06 (0.0045)

Hepatitis

17

0

..........

"'*"'"'

17.71 (< 0.0001)

Hypothyroidism

23

4

6.52

2. 1 3 - 26.51"'"'"'

14.34 (0.0002)

8

0

............

.......
. ....

8.06 (0.0045)

Nephritis

11

0

"'"'"'"'

"'"'"'"'

1 1 .20 (0.0008)

Thrombocytopenia

2

1

1 .97

0. 10 - 1 17. 14*"'"'

0.32 (0.5741)

Clinical finding*

.......

�

Keratoconjunctivitis sicca

Fisher exact
(2-tailed p value)**162

0.0071

0.0071

1.0000

"' Clinical findings either anecdotally linked to hypoadrenocorticism or with a putative autoimmune etiology; comparison group is all other dogs; there
were no cases or controls for either megaesophagus or myasthenia gravis.
"'"' Calculated only if an expected cell value is < 5; the preferred p value for this OR.
"'*"' Exact confidence limits.128
"'"'"'"' Undefined.

for summary data about the entire practice, may not have been aware of all cases
diagnosed. In any event, 0.2 new case per yr might be used as a minimum
benchmark for the number of cases a small animal practitioner could expect to
diagnose each yr. Another useful benchmark was that the average full-time
veterinarian saw 1 ,455.6 dogs (individual dogs, not dog visits) per yr.

Incidence and Prevalence Estimates
The incidence estimate of 0.13 case/1 000 dogs/yr and the prevalence estimate
of 0.6 case/1000 dogs suggested an approximate rate at which new cases may be
acquired, and a rough indicator of how many cases a veterinarian might expect to
be treating at any one time.

Ages
The mean age of all hypoadrenal dogs was higher (6.7 yr) than the mean age
for all control dogs (5.6 yr). This suggested that hypoadrenocorticism tended to
be present in older dogs. Similarly, the average age for live hypoadrenal dogs (6.5
yr) exceeded that for live control dogs (5.5 yr). Since the sample sizes for dead
and lost to follow-up dogs were so small, no meaningful comparisons could be
made between cases and controls.
Age at diagnosis was a poor age definition for this survey. In the survey of
veterinarians whose patients were enrolled in the clinical trial (Chapter 5), the
definition of age was current age or age at death or age when lost to follow-up.
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If a veterinarian or a veterinary assistant looks up the age of a dog in the dog's
medical record, the age found, assuming that the age has been periodically
updated, will likely be current age or age at death or age when lost to follow-up.
If the veterinarian knows the dog is alive, the age will be current age; if the
veterinarian knows the dog is dead, the age is likely to be the age at or near death;
and if the veterinarian does not know whether the dog is alive or dead, then the
recorded age is probably age when lost to follow-up. So the age reported by the
veterinarian is very likely to fit the current age or age at death or age when lost
to follow-up definition. Determining age at diagnosis, on the other hand, requires
some computation. The age listed on the medical record is, unless the dog was
very recently diagnosed with disease, irrelevant to age at diagnosis. The
veterinarian would need to know specifically when the diagnosis was made in
relation to the animal's birth, and some veterinarians may not have gone to the
trouble of making the necessary computation. Consequently, some of the ages
reported in this study were probably specious.
A second reason for making age at diagnosis a poor age definition was that
age at diagnosis has no meaning in a control dog. Thus, case to control
comparisons would be specious.
The age results suggested that they were not reliable. The mean age at
diagnosis estimate was 6.7 yr, much older than the 4.3 yr estimate reported for the
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244 literature review cases (Chapter 2), the 4.9 yr estimate reported for the 232
cases enrolled in the clinical trial (Chapter 3), the 5.4 yr estimate reported for the
329 cases from the veterinary referral hospitals (Chapter 4), or the 4.9 yr estimate
obtained by a weighted average of the previous three estimates (Chapter 5).cld
Therefore, age at diagnosis was a poor way to define age in this survey, and
is probably a poor way to define it in most case control studies; consequently, the
age results obtained from this survey, including Figures 6.3 and 6.4, and Table
6.2, should not be trusted. Future surveys should avoid this error by defining age
as current age or age at death or age when lost to follow-up.

Sexes
The sex data in Table 6.4 can be characterized as equivocal. The 95 %
confidence intervals for the OR all include one except for female-intact
(comparison group all other dogs) which had a 95 % confidence interval of 0.05 0.64 and a p value for its uncorrected chi-square statistic of 0.0021 , and femalespayed (comparison group female-intact dogs) which had a 95 % confidence
interval of 1 .48 - 20.70 and a p value for its uncorrected chi-square statistic of

ddJ:t is notable that the literature review cases, clinical trial cases, and
veterinary referral hospital cases all came from studies which focused specifically
on age at diagnosis.
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0.0032. This suggested that female-spayed dogs were more likely to be
hypoadrenal than intact ones, and that female-intact dogs were less likely to be
hypoadrenal than other dogs. None of the other results, except possibly the one
discussed below, showed any predilection for or against hypoadrenocorticism.
The OR for neutered (either sex) was 1 .75 with a 95 % confidence interval
of 0.96 - 3 .20 (p=0.05 for its uncorrected chi-square statistic). A neutered dog of
either sex may be more likely to have adrenal insufficiency.

Breeds
No OR (Table 6 . 6) except one was significant at the 0.05 level. The one
exception was the Mixed dog which had an OR of 0.45, a 95 % confidence interval
of 0.22 - 0.92, and a p value for the uncorrected chi-square statistic of 0.0177.
This suggested that a Mixed dog was less likely to be hypoadrenal. Though the OR
for the Basset Hound was undefined, the p value for the uncorrected chi-square
statistic was 0.0288, indicating a predisposition for the disease.

Body Weights
As with breeds, sample sizes were too small to establish clear body weight
predilections for or against disease. The statistical comparison of average body
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weight of cases (20.2 kg) with controls (19.8 kg) revealed no significant
difference.
Body weight-specific OR (Table 6.7) revealed little to suggest association
between body weights and either an increase or decrease in the probability of
hypoadrenocorticism. There were two possible exceptions.
First, the 20 kg < weight

=:;

25 kg weight range had an OR of 2.25 with a

95 % confidence interval of 0.97 - 5.33 and a p value for the uncorrected chi
square statistic of 0.0390, suggesting a predilection for hypoadrenocorticism.
Second, the 25 kg < weight

=:;

30 kg weight range had

an

OR of 0.46 with a

95 % confidence interval of 0. 19 - 1 .09 and a p value for the uncorrected chi
square statistic of 0.0524, suggesting they may be less likely to be hypoadrenal.
These results seemed inconsistent, since it is counterintuitive to conclude dogs in
the 20 kg < weight

=:;

in the 25 kg < weight

25 kg weight range were predisposed to disease, and dogs
<

30 kg weight range were less likely to be diseased. This

remains unexplained.

Selected Clinical Findings Associated with Canine Hypoadrenocorticism
Of the five clinical findings with defined OR displayed in Table 6 . 8, anemia,
arthritis, hypothyroidism, and thrombocytopenia had OR which exceeded one. The
OR for cruciate ligament rupture was less than one. The OR for anemia of 25.27
and the OR for hypothyroidism of 6.52 were both highly significant (p < 0.001
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for uncorrected chi-square statistics) . The OR for arthritis, cruciate ligament
rupture, and thrombocytopenia were not significant at the 0.05 Ievel. Though the
OR for diabetes mellitus, hepatitis, keratoconjunctivitis sicca, and nephritis were
undefined, there was evidence that these conditions were associated with
hypoadrenocorticism (p < 0.01 for their uncorrected chi-square statistics). Sample
sizes were too small to permit meaningful stratification by age.

Conclusions
1.

Questionnaire Responses and Description of Veterinary Clinics. With

a response rate of slightly over half (55.5 %), all results of this study should be
considered carefuiiy. Over 90 % of the questionnaire responses received were
·received within 60 da, suggesting a 60 da cutoff would be reasonable in similar
studies. In 1993 the average veterinary clinic had an estimated 2. 10 full-time
veterinarians, and initially diagnosed 0.35 dogs. A veterinarian in small animal
practice might expect to initially diagnose about 0.2 case per yr. This is probably
an underestimate. The average full-time small animal practitioner saw about 1 ,500
dogs (individual dogs, not dog visits) in 1993.
2.

Incidence and Prevalence Estimates. Incidence and prevalence estimates

for canine hypoadrenocorticism were, respectively, 0. 13 case/1000 dogs/yr and 0.6
case/1000 dogs, which were lower than the estimates obtained from the survey of
veterinarians enrolled in the clinical trial (Chapter 5) .
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3.

Ages. The age results should be disregarded since they were unreliable.

4.

Sexes. Female-intact dogs were less likely to have adrenal insufficiency.

Female-spayed dogs were more likely.
5.

Breeds. The Mixed breed dog was less likely than other breeds to be

hypoadrenal. The Basset Hound may be predisposed to hypoadrenocorticism.
There

were

no

statistically

significant

predilections

for

or

against

hypoadrenocorticism in other breeds; this likely resulted from the relatively small
sample sizes rather than from a real absence of them.
6.

Body Weights. Body weight data led to no meaningful conclusions.

7.

Selected

C l i n ical

Findings

Associated

with

Canine

Hypoadrenocorticism. Anemia, diabetes mellitus, hepatitis, hypothyroidism,
keratoconjunctivitis

sicca,

and

nephritis

were

each

associated

with

hypoadrenocorticism at a significance level of less than 0.01 . No significant
associations

were

found

between

the

other

clinical

findings

and

hypoadrenocorticism; this was likely the result of small sample sizes rather than
the real absence of them.
8.

General. While this survey augmented the other studies comprising this

overall study of canine hypoadrenocorticism, it did not in itself provide much
useful information. It was limited by: the small number of cases reported; the
uncertainty about the diagnostic method used by responding veterinarians; the
method of estimation of active dog patients; the definition of age; and the fact that
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veterinarians have different procedures for removing medical records from their
files after a dog's death. Thus, a survey of randomly selected veterinarians would
generally, because of the time and expense required, be a poor vehicle for the
primary study of an uncommon animal disease. If the disease being studied were
more common or if larger samples could be obtained at minimal expense, a survey
of randomly selected veterinarians might nevertheless be appropriate.
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CHAPfER 7 .

CONCLUSIONS

Introduction and Comments Regarding Methodology
These conclusions are an amalgam of those from the preceding six chapters.
However, before the conclusions can be presented, a few issues must be discussed
as background. These include the general strengths and weaknesses of case series,
case control studies, and mail surveys, particularly as they apply to this work.
A case series is a .. cross-sectional study with no defined population and no
comparison group. 11203• The data from the canine literature review (Chapter 2),
from the microcrystalline desoxycorticosterone pivalate (DOCP) clinical trial
(Chapter 3), and from the Veterinary Medical Data Base (VMDB) (Chapter 4)
were case series. Case series are useful since information is available quickly, and
they lend themselves to stimulating more definitive research. They are, however,
prone to overinterpretation, and often provoke

II

authoritarian (rather than

authoritative) clinical advice about etiology, prevention, and therapy. 11 174 Case
series do not prospectively follow patient cohorts, "do not have a time dimension,

II

and 11 suffer from the absence of a comparison group. "52 The use of case series is
particularly appropriate for rare diseases.51 Data in Chapters 2, 3 , and 4
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represented the first logical step in epidemiology: observe and study those cases
already available and documented, then develop other studies. Specifically, the
case series in Chapters 2, 3 , and 4 were used as forerunners of the case-control
studies based on surveys of veterinarians enrolled in the clinical trial of DOCP
(Chapter 5) and randomly selected veterinarians (Chapter 6).
A case-control study is one in which "individuals with a particular condition
or disease (the cases) are selected for comparison with a series of individuals in
whom the condition or disease is absent (the controls). Cases and controls are
compared with respect to existing or past attributes or exposures thought to be
relevant to the development of the condition or disease under study [Italics in
original]. "186 Case control studies are an important way to learn about uncommon
diseases; they generally are inexpensive and the researcher can obtain results fairly
quickly. 53 They make use of readily available cases which are often cataloged in
places like hospitals, disease registries, 187 and veterinary practices.201 This has
become particularly appealing and useful as these records and registries become
computerized. 173 Case-control studies are favored for uncommon diseases and those
with long latency periods, and they enable the researcher to explore large numbers
of potential risk or causal factors.202 While case-control studies are useful and
popular, they suffer from selection bias and measurement bias. 55 The studies using
cases and controls from the clinical trial of DOCP (Chapter 5), and cases and
1 86

controls from the randomly selected veterinarians (Chapter 6) were case-control
studies in which mail survey methodology was used to gather data. These studies
did no matching of cases and controls since little information already existed about
factors associated with hypoadrenocorticism. They were inexpensive, assembled
information from several sources on hundreds of cases of an uncommon disease,
and explored many factors and their possible association with the disease.
Selection bias was at work in the printed literature. Many things have to
come together before a case finds its way into print: an owner willing to seek
treatment for a sick dog; an observant veterinarian willing to carefully diagnose
and document the case; a veterinarian willing and able to write the article; a
compliant editor; and so on. Similarly, specific sets of circumstances are required
before cases find their way into the files of the VMDB or Ciba Animal Health,
and still others have to be present before practitioners respond to mail surveys.
Measurement bias was probably also a� work. There are three kinds of
measurement bias:S4
1.

The presence of the outcome directly affects the exposure. (For

example, if a dog repeatedly has fleas, the dog's owner will try to keep the dog
from being infested with fleas.)
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2.

The presence of the outcome affects the subject's recollection of the

exposure. (For example, a dog's owner is more likely to remember when the dog
was hit by a
3.

car

than when the dog had a mild diarrhea.)

The presence of the outcome affects the measurement or recording of

the exposure. (For example, a dog who has suffered a serious illness is more likely
to have a thoroughly documented medical history than a dog who has received
only routine wormings and vaccinations.)
It is unlikely that this study suffered from the first bias listed, but it almost
certainly did from the second two. It likely occurred with regard to clinical
findings. A veterinarian or dog owner with a hypoadrenal dog is more likely to
recall clinical findings in the dog's history than the owner of a control dog. Along
the same lines, the veterinarian is more likely to inquire about clinical findings in
a hypoadrenal dog compared to a dog presented for a routine visit or minor illness.
The veterinarian is also more likely to do more diagnostic testing and, perhaps, to
record the diagnostic results more carefully when the patient is viewed as "serious"
(cases) rather than "routine" (controls).
The advantages and disadvantages of mail survey methodology were also at
work in these studies. The survey of veterinarians enrolled in the clinical trial of
DOCP (Chapter 5) and the survey of randomly selected veterinarians (Chapter 6)
were both mail surveys. Low response rate is an important problem with mail
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surveys. A prominent text in the field states, "Surveys by mail typically elicited
extremely low response rates, even with short questionnaires, and ·high response
to relatively long questionnaires was very rare indeed

.

. . . "30 Another problem

is nonresponse to particular items on questionnaires among those questionnaires
actually received.33 Another shortcoming of mail questionnaires is that they are
often far shorter than needed to elicit the necessary research data. 32 The survey of
randomly selected veterinarians may have suffered from all these problems, though
particularly from the last.
The need for a high response rate stems from the idea that selection bias is
introduced when some people respond and some do not. If responders and
nonresponders have different characteristics, then the study is biased by these
differences. This problem becomes less important as the response rate increases.
This "unknown bias from refusals"34 is difficult or impossible to quantify, since
it is by definition "unknown. " The mail survey of veterinarians enrolled by Ciba
Animal Health in the clinical trial of DOCP (Chapter 5) was probably not greatly
affected by a response rate problem since the rate was 90.9 % compared to the
survey of randomly selected veterinarians with a rate of 55.5 % . Though no
definitive minimum response rate can be established, one source suggests by
implication that a 50% response rate may be a useful working minimum.3 1 By that
standard, the response rate for both surveys was satisfactory.
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Specific item nonresponse may have been a small problem. The DOCP
clinical trial veterinarians (Chapter 5) were asked for two controls for each of their
cases. They provided 1 . 66 controls per case, ages for 92.6 % of cases and 97.6%
of controls, and sexes for 98.9 % of cases and 96.6 % of controls. The randomly
selected veterinarians (Chapter 6) were asked for one control per case. They
provided 0.93 controls per case, ages for 98.7 % of cases and 97.9 % of controls,
and sexes for 97.4% of cases and 98.6% of controls. There were some
nonresponses for other variables as well, which leads to the question of whether
or not these nonresponses perturbed the results. The answer is no, for two reasons.
First, the samples for these variables were quite large. Given these large samples,
a responder/nonresponder bias, even if present, would have to be overwhelming
before it could materially change the results. Second, it is almost impossible to
postulate how a responder/noriresponder bias could occur which would have
affected the results. Responding veterinarians might have less busy practices than
nonresponders who, having busier practices, have less time to fill out
questionnaires. However, no plausible scenario could systematically change the
characteristics of the case of canine hypoadrenocorticism in a veterinarian's
medical records or the characteristics of the control dog which followed.
Therefore, nonresponses were not viewed as a problem.
The most significant problem with mail surveys is the compromise between
response rate and length of questionnaire. If the questionnaire is long and
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complicated, the response rate will go down. Conversely, if the questionnaire is
short and simple, the response rate will go up, and responder/nonresponder bias
will be less troublesome. These questionnaires were deliberately written to be

brief. The result was good response rates, but lots of unanswered questions. For
example, lots of dogs had anemia, but what kind of anemia? A more detailed
questionnaire might have inquired about the specific nature of each anemia. But
then it might not have been returned. Consequently, shortening the questionnaire
was an undesirable, though unavoidable, part of the mail surveys.
Finally, the estimates of active dog patients reported by the DOCP clinical
trial veterinarians (Chapter 5) and the randomly selected veterinarians (Chapter 6)
may have introduced error in the incidence and prevalence estimates. How this
error may have affected the results is unknown. Some veterinarians probably
guessed at the number of active dog patients; others likely obtained it from
computerized medical records. The method used for these studies did not
determine how the veterinarians arrived at the number of active dog patients.
Future studies should address this issue. In this regard, the numbers of active dog
patients seen per full-time veterinarian were virtually identical for the DOCP
clinical trial veterinarians (1504.7) and the randomly selected veterinarians
(1455.6) .= This suggested that this study flaw was, if present, minimal.

COJ'hese were similar to the estimate of 1600 dogs seen per veterinarian per yr
obtained on July 29, 1996 from personal communication with Dr. J. Karl Wise,
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Overall, the mail survey served a purpose. Assembling a credible group of
several hundred cases with controls of a disease as uncommon as canine
hypoadrenocorticism was useful and the mail survey methodology was the only
practical way to obtain this information.
Recognizing the advantages and disadvantages of case series, case-control
studies, and mail survey questionnaires, the following conclusions are presented.
They are a composite and comparison of the conclusions drawn in Chapters 2
through 6.

Incidence and Prevalence Estimates

The incidence and prevalence estimates appear in Table 7 . 1 . The incidence
was highest for the veterinary referral hospitals; next for the Ciba Animal Health
veterinarians, who might be considered more motivated than the randomly selected
veterinarians since they went to the trouble of enrolling in the clinical trial; and
last for the randomly selected veterinarians. These results suggested that 0.36
case/1000 dogs/yr (a simple mean of the three incidences) can be used as a point
estimate of incidence. Similarly, 1 . 8 cases/1000 dogs can be used as a point
estimate for prevalence. These point estimates can be used by veterinary clinicians.

Center for Information Management, American Veterinary Medical Association.
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Table 7 . 1 . Incidence and Prevalence Estimates Determined in Three Epidemiologic
Studies of Naturally Occurring and Iatrogenically Produced Canine
Hypoadrenocorticism
Incidence estimate
(cases/1 000
dogs/yr)*

Prevalence estimate
(cases/1000 dogs)

Case series: veterinary
referral hospitals

0.6

3 .2

Case control: survey of
veterinarians enrolled in
clinical trial

0.34

1 .7

Case control: survey of
randomly selected
veterinarians

0. 1 3

0.6

Study

*Each estimate differs significantly from each other estimate (p < 0.0001).
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Ages

The average age at diagnosis (SD) (SEMff) (Range) in yr for dogs with
adrenal insufficiency was 4.3 (") (hh) (0.2- 12.0) for dogs included in the
literature review (Chapter 2),ii 4.9 (3 .0) (0.2) (0.3-1 3 . 0) for dogs in the Ciba
Animal Health clinical trial of DOCP (Chapter 3), and 5.4 (3.2) (0.2) (0. 1-15.0)
for the dogs diagnosed in veterinary referral hospitals (Chapter 4). A simple mean
of these three results was 4.9 yr, a result consistent with estimates provided in two
well-known veterinary references.41•43 The results demonstrated that the disease can
be diagnosed in very young and very old dogs.
The ages reported in the survey of veterinarians enrolled by Ciba Animal
Health in the clinical trial of DOCP (Chapter 5) were current age or age at death

or age when lost to follow-up. The mean age (SD) (SEM) (Range) for cases in yr
was for live dogs 8 . 1 (3 .0) (0. 1) (1 .5-18.0), for dead dogs 9.8 (3 .4) (0.2) (1 .01 7.2), and for dogs lost to follow-up 8 .6 (3 . 1) (0.7) (4.0-13 .0) . It was for controls
6. 1 (3 .9) (0. 1) (0. 1-19.0) for live dogs, 10.2 (5.2) (0. 8) (0.3-17.0) for dead dogs,
and 5.7 (4.3) (0.4) (0.2-16.0) for dogs lost to follow-up. Average disease duration
ffStandard error of the mean (SEM) equals the standard deviation (SD) divided
by the square root of the sample size.
"Not reported for all cases.
hhNot reported for all cases.
iiThis assumes that the articles reviewed actually reported "age at diagnosis" ;
in fact, they reported " age. "
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was estimated at 4.9 yr (Chapter 5). This suggested that hypoadrenal dogs tended
to be older than control dogs. Age-specific odds ratios (OR) suggested that the risk
of hypoadrenocorticism increased with age. The ages reported in the survey of
randomly selected veterinarians (Chapter 6) should be disregarded because they
were unreliable.

Sexes

The sexes for hypoadrenal dogs were 16. 8 % female-intact, 47. 8 % female
spayed, 22.3 % male-intact, and 1 3 .0% male-castrated in the literature review
(Chapter 2); 6. 1 , 61 .8, 13 .0, and 19. 1 (percentages ordered female-intact, female
spayed, male-intact, and male-castrated) for the clinical trial of DOCP (Chapter
3); 14.0, 53 .8, 1 3 . 1 , and 19. 1 for veterinary referral hospitals (Chapter 4); 5 .2,
63.9, 10.3, and 20.7 for the mail survey of Ciba Animal Health veterinarians
(Chapter 5); and 2.7, 53 . 1 , 15.0, and 29.3 for the mail survey of randomly
selected veterinarians (Chapter 6). These were remarkably similar, and taken
together using simple averages, suggested that hypoadrenal dogs were 9 % female
intact, 56 % female-spayed, 15 % male-intact, and 20 % male-castrated. This was
consistent with previous assertions that canine hypoadrenocorticism is primarily
a disease of the female dog.41.43.93.14B.IB9
Sex-specific OR and sex-specific incidence estimates calculated from
veterinary referral hospitals (Chapter 4), from the mail survey of Ciba Animal
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Health veterinarians (Chapter 5), and from the mail survey of randomly selected
veterinarians (Chapter 6) supported the conclusion that females were more likely
to be hypoadrenal, but also suggested that female-spayeds were more likely than
female-intacts, that male-castrateds were more likely than male-intacts, and that
neutered dogs were more likely than intact ones. This contradicted one study
which reported that female-intacts had an increased probability of disease
compared to female-spayeds. 148 These associations between neutering and
hypoadrenocorticism could be influenced by the age at which dogs were neutered.
Though these studies did not address this possibility, future studies might do so.
Table 7.2 summarizes the sex-specific OR. These data can be used by veterinary
clinicians when evaluating potential cases of hypoadrenocorticism.

Breeds

The data demonstrated that canine hypoadrenocorticism was widespread
among breeds. Several breeds were at increased risk of disease and several at
decreased risk. The results from veterinary referral hospitals (Chapter 4), the
survey of veterinarians enrolled by Ciba Animal Health in the clinical trial of
DOCP (Chapter 5), and the survey of randomly selected veterinarians (Chapter 6)
were consistent (Table 7.3).
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Table 7.2. Sex-Specific Risks of Canine Hypoadrenocorticism Based on Three Epidemiologic Studies

Study

odds ratio (OR)

Sex-specific

95 % confidence interval
for OR411

Uncorrected
X: statistic (p valuer'

Female-intact

0.56

0.40 - 0.78

13.05 (0.0003)

Female-spayed

2.88

2.28 - 3.64

90.60 ( < 0.0001)

Female-spayed**

3.02

2. 13 - 4.30

45.75 ( < 0.0001)

Female (intact and spayed)

1.97

1.53 - 2.53

30. 81 ( < 0.0001)

Male-intact

0.32

0.23 - 0.45

49.81 ( < 0.0001)

Male-castrated

1 .25

0.92 - 1 .69

2.21 (0. 1371)

Male-castrated•••

2.92

1.9 1 - 4.47

29. 16 ( < 0.0001)

Neutered (either sex)

3.29

2.53 - 4.27

94.99 ( < 0.0001)

Female-intact

0.62

0.23 - 1 .68

1 .05 (0.3061)

Female-spayed

2.40

1 .54 - 3.74

16.94 ( < 0.0001)

Female-spayed**

2. 16

0.79 - 6.03

2.75 (0.0974)

Female (intact and spayed)

2.3 1

1 .46 - 3.66

14.31 (0.0002)

Male-intact

0.35

0. 1 8 - 0.69

1 1.08 (0.0009)

Male-castrated

0.65

0.38 - 1 . 12

2.70 (0. 1 002)

Male-castrated***

1 .71

0.78 - 4.07

2. 19 (0. 1387)

Neutered (either sex)

2.58

1.45 - 4.61

12. 19 (0.0005)

Sexes•

Case series: veterinary
referral hospitals

-

\C)
-...l

Case control: survey of
veterinarians enrolled
in clinical trial

Table 7.2 continued

Study

Sex-specific
odds ratio (OR)

95 % confidence interval
for OR49

Uncorrected
X: statistic (p value)40

Female-intact

0.20

0.05 0.64****

9.50 (0.0021)

Female-spayed

1 . 18

0.72 . 1 .93

0.49 (0.4839)

Female-spayed**

4.88

1.48 - 20.70****

8.68 (0.0032)

Female (intact and spayed)

0.80

0.49 - 1.32

0.85 (0.3572)

Male-intact

0.99

0.49 - 1 .99

0.00 (0.9732)

Male-castrated

1 .33

0.76 - 2.33

1 . 1 1 (0.29 17)

Male-castrated***

1.24

o.ss - 2.82

0.33 (0.5686)

Neutered (either sex)

1 .75

0.96 - 3.20

3.83 (0.0503)

Sexes*

Case control: survey of
randomly selected
veterinarians

-

\0
00

* Except as noted, the comparison group is all other dogs.
** Female-spayed compared to female-intact.
*** Male-castrated compared to male·intact.
**** Exact confidence limits. 128

•

Table 7 .3. Breeds at Increased or Decreased Risk of Canine Hypoadrenocorticism Based on Three Epidemiologic Studies•

Study

Breed

Breed-speci fie
odds mtio (OR)

95 % confidence interval
for OR49

Uncorrected
x.2 statistic (p
value)40

Poodle

3.17

2. 1 8 - 4.58

44.65 ( < 0.0001)

Labrador Retriever

0.49

0.24 - 0.98

4.61 (0.03 17)

Great Dane

4.56

2.28 - 8.83

26.48 ( < 0.0001)

0.0001

West Highland White
Terrier

7.33

3.90 - 13.46

61.83 ( < 0.0001)

< 0.0001

Airedale Terrier

2.6 1

1 .06 - 6.56

5.36 (0.0206)

Basset Hound

3.38

1 .50 - 7.79

10.96 (0.0009)

Bearded Collie

4. 19

1 .20 - 1 8.36***

6.87 (0.0088)

Boxer

0. 12

0.00 - 0.77***

6 . 17 (0.0130)

Cocker Spaniel

0.5 1

0.30 - 0.85

7.44 (0.0064)

Dalmatian

0.00

0.00 - 0.50***

8.51 (0.0035)

German Shorthaired
Pointer

2.52

1 .06 - 6.06

5.41 (0.0200)

Great Dane

7.63

2.50 - 3 1.09***

18.53 ( < 0.0001)

Lhasa Apso

0.22

0.04 - 0. 75**"'

7.09 (0.0078)

Pit Bull Terrier

0.00

0.00 - 0.84***

5.45 (0.0195)

Pomeranian

0. 12

0.00 - 0.77**"'

6. 17 (0.0130)

Poodle

3.55

2.55 - 4.93

67.44 (< 0.0001)

Fisher exact
(2-tailed p
value)"'"'162

Case series: veterinary
referml hospitals

-

1.0
1.0

Case control: survey of
veterinarians enrolled
in clinical trial

0.0165

Table 7.3 continued
Uncorrected

Study

N

g

Breed-specific
odds ratio (OR)

95 % confidence interval
for OR49

x2 statistic (p

Shetland Sheepdog

0. 15

0.03 - 0.47***

13.41 (0.0003)

Shih Tzu

0.25

0.05 - 0. 83***

5.99 (0.0144)

Springer Spaniel

2.54

1.29 - 5.04

8.72 (0.003 1)

West Highland White
Terrier

5.93

2.69 - 13.46

27.69 ( < 0.0001)

Yorkshire Terrier

0. 14

0.02 - 0.58***

9.47 (0.0021)

Mixed

0.45

0.22 - 0.92

5.62 (0.0177)

Breed

value)40

Case control: survey of
randomly selected
veterinarians

* Breeds are included if the 95% confidence interval did not contain one.
** Calculated only if an expected cell value is < 5; the preferred p value for this OR.
*** Exact confidence limits. 128

Fisher exact
(2-tailed p
value)""''162

These results were remarkably consistent in that in no case was a breed found
to be at increased risk in one study and at decreased risk in another. Three of the
breeds reported at increased risk were also reported by another study148 as being
predisposed to hypoadrenocorticism. These were Great Danes, Poodles (the
previously published study reported only Standard Poodles), and West Highland
White Terriers. Portuguese Water Dogs, Rottweilers, and Wheaten Terriers have
been reported to be predisposed to hypoadrenocorticism. 148 This was not confirmed
by this study. A decreased risk among Golden Retrievers, Lhasa Apsos, and
Yorkshire Terriers has been reported .148 This study did not find a decreased risk
among Golden Retrievers, but it did among the other two breeds. One textbook
reported that Labrador Retrievers might be predisposed to adrenal insufficiency.69
This is in conflict with the results of this study, which showed Labrador Retrievers
at decreased risk. This is viewed as a minor discrepancy since the textbook stated
that the predisposition was a possibility, not a certainty. These data

can

be used

by veterinary clinicians when evaluating potential cases of hypoadrenocorticism.
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Body Weights
The average body weight (SD) (SEM) (Range) in kg for dogs enrolled in the
clinical trial ofDOCP (Chapter 3) was 23.4 (13.6) (0.8) (2.7-72.7). For cases and
controls, respectively, the results based on the survey of veterinarians enrolled by
Ciba Animal Health in the clinical trial of DOCP (Chapter 5) were 24.5 (14.5)
(0.6) (2.3-81 .8) and 19.7 (12.7) (0.4) (1 .4-68.2). For cases and controls,
respectively, the results based on the survey of randomly selected veterinarians
(Chapter 6) were 20.2 (14. 1) (1 .2) (1 . 1-63 .6) and 19.8 (13.5) ( 1 . 1) ( 1 .4-74. 1).
Body weight specific OR were calculated in both surveys, Chapters 5 and 6, and
are tabulated in Tables 5.9 and 6.7, respectively.
A simple average of the averages from the three studies above was 22.5 kg;
a weighted average of the averages was 23.6 kg. These were comparable to the
median weight of 20.0 kg reported for 225 hypoadrenal dogs in another study, 148
and suggested that the average dog with hypoadrenocorticism weighs over 20 kg.
Data from the survey of veterinarians enrolled in the clinical trial of DOCP
(Chapter 5) provided evidence that the probability of hypoadrenocorticism
increased with body weight. The average body weight of24.5 kg for cases differed
significantly (p < 0.0005) from the 19.7 kg for controls. Body weight-specific OR
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(Table 5.9) suggested that the probability of hypoadrenocorticism increased with
body weight. Data from the survey of randomly selected veterinarians (Chapter 6)
did not support this conclusion. The average body weight of20.2 kg for cases was
not significantly greater than the 19.8 kg for controls. Body weight-specific OR
(Table 6.7) failed to demonstrate a relationship between body weight and disease.
Table 7.4 summarizes the body weight-specific risks of hypoadrenocorticism. A
few comments are appropriate here.
First, though the survey of randomly selected veterinarians did not confirm
the proposition that the probability of canine hypoadrenocorticism varied directly
with body weight, neither did it refute it. Second, the survey of randomly selected
veterinarians was much smaller than the survey of veterinarians enrolled in the
clinical trial, and thus should not be given as much weight. The counter-argument
is that, though the survey of randomly selected veterinarians was much smaller,
it was still much too large (149 cases and 140 controls for body weight)

to

ignore.

Third, the possibility existed that the ostensible body weight effect is really an
effect from some confounding variable such as breed.
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Table 7.4. Body Weight-Specific Risks of Canine Hypoadrenocorticism Based on Two Epidemiologic Studies

Study

Body weight-specific
odds ratio (OR)

95% confidence interval
for OR•9

Uncorrected
'Jf statistic (p
value)40

0 < weight � 5

0.37

0.24 - 0.58

22.79 (< 0.0001)

5 < weight � 10

0.88

0.68 - 1 . 13

1 . 1 1 (0.2923)

10 < weight � 15

0.57

0.41 - 0.80

1 1 .57 (0.0007)

IS < weight � 20

0.69

0.49 - 0.98

4.62 (0.03 15)

20 < weight � 2S

1 .70

1 .27 - 2.28

1 3.70 {0.0002)

2S < weight � 30

1. 1 1

0.80 - 1 .S2

0.41 (O.S236)

30 < weight � 35

1 . 17

0.84 - 1.61

0.94 (0.3327)

35 < weight � 40

1 .6S

1 . 13 - 2.40

7.51 (0.006 1)

40 < weight � 4S

1 .29

0.78 - 2. 13

1 . 12 (0.2906)

4S < weight � SO

1. 1 1

O.S7 - 2. 14

0. 1 1 (0.7443)

SO < weight � SS

3 . 14

1 .06 - 10.3 7•••

5.58 (0.0182)

weight > S5

5.72

2.36 - 15.86*"'"'

20.40 ( < 0.0001)

Body weight (kg)*

Case control: survey of
veterinarians enrolled
in clinical trial

�

Fisher exact
(2-tailed p
value)"'"' 162

Table 7.4 continued

Study

Body weight (kg)*

Body weight-specific
odds ratio (OR)

95 % confidence interval
for OR4�

Uncorrected
x2 statistic (p
value)40

Fisher exact
(2-tailed p
value)>lnlol62

Case control: survey of
randomly selected
veterinarians

�

0 < weight

:!5:

S

0.65

0.29 - 1 .46

1 .29 (0.2566)

S < weight

:!5:

10

1 .41

0.77 - 2.61

1 . 39 (0.2380)

10 < weight

s

15

0.98

0.50 - 1.91

0.01 (0.94 1 1)

IS < weight

:!5:

20

0.65

0.26 - 1.62

1 .03 (0.31 13)

20 < weight

:!5:

2S

2.25

0.97 - 5.33

4.26 (0.0390)

25 < weight

:!5:

30

0.46

0. 19 - 1 .09

3.76 (0.0524)

30 < weight

:!5:

35

0.94

0.35 - 2.52

0.02 (0.8852)

35 < weight

:!5:

40

0.93

0.38 - 2.32

0.03 (0.8734)

40 < weight

:!5:

45

0.74

0.14 - 3.54•••

0. 19 (0.6645)

2. 19

0.59 - 9.92•••

1 .70 (0. 1920)

weight > 45

• The comparison group is all other dogs.
•• Calculated only if an expected cell value is < S_; the preferred p value for this OR.
••• Exact confidence limits.128

0.7435

Serum Sodium and Potassium Concentrations

The average serum sodium and potassium concentration (SD) (SEM) (Range)
in meq/L for hypoadrenal dogs in the literature review (Chapter 2) were,
respectively, 129.4 (.D) � (1 14.0-150.0) and

7.2 (11) ( ) (4.6-10.8) . The
mm

ratio of serum sodium to potassium concentrations was 1 8 .0. The corresponding
values, in the same order, for the DOCP clinical trial (Chapter 4) and veterinary
referral hospitals (Chapter 5), respectively, were: 13 1 .8 (9.4) (0.6) (104.0-174.0),
6 . 8 (1 .3) (0. 1) (3.2-12.8), 20.2 (4. 8) (0.3) (10.5-3 8.8); and 135.2 (10.6) (0.7)
(97.0-160.0) , 5.9 (1 .7) (0. 1) (2.9-1 1 .7), 25.2 (8.3) (0.5) (1 1 . 1-46.6) . Simple
means of these results yielded 132. 1 for sodium, 6.6 for potassium, and 21 . 1 for
the sodium to potassium ratio. These values supported the propositions that dogs
with adrenal insufficiency are hyponatremic and hyperkalemic,41•43 and that their
sodium to potassium ratios are under 25 . 0129 or 27 .0 .4 1 •43•1 89
Electrolyte results from the clinical trial of DOCP (Chapter 3) established
that hypoadrenocorticism did occur in dogs with normal values for serum sodium,
potassium, and sodium to potassium ratio--specifically, about one case in 20 had

.UNot reported for all cases.
�ot reported for all cases.

11Not reported for all cases.
mmNot reported for all cases.
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normal values for all three diagnostic indicators. The results from the veterinary
referral hospitals (Chapter 4) were that no case was normal for all three diagnostic
indicators. This suggested that a veterinarian with a patient normal for these three
diagnostic indicators should, in most cases, provisionally remove adrenal
insufficiency from the list of differential diagnoses, thereby avoiding the time and
cost of the adrenocorticotropic hormone (ACTH) stimulation test.

Clinical Findings
Clinical findings included: anorexia; vomiting; depression; weakness; weight
loss; azotemia; diarrhea; cardiac anomalies such as microcardia, bradycardia, and
arrhythmias;

skin and hair problems; gastroenteric difficulties such as

gastroenteritis and abdominal pain; polyuria or polydipsia; limb stiffness; muscle
atrophy; shock or collapse; and shaking or trembling. This comprehensive list
mirrors the clinical findings reported elsewhere. 44
The following results should be viewed skeptically. The clinical findings were
selected because of their anecdotal association with canine hypoadrenocorticism or
their putative autoimmune etiology. These included anemia, arthritis, cruciate
ligament rupture, diabetes mellitus, hepatitis, hypothyroidism, keratoconjunctivitis
sicca, megaesophagus, myasthenia gravis, nephritis, and thrombocytopenia.
Ostensible associations between some of these clinical findings, notably anemia and
nephritis, and hypoadrenocorticism may have resulted from the fact that the
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clinical finding can be associated with any chronic disease, not specifically with
hypoadrenocorticism. For example, dogs with normal kidneys presented with
hypoadrenocorticism often appear to have nephritis because of shock and renal
failure produced by poor renal perfusion. This is a normal part of the
pathophysiology of hypoadrenocorticism and should not be confused with true
nephritis, a separate disease. Also, comparisons between cases and controls
probably included measurement bias. The health of cases was probably explored
more thoroughly because of their illness than the health of controls. Thus, it was
more likely that clinical findings were discovered for cases than controls. It is
impossible to determine the extent of this measurement bias.
Anemia, arthritis, cruciate ligament rupture, diabetes mellitus, hepatitis,
hypothyroidism, keratoconjunctivitis sicca, myasthenia gravis, nephritis, and
thrombocytopenia were all associated with hypoadrenocorticism in at least one
study. This is all the selected clinical findings except megaesophagus. This may
be testament to the wisdom of the selection process for clinical findings, or could
be due to measurement bias. Which, if either, of these interpretations has merit
will remain a mystery. These ostensible associations should be explored with
further studies, particularly studies which control measurement bias. Table 7.5
summarizes the clinical finding-specific risks of hypoadrenocorticism.
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Table 7.5. Clinical Finding-Specific Risks of Canine Hypoadrenocorticism Based on Two Epidemiologic Studies

Study

Clinical findingspecific
odds ratio (OR)

95 % confidence interval
for OR49

Uncorrected
X: statistic (p
value)..,

Anemia

18.52

8.43 - 48.03*''""

97.92 ( < 0.0001)

Arthritis

2.50

1.81 - 3.44

35.54 ( < 0.0001)

Cruciate ligament rupture

2.28

1.05 - 5.02

5.21 (0.0224)

Diabetes mellitus

2. 16

0.46 - 10.93•••

1 .38 (0.2403)

Hepatitis

7.41

3 . 15 - 20. 14

30.35 ( < 0.0001)

Hypothyroidism

4.65

3.04 - 7. 12

64.29 ( < 0.0001)

Keratoconjunctivitis sicca

3.51

1.49 - 8.49

10.57 (0.0012)

Megaesophagus

5.19

0.41 - 272.46•••

2.53 (0. 1 120)

0. 1434

Myasthenia gravis

..... .

..... .

5. 18 (0.0229)

0.0494

Nephritis

6.77

3.33 - 14.08

40.85 ( < 0.0001)

Thrombocytopenia

5.22

1.30 - 30.07•••

7.61 (0.0058)

Clinical finding*

Fisher exact
(2-tailed p
value)''"'1162

Case control: survey of
veterinarians enrolled
in clinical trial

N
0
\0

0.3023

0.01 19

Table 7.5 continued

Study

Clinical finding
specific
odds ratio (OR)

95 % confidence interval
for OR49

Uncorrected
X: statistic (p
value)40

Anemia

25.27

3.94 - 1050.33"'"'"'

20.39 ( < 0.0001)

Arthritis

1 .80

0.77 - 4.22

2.20 (0. 1380)

Cruciate ligament rupture

0.98

0. 13 - 7.43•••

0.00 (0.9791)

Diabetes mellitus

••••

••••

8.06 (0.0045)

Hepatitis

••••

••••

17.7 1 ( < 0.0001)

Hypothyroidism

6.52

2. 1 3 - 26.51 "'"'"'

14.34 (0.0002)

Keratoconjunctivitis sicca

••••

• •••

8.06 (0.0045)

Nephritis

••••

• •••

1 1 .20 (0.0008)

Thrombocytopenia

1 .97

0. 10 - 1 17. 14"'"'"'

0.32 (0.5741)

Clinical finding•

Fisher exact
(2-tailed p
value)"'"'162

Case control: survey of
randomly selected
veterinarians•••••

N
.......

0

0.0071

0.007 1

1 .0000

• Clinical findings either anecdotally linked to hypoadrenocorticism or with a putative autoimmune etiology; comparison group is all other dogs.
•• Calculated only if an expected cell value is < 5; the preferred

p

value for this OR.

••• Exact confidence limits. 122
•••• Undefined.
••••• There were no cases or controls for either megaesophagus or myasthenia gravis.

Case Definition in Epidemiologic
Studies of Canine Hypoadrenocorticism
Detailed analyses of the data from the clinical trail of DOCP (Chapter 3)
demonstrated that epidemiologic studies of canine hypoadrenocorticism may be
conducted using a case definition less restrictive than one requiring an ACTH
stimulation test. Data indicated that the population diagnosed using the ACTH
stimulation test was virtually identical to the population diagnosed without it. Thus,
while the ACTH stimulation test is desirable in establishing the diagnosis for an
individual patient, requiring it in epidemiologic studies is unnecessarily restrictive.
Consequently, epidemiologic studies can benefit from the salutary effects .of greater
case numbers, less complexity, more convenience, and less cost afforded by the
less restrictive case definition that, if the veterinarian says the dog has
hypoadrenocorticism, then, by definition, it does.

Logistic Regression
Age, breed, sex, and body weight were significantly associated with the
occurrence of hypoadrenocorticism in the dog. Specifically, the probability of
occurrence of canine hypoadrenocorticism increased with age and body weight,
was greater in females than males, was greater in neutered than intact dogs, and
varied with breed. There was model-dependent evidence of higher order
interactions, but the exact nature of these interactions could not be determined.
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Models were prepared which could, recognizing that many factors other than age,
breed, sex, and body weight are involved in the occurrence of adrenal
insufficiency, predict the relative probability of this disease in different dogs.

Methodology

Data from the veterinary literature, VMDB, clinical trial of DOCP, and mail
survey of veterinarians enrolled in the clinical trial were all useful. The survey of
veterinarians selected from the American Veterinary Medical Association's list of
veterinarians suggested that mail survey methodology was a poor vehicle for
obtaining data about an uncommon disease from randomly selected veterinarians;
this limitation could be mitigated by substantially increasing the sample size and
questionnaire response rate. Mail survey methodology can be useful for studying
other diseases and obtaining basic descriptive data about veterinarians and their
patients. Survey responses may be cut off 60 da after mailing.

Future Studies

The incidence and prevalence estimates presented in Table 7 . 1 , while
different statistically, were the same order of magnitude, and, thus, can be
considered useful overall estimates. Future studies could focus on incidence and
prevalence estimates for particular ages, breeds, sexes, or body weights.
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Mail smveys which request data on clinical findings should, if possible,
precisely define the clinical findings. For example, what exactly constitutes
" anemia" or " nephritis"? This must be done without making the survey so onerous
or complicated that veterinarians do not respond at all.
Matched case-control studies of hypoadrenal dogs would be a logical next
step for those sexes and breeds already identified as associated with the disease.
Matching on sex or breed or both would effectively remove these variables from
the analyses, and permit focus on other variables such as age and body weight, the
influence of which have been less well defined. This would require large data
bases, perhaps the entire 1964-to-date VMDB.
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Al . Case Data Abstract Form (VMDB Participants) (front)

UNIVERSITY OF TENNESSEE
COLLEGE OF VETERINARY MEDICINE
CANINE HYPOADRENOCORTICISM STUDY
CASE DATA ABSTRACT FORM

PLEASE COMPLETE A SEPARATE FORM FOR EACH CASE .
1.

INSTITUTION CODE : __

3.

DATE OF DISCHARGE:

4.

OWNER ZIP CODE :

5.

2.

PATIENT ID NUMBER: ________

---�� -�-�'----

--

day

month

year

LABORATORY TEST RESULTS USED TO MAQ THE DIAGNOSIS :
( These results should come from laboratory reports dated during
Copies of laboratory reports may be sent
this episode of care .
in lieu of completing the information below . )
A.

ACTH STXMULATION TEST ( See attached sample for possible
documentation type ) :

PRE-STXMULATION ( BASELINE OR RESTING ) CORTISOL,_______
POST-STIMULATION CORTISOL�-----

B . PLASMA OR SERUM ELECTROLYTE CONCENTRATIONS :
DATE OF � SODIUM TEST DORING THIS EPISODE OF CARE

month
SODIUM

year

( Na+ ) LEVEL

------

DATE OF E1BS% POTASSIUM TEST DORING THIS EPISODE OF CARE

month
POTASSIUM

( K+ )

year
LEVEL

-------

PLEASE COIIPLE'l'E THE BACK OF '1'BB PORM ALSO .
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A2. Case Data Abstract Form (VMDB Participants) (back)

6.

TREATMENT:
A.

B•

HAS THIS DOG BEEN TREATED WITH FLORINEF
NO
YES
( FLUDROCORTISONE ) ?
HAS THIS DOG BEEN TREATED WITH PERCORTEN
YES
( DESOXYCORTICOSTERONE PIVALATE ) ?

NO

7 . OTHER DIAGNOSES ( Please list all diagnoses from the initial
visit to the present ) :
DATE OF DIAGNOSIS

DIAGNOSIS

THANK YOU .
PLEASE RETURN THE FORMS TO DR . WILLIAM J. KELCH , DEPARTMENT
37901-1071 .
ENVIRONMENTAL PRACTICE , BOX 1071 , KNOXVILLE , TN

240

OF

A3 . Population Data Abstract Form (front)

CANINE HYPOADRENOCORTICISH S'l'tJDY
POPULATION DATA ABSTRACT FORM

PLEASE COMPLETE ONE OF TRESE FORMS PER INSTU'OTION/PACIU'l'Y .

1.

( CRl:TICAI.LY IMPORTANT ! ) NtJHBER OF DOGS SEEN* DURING

1989 :
1990 :
1991 :

THE FOLLOWING INFORMATION IS OPTIONAL BtJ'l' WOULD BE VERY HELPFUL IF
IT I S AVAILABLE .

2 . NtJHBER OF DOGS SEEN* DURING
1989 :
A.

1990 :

1991 :

INTACT FEMALES
SPAYED FEMALES

FEMALE, tnmNOWN

INTACT MALES
NEtJTERED MALES
MALES , UNlCNOWN
SEX tJIIlQfOWN
B.

C.

0 TO 2 WEEKS OLD
2 WKS TO 2 KOS OLD
2 TO 6 KOS OLD
6 TO 1 2 KOS OLD
1 TO 2 YEARS OLD
2 TO 4 YEARS OLD
4 TO 7 YEARS OLD
7 TO 10 YEARS OLD
10 TO 15 YEARS OLD
15 YEARS AND OLDER
IF THE FREQUENCY OF DIFFERENT BREEDS CAN BE DETERKIHED FOR
THE DOGS SEEN DURING 1989 THROUGH 1991 , PLEASE ATTACH A UST

OF BREED FREQUENCY .

*NOT THE NUMBER OF DOG VISITS : A DOG CAN BE COUNTED ONLY ONCE
DURING THE 'l'HREE YEARS .
FOR EXAMPLE , A DOG SEEN FIRST IN 1989
WOULD BE COUNTED ONCE IN 1989 AND WOULD HOT BE COUNTED AGAIN EVEN
IF IT WAS SEEN AGAIN IN 1990 AND/OR 1991 .
PLEASE COMPLETE THE BACJ( OF THE FORM ALSO.
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A4. Population Data Abstract Form (back)

PLEASE INDICATE A PERSON
( USUALLY THE PERSON ABSTRACTING THE
INFORMATION ) WHO COULD BE CONTACTED I F THERE ARE QUESTIONS ABOUT
THE INFORMATION ON THE FORMS .
NAME :

_______

PHONE :

-------

BEST TIMES TO CALL : ________________________________
NAME OF INSTITUTION OR FACILITY = ------

PLEASE RETURN THE INFORMATION IN THE ENVELOPE PROVIDED .
THANK YOU VERY MUCH FOR YOUR ASSISTANCE .
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A5. Case Data Abstract Form (VMDB Non-Participants) (front)

CANINE HYPOADRENOCORTICISM STUDY
CASE DATA ABSTRACT FORM
PLEASE COMPLETE A SEPARATE FORM FOR EACH CASE .
KEY WORDS OTHER
THAN CANINE HYPOADRENOCORTICISM THAT MAY BE HELPFUL IN LOCATING
CASES ARE
ADRENAL CORTICAL HYPOFUNCTION , ADDISON ' S DI SEASE , AND
ADRENAL INSUFFICIENCY .
1.

INSTITUTION CODE : _____

3.

OWNER ZIP CODE :

4.

DATE OF FIRST DIAGNOSIS :

5.

AGE WHEN FIRST DIAGNOSED :

years
6

•.

7.
8.

SEX :

2.

PATIENT ID NUMBER : _______

month

year

day

BIRTH DATE :
OR
year

months

month

( Please mark one category onl y )
Intact female __
Spayed female __
Female , unknown __
Intact male __
Neutered male ___
Ma le , unknown

BREED :
TEST RESULTS USED TO MAKE THE DIAGNOSIS :
( These results should come from laboratory reports dated very
near the same date as the DATE OF FIRST DIAGNOSI S .
Copies
of laboratory reports are desired and can be attached to
If copies of lab reports are attached ,
this abstract form .
the bl anks below do not need to be f i l led i n . )
ACTH STIMULATION TEST :
DATE OF TEST

---,..

month

day

year

RESTING CORTISOL._________
POST-STIMULATION CORTISOL�-----

PLEASE COMPLETE THE BACK OF THE FORM ALSO .
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A6. Case Data Abstract Form (VMDB Non-Participants) (back)

9.

TREATMENT :
A.

B.

10 .

HAS THIS DOG BEEN TREATED WITH FLORINEF
NO
YES
( FLUDROCORTISONE ) ?
HAS THIS DOG BEEN TREATED WITH PERCORTEN
( DESOXYCORTICOSTERONE PIVALATE ) ?
YES

NO

OTHER DIAGNOSES :
( If a summary of other diagnoses is included in the record ,
please attach a copy .
If only a few other diaqnoses are
listed , please record the information below . )
DATE O F DIAGNOSIS

DIAGNOSI S

THANK YOU .

PLEASE RETURN THE FORMS ALONG WITH THE POPULATION DATA ABSTRACT
FORM IN THE ENVELOPE PROVIDED OR MAIL TO DR . JOHN C . NEW , JR . 1
DEPARTMENT OF ENVIRONMENTAL PRACTICE , BOX 1071 , KNOXVILLE , TN ,
3 790 1-1071 .
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A7. Case Control Study of Canine Hypoadrenocorticism (Survey Form for
Veterinarians Enrolled in Clinical Trial) (front)
CASE CONTROL STUDY OF CANINE HYPOADRENOCORTICISM
Investigator Name:

_
_
_
_
_
_
_
_
_
_
_
_

· -----Date._

Cllnic Name: -----Dog's Name:

Owner's Name·

Age' (yr):_ WL (Ib): _

Breed:

Health Status: (Circle one)

Dead

Alive

Cause of Hypoadrenocorticism:

(Circle one)

Lost to follow-up

Lysodren

Other Diseases: (CMck aD that eppty)
Anemia"
Arthritis"

Thrombocytopenia
None of the above
Owner's Name·

Age' (yr): _ WL (lb):_

Breed·
Dead

Alive

Sex:

Anemia"
Arthritis'

HYPothyroidism
Kitratoconjunctiviti sicca

�us

�gravis
'"

Thiomboc:ytopen
None of the above

Dog'S NamA·

Owner's Name·

Age' (yr): __ Wt. (lb):_

Bteecl:
Dead

Alive

Other Diseases: (CIIIclc all that apply)

Anemia"

Arthritis"

Cruciate ligament rupiUre

Diabetes mellitus

Hepatitis•
Hypoadrenocorticism
In your practice how many

1993 and

F FS
(Cft:ll OM)

M MC

Lost to foiJa.v-up

Other Diseases: (CIIIclc 111 that apply)

Health Status: (Cft:ll one)

Unknown

�� gtaVIS
�hritis

Dog's Name·

Cruciate ligament rupture
Diabetes meUitus
Hepatitis.
Hypoadrenocorticism

AdrenalectOmy

Keratoconjunctivitis sicca

Cruciate tigament rupture
Diabetes mellitus
Hepatitis.
Hypothyroidism

Health Status: (Cft:ll one)

Sex: M MC F )FS
(Cin:ll one

Sex:

F FS
(Cft:ll one)

M MC

Lost to follow-up

HYPotflyroidism

Kei'atoconjunctivitis slcca

Megaesophagus

Myasthenia gravis

1\lephritis"
Thrombocytopenia
None of the above

d� were diagnosed with hypoadrenocorticism between January 1 ,

December 31 , 1 993

Approximately how many active dog patients do you have in your practice?'
How many full-time veterinarians work in your practice?
Print the name of person filling out case report form
Footnotes on Reverse
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AS. Case Control Study of Canine Hypoadrenocorticism (Survey Form for
Veterinarians Enrolled in Clinical Trial) (back)

Footnotes

1 Current age gr age at death m last known age

(If lost to follow-up)

2 Anemia from any cause
3 Any inflammatory disease
4 Any

of the joints

inflammatory disease of the liver

5 Any inflammatory disease of the kidney
6 All cases diagnosed regardless of whether they lived or died or how they were treated.
7 Active dog patients is the number of dogs that have visited your practice
(January 1 , 1993 to December 31 , 1993).

Note:

H you

in the last year

have any questions, contact Phyfis HIDing, LVT, Susan Owen or Randy Lynn,
DVM at 1-80D-637-o281 .

Return to:

Ciba Animal Health
Post Office Box 18300
Greensboro, NC 2741s.8300
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A9. Instructions for Filling Out the Case Report Form-Case Control Study of
Canine Hypoadrenocorticism (Instructions for Suxvey Form for Veterinarians
Enrolled in Clinical Trial) (front)
INSTRUCTJONS FOR FIWNG OUT THE CASE REPORT FORM
case Control Study of Canine Hypoadrenocortlcism

1.

FiD in the date you are preparing the fonn i n the upper right comer.

2.

For the hypgadrena! dgg:
a.

The investigator's name, clinic's name, dog's name, and owner's name have
already been filled in.

b.

Please record the dog's current age if alive m age at death m last known age
.
if "lost to follow-up. •
If you are not certain whether the dog is alive or dead, please contact the

owner and find out. "Lost to follow-up" should include a dogs where it Is
impossible to detennine whether the dog is alive or dead. In this case, record
the dog's age at the time it was last known to be alive.
·

c.

Record the dog's health status and presumed cause of hypoadrenocorticism
[lysodren therapy, adrenalectomy or unknown].

d.

Check which "Other Diseases• have been diagnosed in this dog at any time
during its life. [Simply check those that apply.)

3.

For Cpntrpl Qog No

1:

[Your "file" of patients may be a paper file or a computer file: "next" In the file
means next alphabetically.)
a.

The next record (alphabetically) in your file after the record of the hypoadre
nal patient will serve as Control Dog No.

1 provided it has a glfferent owner

and is a dog. If the next record belongs to the same owner or is not a dog,
go to the next record until a stag owned by a different owner is found. (Note:
dogs which live in the same household will be considered to have the same
owner.)
(continued on reverse)
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Instructions for Filling Out the Case Report Form-Case Control Study of
Canine Hypoadrenocorticism (Instructions for Survey Form for Veterinarians
Enrolled in Clinical Trial) (back)
AlO.

4.

b.

Fill in the information for Control Dog No. 1 . It is self-explanatory.

c.

Record age the same way as for the hypoadrenal dog.

For Cgntml Pas� Ng. 2:
a.

Go to the fiflll record after the record for Control Dog No. 1 and use it as
Control Dog No. 2, again prpvlded it has a different owner and is a .dog. If
not, go to the sixth record, seventh record, etc., until you come to a .dog with
a different owner.

s.

b.

Fill in the information for Control Dog No. 2. It is again self-explanatory.

c.

Record age the same way as for the hypoadrenal dog.

For Practice Qata:
a.

Record the total number of cases of canine hypoadrenocorticism diagnosed
in your practice between January 1 , 1 993 and December 31 , 1 993.

This includes all cases diagnosed regardless of whether they were treated,
how they were treated, or whether they lived or died.
b.

Record the total number of dogs seen in your practice (active dog patients)
between January 1 , 1 993 and December 31, 1 993. This is om the number of
dog visits, it is the number of dogs. For example, if an individual dog was
seen fwe times during the year, that dog is counted only .PDC§.

c.

Record the number of veterinarians who work full-time in your practice. If you
have part-time veterinarians, estimate their total work load. For example, two
veterinarians working half-time equals one full-time veterinarian.

6.

.friDt the name of the person filling out the Case Report Form at the end of the
form.

7.

Please mail the Case Report Form(s) in the enclosed postage-paid envelope.
Thanks a Jot!
-2-
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Case Contrql Study of Canine H:YPoadrenocorticism (Survey Form for
Randomly Selected Veterinarians)
Al l .

Investigator's Name ------CASE CONTROL STUDY OF CANINE HYPOADRENOCORTICISM
(Footnotes/Instructions on Reverse)
Approximately how many active dog patients' did you see in

1993?·-------

How many full-time veterinarians work In your practice? -----In your practice how many dogs were initially diagnosed with hypoadrenocorticism between
January 1 , 1993 and December 31 , 1993'?2 -----If your answer to the last question was greater than zero, please complete the following for all
hypoadrenal dog.s diagnosed in 1993 and a control dog for each (please cali 1-8D0-447-2391 for
additional fonns if you need them).
HYPOAORENAL DOG
Age (yr):

(at time of diagnosis)

Wt.

(lb):

Health Status:3 (Circle one)

Alive

Cause of Hypoadrenocorticism:

Sex: M MC F FS
(Cin:lo one)

Breed: -----

_

Dead

(Circle one)

Lost to follow-up
Lysodren

Adrenalectomy

Unknown

Other (Please specify) ------Other Diseases: (CIIeck all thBI apply)
Anemia"
Arthritis5
Cruciate ligament rupture
Diabetes mellitUs
Hepatitis6
Hypothyroidism

Keratoconjunctivitis sicca
Megaesophagus
Myasthenia gravis
Nephritis7
Thrombocytopenia
None of the above ---CONTROL DOG8

Age (yr):

(at last visit in 1993)

Wt. (lb):

Health Status:3 (Circle one)

Breed : -----

_

Alive

Dead

Sex: M MC F FS
(Cin:lo one)

Lost to foUow-up

Other Diseases: (Check all thBI apply)
Anemia"
Arthritis5
Cruciate ligament rupture
Diabetes mellitUs
Hepatitis6
Hypothyroidism

Keratoconjunctivitis sicca
Megaesophagus
Myasthenia gravis
Nephritis7
Thrombocytopenia
None of the above ----
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ol Study of
Instructions for Filling Out the Case Report Form-Case Contr
for Randomly Selected
Canine Hypoadrenocorticism (Instructions for Survey Form
Veterinarians)

A12.

Footnotes/Instructions

1

Record the total number of dogs seen in your praclice (active dog patients) between January 1 ,
1 993 and December 31 , 1 993. This J:i DQ1 th e number of dog visits, it is th e number of dogs. For
example, H an individual dog was seen five times during the year, that dog is counted only mu��.

2 Record the total number of cases of canine hypoadrenocorticism diagnosed in your practice

between January 1 , 1 993 and December 31, 1 993. This Includes all cases diagnosed regardless
of whether they were treated, how they were treated, or whether they lived or died.

3Lost to follow-up means it Is Impossible to �etermine whether the dog Is now alive or dead.
4 Anemia

is a packed cell volume less than 30% from any cause.

5 Any inflammatory disease of the joints.
6 Any inflammatory disease of the liver.
7 Any

inflammatory disease of the kidney.

8 The next record (alphabetically) in your file after the record of the hypoadrenal patient will serve
as the Control Dog pmyjded It was seen in 1 993, has a djfferent mmw: and is a dgg which does
om have hypoadrenocorticism� If the next record belongs to the same owner or is not a dog seen
In 1 993 or has hypoadrenocorticism, go to the next record until a ggg IUD m .1993 is found
which does om have hypoadrenocorticism and is owned by a different owner. (Note: dogs which
live in the same household will be considered to have the same owner.)

Note: If you have any questions, contact Phylis Hilling, LVT or Randy Lynn, DVM at

1-&0o-447-2391 .

Retum to:

Ciba Animal Health
Post Offic e Box 1 8300
Greensboro, NC 27419-8300
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APPENDIX B
COMPUTATION OF em-SQUARE STATISTICS

General 2 x 2 Contingency Table
Variable A
Category 1

Category 2

Category 1

a

b

a + b

Category 2

c

d

c + d

b + d

N = a + b + c + d

Variable B

a + c

x2

{ uncorrec te d)

=

ad
2 ...,.___,.
;:;;.-..
. b;;..;
.;;; c�
; >�
..,...
...
-.,...-.._;
...,_ N
;.;_.:.(..;;.;,.
( a+b) ( c+d) ( a + c) (b+ d)
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C 1 . Evaluation of Logistic Regression Models for Presence or Absence of Canine
Hypoadrenocorticism Using Age, Breed, Sex, and Body Weight as
Independent Variables: All Single Factor Models

Model
• ••
'

Case

Factor

50.37(1)

140.07(1)
94.59(1)

53.36 (1)
26.56(1)
1 3.60(1)

< 0.000 1

0.0709

None

0.0961

None

0.0499

466.52
(373)

0.0007

0.0222

152.42
(124)

0.0423

0. 1 176

138.51
(123)

0. 1605

0. 1234

< 0.0001

< 0.0001
< 0.0001

=

Age
Age•Age
Age•Age•Age

264.37
(125)

< 0.0001

=

Age
AgHAge

Case

1 1 1.56(3)

Chance
probability
of LOF chi
square

< 0.0001

=

Body weight

Case

178.63
(17)

Model
LOF****
chi square
(dO

< 0.0001

=

Sex

Case

154.05(1)

=

Breed

Case

Chance
probability
of Wald chi
square

=

Age

Case

Factor
Wald chi
square
(dO*"*"

< 0.0001
< 0.0001
0.0002
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Model
• ••
,

Case

Case

Factor

Chance
probability
of Wald chi
square

=

Body weight

2.52(1)

0. 1 124

Body weight•
Body weight

0.30(1)

0.5870

=

Body weight

5.20(1)

0.0226

Body weight•
Body weight

2.65(1)

0. 1037

2.82(1)

0.0933

Body weight•
Body weight•
Body weight

•

Factor
Wald chi
square
(dt)***"

Model
LOF****
chi square

Chance
probability
of LOF chi
square

466.80
(372)

0.0006

0.0221

460.62
(371)

0.0010

0.0248

(df)

R2

Case = presence or absence of hypoadrenocorticism in dog.
Age = dog's age in yr.
Breed = dog's breed.
Sex = dog's sex classified as female-intact, female-spayed, male-intact, or male-castrated.

•• All models were significant at p < 0.000 1 .
*** Wald chi square with associated degrees o f freedom i n parentheses.
•••• Lack of fit chi square with associated degrees of freedom in parentheses.
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C2. Evaluation of Logistic Regression Models for Presence or Absence of Canine
Hypoadrenocorticism Using Age, Breed, Sex, and Body Weight as
Independent Variables: All Two Factor Models with No Interactions

Model
• ••
'

Factor

Factor
Wald chi
square
(df)***"

Chance
probability
of Wald chi
square

Case =

Model
LOF****
chi square
(df)

Chance
probability
of LOF chi
square

R:: 1so

440.04

0.0006

0.1673

338.52
(21 8)

< 0.0001

0.0973

1627.57
(1313)

< 0.000 1

0.0958

66.04

0.0526

0. 1 359

688.29
(640)

0.0908

0. 1244

(348)

Age
Breed

140.96(1)
170.93(17)

< 0.0001
< 0.0001

Case =
Age
Sex

103.51(1)
60.51(3)

< 0.0001
< 0.000 1

Case =
Age
Body weight

147.05(1)
71.72(1)

< 0.000 1
< 0.0001

Case =

(49)

Breed
Sex

162. 13(17)
90.27(3)

< 0.0001
< 0.0001

Case =
Breed
Body weight

173.42(17)
47.21(1)

< 0.0001
< 0.0001
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Model
• ••
'

Factor

Factor
Wald chi
square
(df)***"

Chance
probability
of Wald chi
square

Case =
Sex
Body weight
•

104.99(3)
48.93(1)

Model
LOF****
chi square
(df)

Chance
probability
of LOF chi
square

Rl iSO

784.49
(655)

0.0004

0.0715

< 0.0001
< 0.0001

Case = presence or absence of bypoadrenocorticism in dog.
Age = dog's age in yr.
Breed = dog's breed.
Sex = dog's sex classified as female-intact, female-spayed, male-intact, or male-castrated.

•• All models were significant at p < 0.0001.
••• Wald chi square with associated degrees of freedom in parentheses.
•••• Lack of fit chi square with associated degrees of freedom in parentheses.
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C3 . Evaluation of Logistic Regression Models for Presence or Absence of Canine
Hypoadrenocorticism Using Age, Breed, Sex, and Body Weight as
Independent Variables: All Two Factor Models with Interactions

Model
•'••

Factor
Wald chi
Factor

square

(dO•••"'

Chance
probability
of Wald chi
square

Case =
0.16(1)
36.92(17)
12.20(17)

(dO

square

418.23
(331)

0.0008

0. 1764

330.96
(215)

< 0.0001

0. 1005

1626. 18
(1312)

< 0.0001

0.0964

< 0.0001
< 0.0001
0.1394

Case =
Age
Body weight
Age*Body
weight

chi square

Chance
probability
of LOF chi

0.6868
0.0035
0.7876

Case =
84.54(1)
26. 10(3)
5.49(3)

Model
LOP•••

59.24(1)
23.89(1)

< 0.0001
< 0.0001

1.38(1)

0.2393
0.1626

None

Case =
71.18(17)
0.07(3)
15.06(49)

< 0.0001
0.9949
1.0000

660.39
(623)

Case =
Breed
Body weight
Breed*Body
weight

20.27(17)
0.27(1)
20.32(17)

0.2604
0.6034
0.2583
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0.1451

0. 1363

Model
• ••
,

Case

Factor
Wald chi
Factor

square

(dt)***"

Chance
probability
of Wald chi
square

=

Model
LOF* ***
chi square
(dt)

Chance
probability
of LOF chi

777.86

0.0005

(652)
Sex
Body weight
Sex*Body
weight

•

33.35(3)

17.97(1)

< 0.0001
< 0.0001

6.40(3)

0.0935

square

R2

0.0744

Case = presence or absence of hypoadrenocorticism in dog.
Age = dog's age in yr.
Breed = dog's breed.
Sex = dog's sex classified as female-intact, female-spayed, male-intact, or male-castrated.

•• All models were significant at p < 0.000 1 .
••• Wald chi square with associated degrees of freedom in parentheses.
**** Lack of fit chi square with associated degrees of freedom in parentheses.
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C4. Evaluation of Logistic Regression Models for Presence or Absence of Canine
Hypoadrenocorticism Using Age, Breed, Sex, and Body Weight as
Independent Variables: All Three Factor Models with No Interactions

Model
• ••
'

Factor

Factor
Wald chi
square

(df)•••"

Chance
probability
of Wald chi
square

Case =
Age
Breed
Sex

100.55(1)
160. 18(17)
46.47(3)

130.48(1)
163.50(17)
64.83(1)

103.33(1)
59.98(3)
69.20(1)

•

**

159.20(17)
87.37(3)
47.75(1)

0. 1918

0.1873

1598.15
(1444)

0.0027

0. 1922

1784.93
(1519)

< 0.000 1

0. 1217

1012. 13
(954)

0.0935

0. 1646

< 0.0001
< 0.0001
< 0.0001

Case =
Breed
Sex
Body weight

587.96
(559)

(df)

< 0.0001
< 0.0001
< 0.0001

Case =
Age
Sex
Body weight

Chance
probability
of LOF chi
square

< 0.0001
< 0.0001
< 0.0001

Case =
Age
Breed
Body weight

Model
LOF****
chi square

< 0.0001
< 0.0001
< 0.000 1

Case = presence or absence of hypoadrenocorticism in dog.
Age = dog's age in yr.
Breed = dog's breed.
Sex = dog's sex classified as female-intact, female-spayed, male-intact, or male-castrated.
All models were significant at p < 0.0001.

••• Wald chi square with associated degrees of freedom in parentheses.
**** Lack of fit chi square with associated degrees of freedom in parentheses.
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CS. Evaluation of Logistic Regression Models for Presence or Absence of Canine
Hypoadrenocorticism Using Age, Breed, Sex, and Body Weight as
Independent Variables: All Three Factor Models with Two-Way Interactions

Model
• ••
'

Case

Factor
Wald chi
Factor

0.07(1)
17.47(17)
0.03(3)
7.76(17)
7.95(3)
13. 75(49)

0.04(1)
6.99(17)
0. 14(1)
14.71(17)
0. 1 1(1)

0.8491
0.9837
0.7076
0.6163
0.7383

17.51(17)

0.4202

=

Age
Sex
Body weight
Age•Sex
Age•Body
weight
Sex•Body
weight

Model
LOF****

chi square

Chance
probability
of LOF chi
square

RZ 180

494.22
(488)

0.4132

0.2270

1542.30
(1409)

0.0072

0.2171

1769.60
(1512)

< 0.000 1

0. 1286

(elf)

0.7940
0.4227
0.9984
0.9715
0.0470
1 .0000

=

Age
Breed
Body weight
Age•Breed
Age•Body
weight
Breed•Body
weight

Case

square

=

Age
Breed
Sex
Age•Breed
Age•Sex
Breed•Sex

Case

square

(elf)***"

Chance
probability
of Wald chi

45.84(1)
1 1 .42(3)
13. 1 1(1)
3.72(3)
1 .51(1)

< 0.000 1

8.76(3)

0.0327

0.0097
0.0003
0.2933
0.2184
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Model
• ••
'

Factor
Wald chi
Factor

square

(dO***"

Chance
probability
of Wald chi
square

Case =
Breed
Sex
Body weight
Breed*Sex
Breed *Body
weight
Sex*Body
weight
*

13.39(17)
3.43(3)
0. 09( 1 )
12.02(49)
15.63(17)

0.7095
0.3303
0.7678
1.0000
0.5502

6.88(3)

0.0758

Model
LOF****
chi square
(dO

Chance
probability
of LOF chi

919.26
(883)

0.1929

square

R2

0.2051

Case = presence or absence of hypoadrenocorticism in dog.
Age = dog's age in yr.
Breed = dog's breed.
Sex = dog's sex classified as female-intact, female-spayed, male-intact, or male-castrated.

*"' All models were significant at p < 0.000 1 .
*** Wald chi square with associated degrees of freedom in parentheses.
**** Lack of fit chi square with associated degrees of freedom in parentheses.
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C6. Evaluation of Logistic Regression Models for Presence or Absence of Canine
Hypoadrenocorticism Using Age, Breed, Sex, and Body Weight as
Independent Variables: All Three Factor Models with Two- and Three-Way
Interactions

Model
• ••
'

Factor
Wald chi
Factor

square

(dl) ***"

Chance
probability
of Wald chi
square

Case =
Age
Breed
Sex
Age*Breed
Age*Sex
Breed*Sex
Age*Breed *Sex

< 0.01(1)
5.42(17)
0.08(3)
18.26(17)
109.85(3)
8.61(49)
107. 15(44)

< 0.01(1)
9.97(17)
<0.01(1)
8.21(17)
0.03(1)

0.9786
0.9049
0.9460
0.9618
0. 8662

9.10(17)

0.9371

1 1. 85(17)

0.8090

Case =
Age
Sex
Body weight
Age�ex
Age*Body
weight
Sex*Body
weight
Age�ex*Body
weight

Chance
probability
of LOF chi

470. 13
(437)

0. 1322

0.2372

1527.87
(1392)

0.0061

0.2235

1768.21
(1509)

< 0.0001

0. 1292

(dl)

square

0.9966
0.9963
0.9946
0.3729
< 0.0001
1.0000
< 0.0001

Case =
Age
Breed
Body weight
Age*Breed
Age•Body
weight
Breed•Body
weight
Age•Breed*
Body weight

Model
LOF****
chi square

37.33(1)
5. 1 1(3)
1 1.31(1)
2.68(3)
1.61(1)

< 0.000 1
0. 1640
0.0008
0.4436
0.2042

0.39(3)

0.9417

1.36(3)

0.7 153
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Model
• ••
'

Case

Factor
Wald chi
Factor

square

=

Breed
Sex
Body weight
Breed*Sex
Breed*Body
weight
Sex*Body
weight
Breed*Sex*
Body weight
*

square

(df)***"

Chance
probability
of Wald chi

7.96(17)
0. 15(3)
< 0.01(1)
17. 19(49)
2260.49
(17)
74. 17(3)
8226.35
(42)

Model
LOF****
chi square

Chance
probability
of LOF chi

895.30
(832)

0.0630

(df)

Rz

< 0.0001
< 0.0001

Case = presence or absence of hypoadrenocorticism in dog.
Age = dog's age in yr.
Breed == dog's breed.
Sex = dog's sex classified as female-intact, female-spayed, male-intact, or male-castrated.

Wald chi square with associated degrees of freedom in parentheses.

**** Lack of fit chi square with associated degrees of freedom in parentheses.
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0.2155

0.9675
0.9857
0.9969
1.0000
< 0.0001

** All models were significant at p < 0.0001.
***

square

C7. Two Logistic Regression Models Fit for Presence or Absence of Canine
Hypoadrenocorticism Using Age, Breed, Sex, and Body Weight as
Independent Variables
Model
•'••

Factor

Factor
Wald chi
square
(dt)***"

Chance
probability
of Wald chi
square

Case =
Age
Age•Age
Breed
Sex
Body weight

82.51(1)
5 1.96(1)
148. 12(17)
40.27(3)
46.06(1)

<
<
<
<
<

Model
LOF*•••
chi square
(dt)

Chance
probability
of LOF chi
square

R2 1so

1612. 14
(1578)

0.2692

0.2418

0.000 1
0.000 1
0.000 1
0.000 1
0.000 1
Estimate

Parameter
estimates:
Intercept
Age
Age*Age
Breeds

Sexes

-5.71413
0.67965
-0.03073
Airedale Terrier
Basset Hound
Bearded Collie
Boxer
Cocker Spaniel
Dalmatian
German Shorthaired Pointer
Great Dane
Lhasa Apso
Pit Bull Terrier
Pomeranian
Poodle
Shetland Sheepdog
Shih Tzu
Springer Spaniel
West Highland White Terrier
Yorkshire Terrier
Other

1 . 37241
2.7223 1
2.26271
-6.86806
0.68076
-7. 15408
1 .72756
3 . 18304
-0.95415
-7. 18512
-0.01 101
2.54412
-0.43610
0.48986
2.62266
3.60843
0.00000
0.93638

Female-intact
Female-spayed
Male-intact
Male-castrated

-0.05424
0.53356
-0.55904
0.00000

Body weight

0.03585
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Model
• ••

Factor

'

Factor
Wald chi
s uare
(d ***"

�

Chance
probability
of Wald chi
square

Case =
Age
AgHAge
Breed
Sex
Body weight
Age•Body
weight
Sex•Body
wei ht

80.25(1)
60. 18(1)
143.08(17)
13.03(3)
25.84(1)
12.85{1)

< 0.0001
< 0.0001
< 0.000 1
0.0046
< 0.0001
0.0003

8.49(3)

0.0370

Model
LOF****
chi s uare
(d

Chance
probability
of LOF chi
square

R2 tso

1590.04
(1574)

0.3833

0.2516

m

Estimate

Parameter
estimates:
Intercept
Age
Age*Age
Breeds

-6.84159
0.88919
-0.03638
Airedale Terrier
Basset Hound
Bearded Collie
Boxer
Cocker Spaniel
Dalmatian
German Shorthaired Pointer
Great Dane
Lhasa A so
Pit Bull errier
Pomeranian
Poodle
Shetland Sheepdog
Shih Tzu
Springer aniel
West Hig and White Terrier
Yorkshire Terrier
Other

1.35685
2.80167
2.29040
-6.80605
0.7351 8
-7.01512
1.87936
2.57387
-0.96808
-7.07281
-0. 1 1475
2.54819
-0.55209
0.47 1 10
2.67659
3.80993
0.00000
0.95373

Female-intact
Female-spayed
Male-intact
Mate-castrated

0.73018
0.32866
-0.64710
0.00000

Body weight
Age•Body weight
Female-intact•Body weight
Female-spayed•Body weight
Male-intact•Bod weight
Male-castrated• ody weight

0.06772
-0.00527
-0.03871
0.01 1 12
0.0063 1
0.00000

�

�

Sexes

�
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*

Case = presence or absence of bypoadrenocorticism in dog.
Age = dog's age in yr.
Bieed = dog's breed.
Sex
dog's sex classified a5 female-intact, female-spayed, male-intact, or male-astrated.
=

** Both models were significant at p < 0.0001 .
*** Wald chi square with associated degrees of freedom in parentheses.
**"'* Lack of fit chi square with associated degrees of freedom in parentheses.
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APPENDIX D
CAUSALITY: A COMPLEX ISSUE

Melissa called her husband George at his office at three o'clock in the
afternoon. Their six-month-old son Jason had a terrible case of diaper rash, and
her last can of medicated diaper powder had become thoroughly soaked and
useless when a pipe above the bathroom medicine cabinet leaked. Would George
stop by the store on the way home and pick up some more powder? George, good
husband and father he, said he would.
George-after a long delay in his usual five o'clock departure because he was
forced to listen as his boss bloviated endlessly about a myriad of hopelessly inane
topics-left his office, got in his car, and drove toward the store. About a mile
before the store, George heard a thumping noise from the right rear of the car.
Recognizing that he had a flat tire, George pulled over, threw open the door, and
stepped out of the car directly into the path of an oncoming truck. George was
killed instantly. Question: What caused George's death?
The issue of causality is a complex one which philosophers and scientists
have been struggling with for centuries. Epidemiologists are often inclined to
quickly and, as it turns out, facilely dismiss the issue as simple and self-evident.
For example, asked the question posed in Chapter 5 whether age, breed, sex, and
body weight cause canine hypoadrenocorticism, many epidemiologists would
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condescendingly respond assertively in the negative. Age, breed, sex, and body
weight may be associated with canine hypoadrenocorticism, they would say, but
to speak of causation would be naive. This appendix demonstrates that, while these
epidemiologists may or may not be correct, questions of causality are definitely not
answered simply. Put by another:
. . . it is apparent that some of the main philosophical problems of causation
do not yield to any easy solution. The idea of a necessary connection
between cause and effect may be, as Hume thought, an esoteric and
metaphysical one, but it is doubtful whether anyone can render an adequate
analysis of the causal relation without it [Italics added].221
The author will, risking nihilism, assert that, given the present state of human
knowledge and understanding, assertions that such and such is or is not the cause
of something else are virtually always naive. This will be based on the premise
that such assertions are usually at variance with human understanding of the
physical universe.
This discussion of causality in epidemiology must be preceded by the
disclaimer that it does not pretend to be comprehensive, and its author

acknowledges up-front that he is a rookie philosopher of the rawest sort.
Nevertheless, as appropriate in an interdisciplinary endeavor like the Comparative
and Experimental Medicine Program, the author attempts in his probably
hopelessly puerile way to, in the spirit of the first Ph.D. granted in " General" by
The University of Tennessee in 1886 (see Preface), grapple with this thorny issue.
His purpose is not to settle the issue of what is and what is not a cause, but to
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establish that the issue is a complex one not given to flip, pat pronouncements.
The fact that a well-known and respected epidemiologist has seen fit to devote an
entire section in his epidemiology text to causation, 165 and to edit another entire
book on the subject,l69 testifies to the issue's complexity. Indeed, he says, "We
know from Hume, Popper, and others that causal inference is at best tentative and
is still a subjective process. " 1 70 In addition, his book on causation says the
following about whether or not the epidemiologist, as a scientist, is

obliged to

consider the philosophic complexity of this issue:
Thus it is in good conscience that one may recommend to the empirical
scientist to stand back occasionally and engage in philosophical reflection
upon the ultimate nature and significance of his enterprise. He should find
it worthwhile to study philosophical literature, for it contains matters of
substance that may provide insight and intellectual satisfaction. tas
Finally, if Aristotle, David Hume, John Stuart Mill , Immanuel Kant, Isaac
Newton, and Bertrand Russell cannot sort out the causality issue, only an act of
incredible hubris would lay claim to having done so. The author makes no such
claim.
Western culture and thought about the physical universe have gone through
three major eras: Aristotle's rationalism, Locke's and Newton's empiricism and
determinism, and Planck's and Einstein's quantum and relativity theory. Each of
these eras was characterized by a different view of

cause (and, of course, some

individuals in each of these eras naively asserted the absolute 11rightness" of these
different views).
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Aristotle, whose thought about causes prevailed until the Renaissance,
defined four kinds of causes, 18•n and, most important, he felt that rational thought
rather than empiricism was the most reliable method for obtaining truth. The
doctrine of rationalism held that "scientific knowledge accumulated through reason
and intuition rather than by empirical observation. " 1 64 Indeed, Aristotle's ontology
suggested that reason was "far more real and trustworthy . . . than the fleeting and
undependable experience of the senses. " 204 Aristotle, for example, might well have
asserted the superiority of his rationally-reasoned belief that a large rock falls
faster than a small one even, had the results been available to him, in the face of
Galileo's empirical experiment.204 In other words, rational thought was supreme.
A corollary of rationalism was the preeminence of mathematics as the "highest
form of knowledge. " 1 64
John Locke rejected Aristotelian rationalism in favor of empiricism. He
claimed that the human mind was a tabula rasa (blank tablet) at birth and that
experience dictated knowledge.205 Locke's philosophic position led naturally to the
empiricism and determinism of the scientific method and the new physics of Isaac
Newton. Rationalism and reason were not entirely rejected, of course, but they
were accepted only within the "well-defined activities of calculation and logic. "205
Put more succinctly:
With Newton, the world was not only thought of as a machine, but was
exhibited in detail as a function of mechanical laws-a system of the world.
All matters of celestial and terrestrial mechanics, scattered and disconnected
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in Kepler, Copernicus, Huygens, Halley, Wren, Hook, and Galileo, were
unified into a grand system of mathematical-mechanical laws [Italics
added] . IID,B4
According to this view, the world was a giant machine, the components of which,
having already been set in motion, would interact in wholly predictable ways in
accordance with the "laws" of physics. Newton's universal law of gravity and his
laws of thermodynamics exemplified these laws, and science has, since the time
of Newton, been largely engaged in finding and refining these laws-all the while,
of course, assuming that such laws existed, and that they could be systematically
described, principally using mathematics. 00 This belief in definable physical laws
has been described as follows:
Nonetheless, the notion arose in the eighteenth century that " all sufficiently
smooth Newtonian systems were exactly and meaningfully solvable. In
consequence, one no longer spoke of unsolvable systems, only those not yet
solved [Italics added] . " 56
In other words, everything can be explained by the new physics, and, if something
appears not to be explainable, it is not because there is no mechanistic explanation,
the mechanism simply has not yet been discovered and defined.PP (This, arguably,
IIDJt is a paradox that, while rejecting Aristotelian rationalism, Newtonian
physics heavily emphasized mathematics, a discipline which, as mentioned above,
was, according to the rationalists, the "highest form of knowledge. "220
00Newton, in fact, had to specifically develop differential calculus in order to
explain this new physics.
PPJ'his view of the universe led naturally to the deistic theologic assertion by
the French philosophes (and Thomas Jefferson) that the universe was like a giant
clock which had been wound up by God, and then abandoned by Him to tick on
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could be described as the ultimate in human hubris: the assertion that the human
mind was capable of comprehending

everything which goes on in the universe.)

This worldview largely underpins late twentieth-century science, and, within the
scientific community at least, remains, rightly or wrongly, largely unchallenged.
The late nineteenth- and early twentieth-century thought of men like Max Planck
and Albert Einstein challenged some of the tenets of this worldview.
What will be called here " modern physics" (emphatically recognizing that
Newtonian physics is

very much alive today in all sorts of real-world applications)

includes quantum mechanics which began with Max Planck's quantum theory in

1900,248 relativity theory which began with Albert Einstein's special theory of
relativity in 1905,248 and chaos theory which began with men like Mitchell
Feigenbaum in the 1970s.qq·63 Each of these (quantum mechanics, relativity, and

in perpetuity. This view, mirrored to some extent by the fatalism of Calvinism, led
inevitably (and sadly) to a determinism which denied human volition.
This view similarly led to much of the conflict over the centuries between the
religious and scientific communities-dating from the house arrest of Galileo in the
seventeenth century, including the Scopes " monkey trial'' in Dayton, Tennessee in
1925, and (amazingly!) also including the current debate in the Tennessee
legislature (this is written on 7 March 1996) about the teaching of evolution in
schools.
q"The author acknowledges here that the lumping together of quantum theory,
relativity, and chaos into "modern physics" is wholly arbitrary and is done for two
reasons: convenience, and the author's nearly overwhelming ignorance of these
fields . The author recognizes that these are three different kinds of physics as
explained in the following: "The most passionate advocates of the new science
[chaos theory] go so far as to say that twentieth-century science will be
remembered for just three things: relativity, quantum mechanics, and chaos.
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chaos) challenges the Newtonian mechanistic view of the universe. An example of
each challenge follows.
Newtonian physics says that, given the position and momentum of an object
moving in space, it is simple to compute the position and momentum of the object
at a future time. Quantum mechanics, on the other hand, has demonstrated that
sub-atomic particles do not behave in this way. Not only can the future position
and momentum of a sub-atomic particle not be predicted from its present position
and momentum, it is

impossible to accurately measure both the present position

and momentum of the sub-atomic particle in the first place. The particle's position

or its momentum can be accurately measured, but not both. This is Heisenberg's
uncertainty principle, and it has been empirically verified by many experiments.
Since both the particle's position and momentum cannot be determined, quantum
mechanics, in contrast to Newtonian physics, cannot predict specifically where the
particle will be at some future instant, but

can

predict the

probability that the

particle will be at a particular position with a particular momentum.249 This
illustrates one of the essential differences between the Newtonian and quantum
mechanical worldviews: the Newtonian world is

precisely predictable--always

Chaos, they contend, has become the century's third great revolution in the
physical sciences. Like the first two revolutions, chaos cuts away at the tenets of
Newton's physics . As one physicist put it: 'Relativity eliminated the Newtonian
illusion of absolute space and time; quantum theory eliminated the Newtonian
dream of a controllable measurement process; and chaos eliminates the Laplacian
fantasy of deterministic predictability. ' "64
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measurable and certain; the quantum mechanical world is probabilistically
predictable--often immeasurable and uncertain. So the Newtonian worldview is
rr

imperfect.
Relativity also challenges Newtonian physics. Indeed, Einstein's "proof' that
light is composed of photons (recognizing that no theory of physics has
satisfactorily explained the wave-particle duality of light), coupled with Thomas
Young's double-slit experiment conducted in the early nineteenth century, leads
to the strong, but very unsettling, possibility that light has consciousness.250
Indeed, to quote from a book on physics: "We have little ·choice but to
acknowledge that photons, which are energy, do appear toprocess information and

to act accordingly [Italics added] . "25 1 Ironically, Einstein himself would probably
have totally rejected this possibility. He is quoted as saying:
. . . I should not want to be forced into abandoning strict causality without
defending it more strongly than I have so far. I find the idea quite intolerable
that an electron exposed to radiation should choose of its own free will, not
only its moment to jump off, but also its direction. In that case, I would
rather be a cobbler, or even an employee in a gaming house, than a physicist
[Italics in original] . 38
Nevertheless, photons of light and electrons may be conscious.
Relativity, as is well-known (tritely so, perhaps), says that time itself is
relative; e.g. , a cigarette smoked by an astronaut moving through space bums

rrone philosopher tries to reconcile this conflict between precise and
probabilistic predictability. 240
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longer (literally!) than a cigarette smoked by an earthbound astronaut.252 This
relativity of time has been empirically verified by flying atomic clocks around the
world.".2S3 The strange nature of relativity can be described as follows:
The physical theories of Einstein, and the variants developed by others,
which have each been called the "theory of relativity" are so named because
they have relativized some of the attributes and relations (spatial distance,
time interval, mass) which the Newtonian theory had asserted to be invariant
(absolute). 67
Finally, chaos theory has been defined as "the qualitative study of unstable
aperiodic behavior in deterministic nonlinear dynamical systems. "90 It is
schizophrenic in that it at once confirms that chaotic systems11 are in principle
predictable, but that they are, due to "sensitive dependence on initial conditions, "
almost wholly unpredictable as a practical matter. 88 In other words, specifying
initial conditions is well nigh impossible, and the ability to compute results does
not exist even if the initial conditions were known. For example, what does
watching two bits of foam floating side by side at the bottom of a waterfall tell
about where they were at the top? "Nothing. As far as standard physics [is]

"It is an interesting conundrum that, although belief in things like "conscious
photons" and "relative time" seems intuitively based more in faith and spirituality
than in science, the "proof' of these beliefs still, to be satisfying, must rest on
empirical evidence. This may be a measure of just how powerfully the Newtonian
way of thinking has been hammered into our twentieth-century brains.
nwhich "can appear in the context of exceedingly simple and entirely
Newtonian equations of motion " 88 ; i.e. , chaotic systems are easily and everywhere
to be found.
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concerned, God might just as well have taken all those water molecules under the
table and shuffled them personally. "65 This leads to the humbling paradox that the
universe is at the same time deterministic, but not deterministic in the sense of a
Newtonian timepiece. This has been better said:
The curious nature of chaotic unpredictability also raises questions about
scientific determinism. These systems with sensitive dependence on initial
conditions produce random or chancy behavior, the opposite of what we
would expect from a picture of the universe as strictly determined clockwork.
Yet chaos theorists consistently describe their models as "deterministic." . .
. Not only does chaos theory suggest that predictability should be considered
separately from determinism, but in conjunction with quantum-mechanical
considerations it raises serious doubts about the viability of the doctrine of
determinism in the context of modem physics [Italics added]. uu,s9
This alludes to the conundrum of " causation without determinism," a seemingly
oxymoronic phrase which philosophers have, in light of modem physics, recently
been grappling with. 146 It may also allude to problems sometimes introduced into
philosophic arguments "as a consequence of customary linguistic usage. "220 In
other words, there is a point at which these arguments become moot because they
depend on the limited ability of humans to communicate with words. At that point,
and it is impossible to determine precisely where that point is, further argument
becomes meaningless.

uuln

other words, "predictability .. and 11determinism" are separate ideas. What?
(The author confesses that he is now at or beyond the edge of his intellectual
capability.)
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Finally, contemporary scientific training emphasizes an epistemology which
at best ignores and at worst is openly hostile to the apparently disorderly conduct
of chaotic nonlinear systems. In other words, though we live in a decidedly
nonlinear world (as defined by Aristotle or Newton or Einstein), the contemporary
training of and practice by scientists tries to force the world to be linear. This bias
against the nonlinear has been succinctly described:
. . . the professional training of scientists . . . diverted attention away from
areas where chaos might have been discovered and studied. By training
students to disregard apparently disordered behavior, to focus attention on
linear models, and to seek simple exact solutions, scientific education
screened off chaos . . . . Education in the natural sciences created the
impression that linear and solvable systems were the only ones (or at least
the only important ones)-an impression that came very close to being a
prejudice in favor of systems as regular and predictable as clockwork. . . .
Professional instruction rendered chaos less visible in two ways: on the one
hand, students were indirectly steered away from nonlinear systems (the only
systems in which chaos is possible) by being taught that they were
uninteresting or exceptional cases. On the other hand, when apparently
bizarre or even chaotic behavior was found in these nonlinear systems, it was
dismissed as mere noise or experimental error . . 91
.

In other words, scientists are taught to shun results which they cannot understand
in favor of those which fit their (often preconceived) idea of how the world
to work. wntis is a very

ought

unscientific attitude!

VVJiow many times have you heard a scientist say, "The experiment did not
work"? Amazing! According to Newtonian thought, which shapes most
contemporary scientific thought, experiments always work; i.e. , the molecules
always do what they are supposed to. The problem is human understanding, not
molecular incompetence.
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So, what does all this have to do with the question of whether or not age,
breed, sex, and body weight cause canine hypoadrenocorticism? The answer is,
recognizing the possibly just accusation of nihilism, unknown and unknowable
given contemporary human understanding of how the world works.

ww

How can

causality be conclusively determined if the physical world is as yet ill-defined? It
cannot. Assertions to the contrary are naive and symptomatic of contemporary
hubris among scientists.
So, back to Melissa and George: What caused George's death? The answer
is unknown and unknowable. On the macro-, non-scientific level, one could argue
that the causes were the plumbing problem at George's house; the baby Jason's
diaper rash; Melissa's call to George; George's delay leaving work while his boss
blathered on; the manufacturer of George's tires; the person who dropped the
object on the road which punctured George's tire; George's carelessness in getting
out of his car; and so on. On the micro-, scientific level, one could argue that the

causes were being hit by a truck (the forensic pathologist's view); the sudden
collapse of the cranium with its incumbent near-instantaneous cessation of all
ordered neural activity in the brain (the neuropathologist's view); a failure to

4
WW'fhe question could, trivially , be answered yes.4•19• 100• 12 1 • 124• 137• 1 5•166• 167 (Each
of these nine references--with specific page numbers cited--is a work of either
philosophy or epidemiology in which the definition of causality leads to the answer
yes. The author recognizes that other references could be found in which the
definition of causality leads to the answer no.)
28 1

breathe

accompanied by

sudden,

irrevocable cardiovascular collapse

(the

cardiologist's view); the necrosis of tissues and cells due to massive hemorrhage
and near-complete interruption of blood supply (the histopathologist's view); the
necrosis of tissues and cells due to profound alterations in their cellular milieu
(oxygen tension, pH, electrolyte concentrations, etc.) (the biochemist's view); and
so on.xx Therefore, the question of causality remains puzzling in even seemingly
simple situations.
So, what is the point? It is that the epidemiologist should
the post hoc

neither fall prey to

ergo propter hoc fallacy nor be too quick to cavalierly dismiss factors

associated with diseases as

surely not causally related. The epidemiologist should,

recognizing just how complex the causality issue is, avoid both errors-in most
cases by recognizing that what

causes something is usually unknown and

unknowable.
Finally, a spiritual, mystical element has crept into this discussion. This was
deliberate, and while some scientists dismiss appeals to the supernatural as
primitive superstition, some of the world's best scientific thinkers do not. So, lest
the author's thoughts about science generally and causality specifically-and their
possible relationship to the spiritual--be casually dismissed, the reader is referred
to the words of Stephen Hawking, a mathematician and physicist who has (unlike

:antis reasoning parallels almost exactly that used in a well-known textbook
of epidemiology. 99
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the author) thoroughly understood Aristotelian rationalism, Newtonian physics, and
modern physics; who has in fact filled the same professor's position at Cambridge
University once filled by Isaac Newton; and who has been described175 as a
"legend " and a "worthy successor" of Newton by Carl Sagan:
However, if we do discover a complete theory [of the universe] it should in
time be understandable in broad principle by everyone, not just a few
scientists. Then we shall all, philosophers, scientists, and just ordinary
people, be able to take part in the discussion of the question of why it is that
we and the universe exist. If we find the answer to that, it would be the
ultimate triumph of human reason--for then we would know the mind of
God.74
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